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Abstract
Atrial fibrillation (AF) is the most common abnormal heart rhythm, affecting 1% of
people worldwide, and is predicted to double in incidence within the next two to
three decades. During AF multiple excitation wavefronts are observed to propag-
ate continuously in atrial muscle tissue (myocardium) in an apparently disorganised
manner. Ablating atrial myocardium extensively and empirically via catheter elec-
trodes may cure AF in some cases. However, an inability to identify the specific re-
gions critical to the persistence of AF has resulted in failure to improve on disappoint-
ing clinical outcomes.
Another clinical challenge is to understand patient variability in AF and AF pro-
gression. It is commonly thought that AF-induced tissue remodelling and age-related
increases in fibrosis supports the notion that AF inexorably becomes worse. How-
ever, a recent body of clinical observations now questions how large this effect is in
humans and lacks a mechanistic explanation.
In this thesis, we propose that both of these clinical challenges can be addressed
by better understanding the relationship between the microstructure of myocardium
and the dynamics of cardiac excitation waves. We investigated this relationship us-
ing a simple mathematical model which integrates phenomenological cardiac dynam-
ics with a structure that mimics the anisotropic, branching, cable-like structure of
myocardium.
As we reduced the transversal connectivity of myocardium below a threshold
value, mimicking the effects of fibrosis, the creation of micro-re-entrant circuits resul-
ted in the sudden onset of AF in the model. AF in the model was driven by periods of
perpetual birth and death of these micro-re-entrant circuits. We showed that this pro-
cess is determined by the presence of specific local configurations of connectivity and
dysfunctional cells, so-called critical regions, and the collisions between wavefronts
and wavetails. The simple model reproduced many clinically observed features of
AF. These included: the spontaneous onset and self-termination of AF episodes of
variable duration, the observation that ablation of critical regions could sometimes
terminate AF, and variability in AF behaviour and AF progression. Our studies of
this model generate novel hypotheses regarding the mechanisms of AF and its pro-
gression, and could inform future ablation strategies.
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Chapter 1
Introduction
This thesis primarily addresses atrial fibrillation: the most common abnormal heart
rhythm affecting 35 million people worldwide. Atrial fibrillation is a poorly under-
stood arrhythmia where multiple excitation wavefronts are observed to propagate
continuously in atrial muscle tissue in an apparently disorganised manner. The re-
lationship between the microstructure of heart muscle tissue and the dynamics of
excitation wavefronts may provide a key mechanism for the initiation and mainten-
ance of atrial fibrillation. We explore the relationship between the microstructure of
heart muscle tissue and wavefront dynamics using a simple mathematical model.
Thus we begin this chapter by describing the structure and function of the heart.
We then review the mechanisms of atrial fibrillation and recent developments in this
field. In particular, we focus on studies connecting atrial fibrillation and tissue struc-
ture. After this, we discuss a complex systems view of the heart and how this guides
the approach to mathematical modelling used in this thesis. We provide a broad re-
view of different models of cardiac wavefront dynamics; in particular we explore
cellular automaton models in depth.
A shorter segment of this thesis addresses the prediction of fainting on head-up
tilt table tests. Head-up tilt table tests are used to diagnose a cause of fainting known
as vasovagal syncope. The ability to predict the outcome of a head-up tilt table test
early during a procedure could reduce both the duration of the test and consequently
the stress on the patient. We try to predict the outcome of the head-up tilt table test us-
ing a comparative signals processing engine and machine learning on a large clinical
data set. We provide a brief overview of vasovagal syncope and head-up tilt testing
towards the end of this chapter. Lastly, we outline the full structure of this thesis.
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1.1 The Heart
1.1.1 Structure and function
The primary function of the heart is to pump blood through the circulatory system
to deliver oxygen and remove waste products to and from cells within the body [5].
To perform this task, a plethora of electrical, biochemical and mechanical processes
occur in a well coordinated manner at a range of scales from the sub-cellular to organ
level [6]. The interdependence of structure and function at each scale and between
scales result in a multitude of pathways for various pathologies to emerge [6]. It is
therefore useful to study the heart from a multi-scale perspective. Thus, in this section
we present a short summary of the physiological processes of the heart from organ to
cell.
The human heart is composed of two segments, right and left, which act as pumps
operating in series. Each segment is further divided into two chambers: an upper
chamber known as the atrium and a lower chamber known as the ventricle, see Fig.
1.1. Periodic coordinated contractions between the two segments result in blood cir-
culating around the body.
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Figure 1.1: Blood flow around the chambers of the heart. The right segment first receives de-oxygenated
blood from the body into the right atrium through the inferior vena cava. The blood is then forced into
the right ventricle through the tricuspid valve where it is ejected from the heart into the lungs through
the pulmonary valve to be oxygenated. The left segment receives oxygenated blood from the lungs into
the left atrium through the pulmonary veins. The blood is then forced into the left ventricle through
the mitral valve where it is ejected from the heart into the body through the aorta where it becomes
de-oxygenated. Reproduced from [7] under a CC-BY 3.0 license.
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1.1.2 Electrical conduction system of the heart
The myocardium contracts in response to an electrical stimulus, the cellular mechan-
isms of which are discussed in Sec. 1.1.3.1. This stimulus is said to electrically ac-
tivate or excite the myocardium. Local electrical excitation triggers further excitation
in neighbouring myocardial tissue. This results in a wave of excitation propagating
through the myocardium and specialised conduction pathways. The propagation of
an electrical wavefront across the heart results in a smooth coordinated contraction
between all chambers.
In a normal heart, the sino-atrial (SA) node self-excites and propagates a wave of
excitation throughout the atrium and into the ventricles through specialised conduc-
tion pathways (see Fig. 1.2). An arrhythmia is when this sequence of excitation is in
some way disturbed.
Figure 1.2: A diagram of the cardiac electrophysiological system. The two atria are electrically coupled
by excitable tissue, as are the two ventricles. However, the atria and ventricles are electrically isolated by
a septum of non-excitable tissue and are only coupled at a junction known as the atrio-ventricular (AV)
node. A group of pacemaker cells, known as the sino-atrial (SA) node, is located in the right atrium. The
SA node self-excites periodically and propagate waves of electrical excitation throughout the atria to the
AV node. The excitation then travels from the AV node through a specialised network of cable-like cells,
the Bundle of His and the Purkinje fibre network, and is then propagated throughout the ventricles. This
regular pattern of activity is known as sinus rhythm. Reproduced with permission from [8].
The electrical activity of the heart can be inferred from electrodes placed on the
body surface; the resultant signal is called an electrocardiogram (ECG), see Fig. 1.3
a. Normal sinus rhythm and cardiac arrhythmias, such as atrial fibrillation, have
characteristic ECG waveforms, see Fig. 1.3 b.
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Figure 1.3: An electrocardiogram (ECG) in sinus rhythm and atrial fibrillation. a, A schematic of the
ECG. The P-wave is due to atrial depolarisation, the QRS complex is due to ventricular depolarisation,
and the T-wave is due to ventricular repolarisation. Modified from [9] under a CC-BY 3.0 license. b,
During AF the atrial myocardium is being rapidly and irregularly depolarised and repolarised, this
results in a lack of well a defined P-wave (pink arrow) compared to sinus rhythm (purple arrow). The
irregular atrial activity causes the ventricles to be depolarised at irregular intervals, as can be seen in the
AF ECG by the presence of varying intervals between R waves (RR intervals). Reproduced from [10]
under a CC-BY 3.0 license.
1.1.3 Cellular electrophysiology
1.1.3.1 Action potential
Cardiac cells have an electric potential difference across the cell membrane known as
the membrane potential. The membrane potential is the result of a difference in the
concentration of ions inside and outside of the cell. Ions can pass through different
types of pore-forming membrane proteins in the cell membrane known as ion chan-
nels, pumps and exchangers. Ion channels that are classified by the nature of their
gating, for example, voltage-gated ion channels open and close in response to the
magnitude of the membrane potential. Ion pumps actively regulate the membrane
potential by transporting specific ions into or out of the cell using energy in the form
of ATP. Ion exchangers use energy stored in the concentration difference of a particu-
lar type of ion across the cell membrane to transport another type of ion into or out of
the cell.
The electrical excitation of a cell is called an action potential: a threshold-triggered
transient event in which the membrane potential rises (depolarises) and falls (repol-
arises) as a result of the opening and closing of ion channels, as well as the action of
ion pumps and exchangers. The membrane potential of a cardiac cell not undergoing
an action potential is known as the resting potential and is between -90 mV and -70
mV [11]. The ionic mechanisms which result in the action potential are described in
Fig. 1.4.
During the action potential there is a period of time in which the cell cannot be re-
excited, this is called the absolute refractory period (ARP). There is a short period of
time after the ARP whilst the cell is repolarising in which a sufficiently strong stimulus
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Figure 1.4: An illustration of an action potential for a a heart muscle cell, myocyte, and b a SA nodal
cell. a, The action potential is described by five phases. Phase 0) If the membrane potential is increased
to a threshold value, caused perhaps by an influx of ions from neighbouring cells, fast sodium channels
open leading to a large influx of Na+ ions depolarising the cells from -90 mV to +20 mV. This time-
scale is typically around 0.6 ms. Phase 1) Initial repolarisation occurs because sodium channels close
and potassium channels open which result in the efflux of K+ ions. Phase 2) A plateau phase occurs
due to an influx of Ca2+ ions into the cytosol of the cell which balances the efflux of K+ ions resulting
in a steady membrane potential. Phase 3) The cell fully repolarises as a result of the calcium channels
closing and more potassium channels opening which lead to a greater efflux of K+ ions. Phase 4) The
membrane potential returns to its resting value at which it remains in the absence of external stimuli.
The period of time over which the cell is unexcitable is known as the refractory period, 200 ms here. b,
Pacemaker action potentials have no true resting membrane potential, instead a slow background influx
of ions known as “funny currents” depolarise the membrane until the threshold potential is reached and
another action potential is ignited [5]. It is during the action potential that calcium ions enter the cell and
activate pathways which result in the cell contracting [5]. Modified from [12] and [13] under a CC-BY
3.0 license.
could illicit an additional action potential, this is called the relative refractory period.
The action potential duration (APD) is the time between depolarisation and the end
of repolarisation.
Electrically excitable cells can be divided into two general types: 1) pacemaker
cells such as the SA and AV nodal cells which can self-excite and 2) non-pacemaker
cells such as the atrial myocytes which excite in response to ionic currents generated
by neighbouring excited cells. The contractile atrial tissue is composed of atrial myo-
cytes and is therefore a passive medium which is driven by the SA node.
The action potential causes the myocyte to contract via excitation-contraction coup-
ling. Within a myocyte, calcium is stored within a large compartment known as the
sarcoplasmic reticulum. Calcium channels, known as ryanodine receptors, exist all
over the membrane of the sarcoplasmic reticulum. When calcium binds to ryanodine
receptors the channel opens allowing calcium to be released from the sarcoplasmic re-
ticulum into the cytosol of the cell. This then leads to the opening of more ryanodine
receptors, hence this process is called calcium induced calcium release. The released
Ca2+ ions bind with the protein troponin, altering its position and shape, this allows
the proteins actin and myosin to bind together. This results in the shortening of the
muscle fibres.
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1.1.3.2 Restitution
The time between the end of a previous action potential and the start of a new action
potential is known as the diastolic interval. The action potential duration (APD) and
conduction velocity (CV) is a function of the diastolic interval, this property is known
as APD and CV restitution [14]. In atrial myocardium the APD and CV is proportional
to the diastolic interval [15]. Thus rapidly excited myocardium will have a shorter
APD and a slower CV.
1.1.3.3 After-depolarisation
An additional depolarisation that occurs later during an action potential, for example
during phase 2 or 3, is known as an after-depolarisation. If the after-depolarisation is
sufficiently strong it can trigger an additional action potential. After-depolarisations
can occur due to a spontaneous calcium spark. A calcium spark is where a local group
of ryanodine receptor opens, perhaps due to a local fluctuation increasing Ca2+ ion
concentration, releasing a small amount of Ca2+ into the cytosol. The release of a
small amount of Ca2+ ions into the cytosol can depolarise the cell, however, usu-
ally not to threshold. A calcium wave is where a wave of calcium induced calcium
release propagates across the sarcoplasmic reticulum as a result of a caclium burst.
Capogrossi et al. [16] observed that it is possible for a spontaneous calcium spark to
initiate a wave of calcium release across the entire cell, this large efflux of calcium into
the cytosol of the cell can depolarise the cell sufficiently to initiate an action potential.
A calcium spark does not always create a calcium wave.
After-depolarisations which occur during phase 2 or 3 are called early after depol-
arisations (EADs), those which occur during phase 3 or 4 when the action potential is
nearly depolarised are called delayed after-depolarisations (DADs), see Fig. 1.5.
DADs occur in conditions producing excess intracellular Ca2+ concentration such
as: β-adrenergic stimulation, ischaemia, low extracellular K+ concentration, and ta-
chycardia [17, 18]. The excess Ca2+ is extruded from them cell through an ion chan-
nel known as the sodium-calcium exchanger. The sodium-calcium exchanger brings
in three Na+ from the extracellular space in exchange for removing one Ca2+, thus
producing a net inward current which depolarises the cell.
EADs can also occur in the presence of excess intracellular Ca2+. During β-adrenergic
stimulation spontaneous calcium release from the sarcoplasmic reticulum to the cytosol
can occur [19]. This further increases intracellular Ca2+ concentrations and can induce
an inward current through the sodium-calcium exchanger discussed above. Other
mechansims of EADs exist [20, 21].
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Figure 1.5: An illustration of delayed after-depolarisations (DADs) and early after-depolarisations
(EADs). If the EAD or DAD is not sufficiently large then we only observe a small change to the usual
action potential (AP). If the EAD or DAD is sufficiently large it can trigger additional action potentials.
Figure adapted with permission from [11].
1.1.4 Architecture of the myocardium
The myocardium consists of discrete cardiac muscle cells, myocytes, which are packed
in brick-wall like pattern and are electrically coupled by channels known as gap junc-
tions. Gap junctions are primarily located at the cell ends and facilitate the diffusion
of ions between the interiors of coupled cells (see Fig. 1.6 a). Healthy myocardium
can be thought of as an anisotropic, branching cable-like structure which is a function-
ally continuous medium; this is because gap junctions act as low resistance pathways
for ions to flow between cells. Cardiac myocytes are nearly cylindrical and are thus
structurally anisotropic. The myocardium is therefore structurally and functionally
anisotropic (see Fig. 1.6 b), that is, action potentials propagate fastest along the long
axis of the cell.
Heterogeneous changes in structure and function in the myocardium are associ-
ated with atrial fibrillation [11]. Two important changes in structure are fibrosis and
gap junctional uncoupling. These are discussed in detail in Sec. 1.3.
1.1.5 Emergent and functional behaviour of myocardium
We now summarise the functional and emergent behaviour of myocardium discussed
so far and introduce new functional behaviours which provide intuition regarding
how cardiac waves propagate in the myocardium.
Excitability: Cells undergoing an action potential will efflux ions into adjacent
cells, thus depolarising them. Once a cell has been depolarised to a threshold an
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a b
Figure 1.6: A cardiac myocyte and a section of myocardium. a, A cardiac myocyte with clusters of gap
junctions revealed to be primarily at the cell ends using immunoconfocal microscopy. Modified with
permission from [22]. b, A photomicrograph of a section of atrial goat myocardium using azan staining
illustrating that cells are arranged in a brick wall like pattern. Modified with permission from [23].
action potential will ensue. This results in the propagation of a wave of depolarisation
followed by a wave of repolarisation across the myocardium. This process can be
thought of as a cell becoming excited when a threshold is met due to a local interaction.
Refractoriness: The period during an action potential when a cell cannot re-excite
is known as the absolute refractory period. During this period the cell is unexcitable.
But, during phase 3 of the action potential a cell may re-excite if a larger than normal
stimulus is applied to the cell, this period is known as the relative refractory period.
Restitution: The APD and CV is proportional to the diastolic interval. So rapidly
excited myocardium, short diastolic interval, will have shorter APD and a slower CV.
An excited, or depolarised, cell can be thought of as a source of current and an
unexcited, or repolarised, cell can be thought of as a sink for current. Properties of
conduction, such as conduction velocity and conduction block, are related to the bal-
ance between the local amount of current source and to how much current sink it is
attached. We now describe functional behaviours of myocardium which occur due to
the relationship between conduction and source-sink phenomena.
Source-sink mismatch: We consider a cell to be excited during the initial phase
of an action potential. Ions which entered a cell during the action potential electro-
chemically diffuse to neighbouring resting cells. Thus an excited cell can be thought
of as a current source and a resting cell can be thought of as a current sink. The suc-
cessful propagation of an action potential depends on the balance between current
source and sink. Specifically, for a cell to depolarise it must receive more current than
it passively dissipates. If an excited cell is coupled to too many unexcited cells there
is not enough current to depolarise the recipient cells to threshold, so an action poten-
tial does not propagate. This phenomena is known as source-sink mismatch [24, 25]
and plays an important role in considering the effects of heterogeneity in cell-to-cell
connectivity.
Liminal length: Consider a continuous 1-D myocardial fiber. An injected current
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will locally depolarise a region of the fiber, however, the current dissipates across
the inside of the fiber, this is known as an electrotonic current. This dissipation acts
against raising the local region of the fiber to threshold. Thus the injected current
must be strong enough to depolarise the fiber to threshold whilst also ensuring that it
overcomes the repolarising effect of electrotonic current flow to neighbouring regions
of fiber. This introduces a new length scale at which a large enough region of fiber
must be directly stimulated, independent of stimulus strength and duration, to gen-
erate a propagating action potential. This minimum length is called the liminal length
and in cardiac fibers is on the order of 1 mm [26, 27, 28]. There is also a corresponding
liminal area and volume, however, this depends on the coupling between cells and
the threshold of excitation. Thus liminal scales are model dependent.
Curvature-dependent conduction velocity: A convex wavefront of excited cells
abut a greater number of resting cells than does a concave wavefront, as a result con-
vex wavefronts travel more slowly than concave wavefronts [29], see Fig. 1.7. This
is another manifestation of the source-sink phenomena: it takes more time to transfer
the same amount of current when there is less source and more sink.
v = vp v < vp v > vp 
Planar Convex Concave
Figure 1.7: Conduction velocity in well coupled tissue is dependent on wavefront curvature. Convex
wavefronts are slower than concave wavefronts as a result of source-sink effects.
1.2 Atrial Fibrillation
1.2.1 What is atrial fibrillation?
Atrial fibrillation is the most common abnormal heart rhythm [30, 31]. It affects ap-
proximately 1% of the total population and is predicted to double within the next two
to three decades [30, 32]. AF at the organ scale is observed as a period of rapid and
irregular electrical activation of the atria. During AF the atria mechanically quiver
and do not contract in coordination. This causes inefficient transport of blood around
the body. The lack of coordinated contraction also results in pooling of blood in the
atria, which increases the risk of stroke [33].
Clinically, AF is classified by its temporal duration into three forms: (1) paroxysmal,
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in which an episode can last seconds to days but self terminates within seven days; (2)
persistent, in which the episode is longer than seven days and does not self-terminate
and (3) permanent, in which medical treatment is not possible, not wanted by the pa-
tient or has been unsuccessful [34]. The seven day cut-off is arbitrary and the nature
of AF episodes is likely to vary, but the above classification scheme is convenient in
broadly classifying and managing the arrhythmia. Observational studies show that
AF tends to occur as paroxysmal episodes. With time, typically over decades, these
episodes get longer until persistent AF develops [35, 36]. However, some patients
never progress from paroxysmal to persistent AF, others develop persistent AF as the
first episode, and some even remit from persistent to paroxysmal AF [37, 38].
Currently, the two most common treatments strategies for AF are: anti-arrhythmic
drug therapy and catheter ablation therapy [30]. Anti-arrhythmic drug therapy at-
tempts to either restore and maintain sinus rhythm, or control heart rate to ensure the
ventricles are not rapidly activated. Catheter ablation therapy involves destroying
localised regions of myocardium which may contribute to initiation or maintenance
of AF. The motivations for and limitations of these therapies are better understood in
the context of AF mechanisms. Thus, we introduce the mechanisms of AF first and
discuss the details of treatment strategies afterwards.
1.2.2 Mechanisms
In this section we provide an overview of the diverse mechanisms thought to under-
lay AF. AF is due to the initiation and propagation of abnormal electrical wave activity
where multiple activation wavefronts are observed to propagate continuously in the
atrial muscle tissue in an apparently random manner. Thus understanding the follow-
ing points has been the object of much research [11]: (1) which processes can initiate
abnormal patterns of activation; (2) how can abnormal wave activity be maintained,
and (3) which properties of the myocardium increase or decrease the propensity for
initiation and maintenance of abnormal electrical activity. Less research has focused
specifically on the factors relating to the spontaneous termination of AF.
We will describe how the abnormal electrical activity associated with AF can be
driven and maintained by so-called “hierarchical” and “anarchical” mechanisms [11].
As we discuss each mechanism which maintains AF we will also outline the processes
which may initiate and terminate them.
1.2.2.1 Hierarchical mechanisms of AF
“Hierarchical” mechanisms are where AF is maintained by a single local source of
excitation outside the SA node which drives the surrounding atrial tissue at high
frequencies. High frequency activity can create heterogeneous regions of refractory
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tissue and slow conduction, this results in irregular wave propagation through the
atria. Removing the localised source would thus terminate AF. We extend the concept
of “hierarchical” mechanisms to include multiple localised sources, because AF can
also be terminated in this case by removing the localised sources.
Haissagure et al. [39] showed that the pulmonary veins contain localised sources
and by electrically isolating the atria from the pulmonary veins paroxysmal AF could
be terminated. We return to this point in Sec. 1.4.
We categorise “hierarchical” mechanisms into two: 1) cellular pro-arrhythmic mech-
anisms and 2) re-entrant mechanisms.
Cellular pro-arrhythmic mechanisms
Cellular pro-arrhythmic mechanisms are mechanisms whereby abnormal processes
at the cellular and sub-cellular level results in abnormal action potential generation
and propagation. Cellular pro-arrhythmic mechanisms for AF can be split into two:
1) abnormal automaticity and 2) triggered activity.
Abnormal automaticity: Automaticity is the property of a cardiac cell to spontan-
eously depolarise and generate an action potential. Abnormal automaticity refers to
the process of cells which do not normally self-excite (e.g., purkinje cells, myocytes)
acquiring automaticity. This can occur when cells become oxygen deprived due to a
reduced bloody supply to the myocardium, for example, in ischaemic heart disease
or after a myocardial infarction [40]. Whilst the cells are oxygen deprived the resting
membrane potential of the cell is reduced from -90mV to -50mV, which contributes to
the ability of these cells to change their action potential behaviour to be more pace-
maker like.
Triggered activity: Triggered activity is the generation of abnormal action po-
tentials which are triggered by a preceding normal action potential. Additional de-
polarisations, called after-depolarisations, are required to generate these abnormal
action potentials, as discussed in Sec. 1.1.3.3. To summarise, after-depolarisations
occur in conditions which produce excess intracellular Ca2+ concentration such as: β-
adrenergic stimulation, ischaemia, low extracellular K+ concentration, and tachycar-
dia [17, 18, 19]. The excess intracellular calcium can cause calcium sparks and calcium
waves. Calcium sparks can further increase the intracellular calcium concentration.
A high intracellular calcium concentration activates the sodium-calcium exchanger to
remove excess calcium from the cell, but this produces a net inward current which
can depolarise the cell to threshold. Calcium waves themselves can also depolarise a
cell sufficiently to induce an abnormal action potential [16].
Cellular pro-arrhythmic mechanisms mechanisms need to overcome source-sink
mismatch to be able to propagate action potentials rather than just initiating action po-
tentials in affected cells. Xie et al. [41] showed in a simulation study that up to 800,000
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contiguous well coupled myocytes in 3-D tissue would be required to undergo EADs
or DADs to provide enough current source for an acton potential to propagate. How-
ever, they also showed that this number is significantly decreased by reduced gap-
junction conductance and fibrosis, an important point in the context of the theme of
this thesis. This is the first point in this review where we highlight the importance
of tissue structure in arrhythmia. The importance of tissue structure in arrhythmia is
much more prominent in re-entrant mechanisms, which we will now discuss.
Re-entrant mechanisms
Re-entrant mechanisms refer to any mechanism where an excitation wavefront travels
in a self-sustaining circuit or loop, often called a re-entrant circuit. Whilst the excit-
ation wavefront travels repeatedly in a circuit, an excitation wavefront is emanated
into the surrounding tissue. We now describe the generic conditions and properties
of re-entrant mechanisms before providing an overview of specific examples.
The spatial extent of an excitation wavefront and its wake of refractory cells is
given by the wavelength, λ, defined by
λ = CV ×RP, (1.1)
where CV is the conduction velocity and RP is the refractory period. If the path-
length of the circuit is shorter than the wavelength then a re-entrant circuit cannot
form as the excitation wavefront would collide with its refractory wake. If the path-
length of the circuit is greater than the wavelength then there is a temporal excitable gap
and spatial excitable gap. A temporal excitable gap is the time that a cell in the circuit
is at rest between excitations. A spatial excitable gap referring is the distance between
the wavefront and its refractory wake, see Fig 1.8a. We now discuss different types of
re-entry.
Anatomical re-entry: This is where the re-entrant circuit occurs around an ana-
tomical obstacle such as scar tissue, fibrosis or even larger structures such as the
pulmonary veins, see Fig 1.8a. The size of the anatomical obstacle, the conduction
velocity and the refractory period primarily determine the behaviour of this form of
re-entry. Due to this size dependence we will distinguish macro-re-entrant circuits
from micro-re-entrant circuits. Macro-re-entrant circuits are determined by larger
obstacles, such as the pulmonary veins and large patches of scar tissue. Micro-re-
entrant circuits can occur around much smaller obstacles, such as strands of fibrosis.
In both cases, this form of re-entry can be terminated by ablating a portion of the
circuit.
Leading circle re-entry: This is where the re-entrant circuit occurs around a func-
tional obstacle. Depolarising currents from the re-entrant circuit continuously depol-
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Figure 1.8: Re-entrant mechanisms.a, Re-entry around an anatomical block. The spatial excitable gap is
the amount of tissue that is excitable between the excited wavefront and tail. b, Re-entry around a func-
tional block, that is, refractory tissue. The tissue at the center is continually depolarised by the re-entrant
wavefront and is therefore unexcitable. The size of this circuit is determined by the refractory period
and the conduction velocity. The circuit tends to minimise the excitable gap. c, A spiral wave. Conduc-
tion velocity is inversely proportional to the curvature of the wavefront. Conduction fails at the centre
of the spiral where the curvature is high. As a result the wavefront rotates around an excitable region of
tissue.d, Multiple wavelets, this is an “anarchical” mechanism of AF. Reproduced with permission from
[11].
arise the core rendering the core unexcitable, see Fig. 1.8b.
Spiral waves: Spiral waves, also known as rotors, are a form of re-entry with
an excitable yet unexcited core, see Fig. 1.8c. This occurs as a result of curvature
dependent conduction velocity, which in turn occurs as a result of the source-sink
phenomena described in Sec. 1.1.5. At the centre of the spiral wave the curvature is
high enough that the conduction velocity becomes zero and therefore excitation does
not penetrate into the core. Recently, spiral waves have received significant attention
after Narayan et al. [42] claimed to observe stable spiral waves in humans and that
it was possible to treat AF by ablating these spiral waves. However, there is much
debate as to whether Narayan et al. [42] have actually observed spiral waves as the
electrical activity was mapped with a low density array of electrodes [43].
Re-entrant mechanisms can be initiated by different forms of uni-directional block:
this is where a wavefront is able to propagate in one direction, but not the other. This
can come about through heterogeneity in structure (e.g., scar and fibrosis) and func-
tion (e.g., refractory period and conduction velocity), see Fig. 1.9. Spiral waves can
be initiated through a well-timed extra stimulus just behind the refractory wake; the
extra stimulus cannot propagate into the refractory wake but can in all other direc-
tions, hence this is effectively another form of uni-directional block, see Fig. 1.9. The
extra-stimulus may occur as a result of triggered activity or abnormal automaticity.
In general, re-entrant mechanisms can be terminated by interrupting the circuit.
This can be done by ablation or by pacing the tissue. However, questions remain
as to whether ablations would in fact create larger obstacles around which re-entry
occur rather than terminating the circuit. Spiral waves can meander and are thought
to terminate by drifting into boundaries of unexcitable tissue, which can be created
through ablation [44, 45].
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Figure 1.9: Illustration of the methods of initiation of re-entrant arrhythmias. a, a computer simulation
showing the initiation of a pair of spiral waves (white crosses). A stimulus, S1, initiates a planar wave.
A well timed extra focal stimulus, S2, is applied such that the wavefront is blocked in the direction of
the wave but can propagate radially in all other directions. This creates a wave break in the S2 induced
wavefront and allows the formation of two spiral waves. b, A plot of the intensity of the S2 stimulus
delivered at a time interval after the S1 stimulus. The S2 stimulus fails to generate an excitation below
the strength interval curve (solid red line). Above this curve, S2 only induces spiral waves within the
vulnerable window and a single focal wave outside of the window. c, An illustration of the initiation of
anatomical re-entry by a uni-directional block. In this case, a region with an increased refractory period
(brown tissue) is required to initiate re-entry.
1.2.2.2 Anarchical Mechanisms of AF
“Anarchical” mechanisms are where AF is maintained in the absence of a localised
source and therefore cannot be clinically treated in the same way as “hierarchical”
mechanism. Only one mechanism of this sort has been observed: multiple wavelets.
Multiple wavelets: This is where multiple wavefronts of excitation known as
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wavelets meander throughout the tissue and are self-sustained if enough excitable
tissue presents itself to the path of the wavelet [46], see Fig 1.8d. Maintenance of AF
in this scenario can be compared to a forest-fire like process where excitable tissue
acts like a “fuel” to keep the “fire” going, or a branching process where wavelets split
to give “birth” to daughter wavelets and can “die” by colliding with refractory tissue.
The multiple wavelet hypothesis was original proposed by Moe et al. [46] where in
a computer model it was shown that functional, as opposed to structural, heterogen-
eity was necessary to create multiple wavelets. The Cox Maze procedure to terminate
AF was developed on this hypothesis [47] where the atrium is segmented into small
connected regions which are thought to be too small to support wavelets.
1.2.3 Discussion
There are many mechanisms of AF which can initiate, maintain and terminate AF.
Clinical observations as of yet are unable to make strong distinctions as to which
mechanism is driving AF in any given patient. As we have seen, the best method
of AF treatment depends upon which mechanism is driving AF. We will now dis-
cuss how the microstructure of myocardium promotes some of the mechanisms listed
above.
1.3 Role of Structure
In this section we will discuss how changes in microstructure, in particular gap junc-
tional re-modelling and fibrosis, alter conduction characteristics to promote AF.
1.3.1 Fibrosis
Fibrosis is the accumulation of collagen within the myocardium created by cells known
as fibroblasts. Fibrosis most commonly occurs as a reparative process to replace de-
generating functional myocardial tissue [48, 49]. Fibrosis is strongly associated with
AF [50] and both increase with age [51]. We now discuss how fibrosis changes the
myocardium to promote arrhythmia.
Fibrosis occurs as different textures [52, 53], see Fig. 1.10, which can change
the structure of myocardium in different ways, this in turn can promote arrhythmia
through a number of mechanisms. The presence of fibrosis disrupts electrical coup-
ling between myocytes or groups of myocytes, it also alters conduction characteristics
of myocytes in fibrotic regions due to source-sink effects.
Large patches of fibrosis, see Fig. 1.10 b, act as large anatomical obstacle for re-
entry. In the case of interstitial fibrosis the coupling between cells is reduced and
the tissue no longer behaves as a functional continuum. This results in much more
38 1. INTRODUCTION
a b c d
Figure 1.10: Types of fibrosis (red) in myocardial (yellow) slices from light microscopy images, tissue
is stained with piscorius red [53]. a, Interstitial fibrosis comprises the extracellular matrix separating
strands of myocytes. b, Compact fibrosis consists of areas of dense collagen deprived of any myocardial
tissue. c, Diffuse fibrosis involves areas where myocardial and collagen fibers intermingle; collagen
fibers consist of short stretches. d, Patchy fibrosis consists of a mixture of myocardial and collagen
bundles; collagen fibers are long. Scale bars are 1 mm. Reproduced with permission from [52].
a
b
Figure 1.11: a, Schematic of an area of fibrosis consisting of myocardial and fibrotic tissue where activa-
tion follows a zig-zag path. This tortuous path results in an effective conduction delay of the electrical
impulse, however, longitudinal conduction is actually enhanced. b, Electrograms recorded from such
regions show fractionation because of the asynchronous excitation in the different tracts of tissue. Re-
produced with permission from [52].
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stochastic conduction in these fibrotic regions as a result of source-sink mismatch [54].
This can result in a uni-direction block and as a consequence cause a micro re-entrant
circuit around thin strands of interstitial fibrosis [54]. Indeed, it has recently been
shown in goats that thin long strands of fibrosis which interrupt coupling between
single strands of myocytes is associated with AF [55].
Fibrosis tends to uncouple cells in an anistropic fashion [56], so that transversal
coupling is impaired. It has also been shown that anisotropy in conduction velocities
in these regions are enhanced. As the wavefronts travel through patches of fibrosis,
so called zig-zag like conduction occurs, see Fig. 1.11. In this case, overall conduction
velocity through fibrotic regions are reduced, despite the fact that conduction through
groups of myocytes sandwiched by fibrosis enhances longitudinal conduction.
A small necropsy study of 13 human hearts from permanent AF patients [57] did
not find a positive correlation between various micro-structural heterogeneities due to
fibrosis and AF. Such heterogeneities include myocardial disconnections, abrupt turns
and crossings. Thus, although fibrosis is known to alter conduction characteristics,
the precise interactions between the properties of fibrosis (e.g., geometry, texture),
and wavefront dynamics which might promote AF are not understood.
1.3.2 Gap junctional uncoupling
Gap junctions are intercellular channels that provide low-resistance pathways for ions
to travel between myocytes, thus facilitating the propagation of action potentials. In
healthy conditions there are more gap-junctions end-to-end than side-to-side, see Fig.
1.6 a, thus contributing to anisotropic conduction. In AF, the gap-junctions lateralise,
that is, the spatial distribution changes such that a greater proportion of gap junc-
tions appear on the side-to-side of the cell [58]. An electrophysiological study in rats,
with a similar re-distribution of gap junctions as humans after sustained rapid pa-
cing, showed that the re-distribution of gap junctions reduced conduction velocity
anisotropy by slightly enhancing transversal conduction velocity [58].
Peters and Wit [59] suggested that on a microscopic scale gap-junctional redistri-
bution allows for the anisotropy of conduction to vary non-uniformly across tissue,
thereby increasing heterogeneity in conduction, and create regions which block con-
duction [60] which promotes re-entry. Furthermore, as conduction between cells is
determined by cell size, geometry, packing and connectivity between cells [59] it is
unclear how a redistribution of gap junctions may manifest on the smaller-than-tissue
scale of cell-to-cell conduction. In the presence of fibrosis, where myocytes are much
less coupled, the distribution of gap-junctions may play a much greater role in de-
termining the stochastic propagation of action potentials. As a result of source-sink
mismatch, gap junctions may be important in creating situational blocks of action
potential propagation.
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1.3.3 Discussion
Reduced coupling from fibrosis and gap-junction redistribution modulate wavefront
propagation and can induce re-entry. Fibrosis is associated with AF, however, pre-
cisely how fibrosis promotes AF is unknown. In the next section, Sec. 1.4, we find that
patients with similar amount of fibrosis can have very different temporal patterns of
AF. Further illustrating that the relationship between fibrosis and AF is potentially
more complex. Gap-junction redistribution in addition to fibrosis could create a com-
plex substrate for altered conduction and conduction block due to source-sink effects.
However, the precise mechanisms of how gap-junction redistribution and fibrosis in-
teract to drive AF is unknown. As we discuss AF therapies in the next section we find
that the inability to identify particular regions which drive AF has resulted in poorer
clinical success rates. Understanding how areas of reduced coupling contribute to
AF initiation, maintenance and termination is therefore directly related to therapeutic
strategies. Thus, in this thesis we will focus on how the microstructure affects wave-
front dynamics. But first, we will discuss the limitations of current AF therapies and
then summarise clinical unknowns related to the microstructure of myocardium.
1.4 Atrial Fibrillation Treatment and Clinical Challenges
In this section we will further motivate the study of myocardial structure in under-
standing atrial fibrillation. We will do this by providing an overview and discussion
of the limitations of modern AF treatment strategies: anti-arrhythmic drug therapy
and catheter ablation therapy. We also discuss new challenges posed by recent clin-
ical observations of patient variability. We will argue that AF treatment could be
enhanced and patient variability understood by a study of the relationship between
myocardial structure and wavefront dynamics.
1.4.1 Anti-arrhythmic drug therapy
Anti-arrhythmic drug therapy is used to either control the rate of ventricular activa-
tion or control the rhythm, that is, restore and maintain normal sinus rhythm. The ef-
ficacy of these two strategies on mortality and morbidity has been shown to be similar
[61]. Restoring and maintaining normal sinus rhythm of AF patients is accomplished
by pharmaceutical agents which modify cardiac ion channel behaviour [62]. Thus,
these pharmaceutical agents change action potential and conduction properties. For
example Type 1 anti-arrhythmic drugs modify sodium channels, this allows the action
potential duration, excitability and rate of depolarisation to be increased or decreased.
We note that changing the rate of depolarisation will change the conduction velocity.
Type 3 anti-arrhythmic drugs modify potassium channels, this allows for the rate of
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repolarisation to be decreased thereby increasing the refractory period.
Depending on the mechanism of AF, changing tissue properties may promote AF
termination. For example, increasing the refractory period will increase the wavelength
of a re-entrant circuit such that the wavefront collides with it’s refractory wake and
thereby terminate the circuit. However, AF could be exacerbated by such agents also,
for example, an increased refractory period would promote wavefront collisions with
refractory tissue, if the refractory tissue is heterogeneously distributed this is known
to promote AF.
The success rate of anti-arrhythmic drug therapy for AF is 52%, where success is
defined as lack of AF recurrence on follow-up [63]. A number of reasons may contrib-
ute to this low success rate. Anti-arrhythmic drugs act on the entire myocardium and
do not target specific regions of myocardium which may be responsible for the ar-
rhythmia. Anti-arrhythmic drugs do not take into account the specific mechanism of
AF in a given patient, in some cases anti-arrhythmic drugs can promote arrhythmia.
Patients who did not improve on anti-arrhythmic drugs are often referred for abla-
tion where success rates are higher. This suggests that targeting specific regions of
myocardium in treating AF is important, and consequently the underlying structure
of tissue in those regions are important in maintaining AF.
1.4.2 Catheter ablation therapy
Catheter ablation therapy is the controlled localised destruction of myocardium using
radio-frequency energy delivered by a catheter electrode, see Fig. 1.12 a. Thin catheter
electrodes are passed from the blood vessels around the groin or wrist into the heart.
The electrode is then used to deliver a radio-frequency current which causes resistive
heating of the tissue, this results in localised cell death. Overall, the success rate of
catheter ablation therapy after a single procedure is 57%, after multiple procedures is
71% and after multiple procedures with anti-arrhythmic drugs is 77% [63]. However,
the results depend on the type of AF.
Catheter ablation therapy was initially used as a treatment for paroxysmal AF
when localised sources of activity were found to occur within the pulmonary veins
[39]. Pulmonary vein isolation, whereby the pulmonary veins are electrically isol-
ated from the rest of the atria by ablation, can achieve a success rate of approximately
80% depending on the treatment centre and meta-analysis [64, 65]. However, not
all drivers of AF have been located in the pulmonary veins [66], hence, paroxysmal
AF may not always be successfully treated with pulmonary vein isolation. Pulmon-
ary vein isolation has not been as successful in treating persistent AF with success
rates of 40% for a single procedure which could be increased to 60% with use of anti-
arrhythmic drugs [67, 68].
For persistent AF other target sites for ablation have been sought. The catheter
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electrode also records the local electrical activity of the myocardium, the subsequent
signal is known as an electrogram (see Fig. 1.12b). The electrogram provides a meas-
ure of local electrical function inferred from the complexity and amplitude of the sig-
nal. Architectural changes of local regions of myocardium, principally fibrotic scar
[69, 70] can also be inferred from the electrogram. Multiple electrograms collected
from an array of electrodes, such as a basket catheter, are able to re-construct a coarse
grained map of the electrical activity over the atrium.
Figure 1.12: a, An irrigation tip ablation catheter, the white arrow points to a metal ring electrode.
Reproduced with permission from [71]. b, Electrograms. A single wavefront of excitation appears as a
‘single potential’, that is, a waveform with a positive deflection followed rapidly by a negative deflection
on the unipolar electrogram. Recordings in which the waveform appears fragmented or ‘fractionated’
are associated with regions of fibrosis, slow conduction and wavefront collision [69, 70]. Modified with
permission from [69].
Complex fractionated atrial electrogram (CFAE) ablation was developed to tar-
get other atrial sites which might initiate or maintain AF [72]. Sites were considered
targets for ablation if the electrogram at that site was fractionated, this is where the
electrogram contains multiple deflections, see Fig. 1.12b. A CFAE site was thought to
correlate with features that would generate local sources of AF, however, it has been
show that CFAE ablation in addition to pulmonary vein isolation does not improve
single procedure success rates in persistent AF [73].
Recently, spiral waves have become new targets for persistent AF. Narayan et al.
[74] first claimed to have observed and terminated stable spiral waves in humans; the
study used a low density basket catheter to create a coarse-grained map of electrical
activation in the atria. This was called focal impulse and rotor modulation (FIRM)
ablation. Following this study, initial multi-center studies suggest that ablation of
spiral waves can achieve success, defined by freedom from AF on follow-up, rates of
80% in a single procedure for persistent AF. However, larger controlled studies are
required before the efficacy of FIRM ablation can be established. Due to the limited
resolution offered by low-density mapping catheters there has been much debate as to
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whether these are actually spiral waves [43], this is in part due to speculation of how
ablation could terminate a spiral wave as opposed to produce an anatomical obstacle
around which a re-entrant circuit would form. Rappel et al. [75] have run computer
simulations to propose hypothetical mechanisms of how ablation could terminate a
spiral wave, for example, ablation in regions with a spatial gradient of excitability was
found to cause spiral waves to meander freely into non-excitable obstacles. In addi-
tion, how these spiral waves or re-entrant circuits are initiated, why they are stable,
and why they pin to the regions they do is not understood. A greater understanding
of how the structure of myocardium can affect and maintain re-entrant mechanisms
needs to be understood.
A better understanding of the mechanisms of AF and their relation to myocar-
dial structure could improve on the clinical success rates. In particular, the effects of
myocardial microstructure on the dynamics of wavefronts may provide immediate
insight into sites which should and should not be considered a target for ablation.
1.4.3 Patient variability
Recent counter-consensus clinical observations regarding how AF progresses could
be explained by a better understanding of how myocardial microstructure affects AF.
Currently it is thought that AF typically begins as short paroxysmal episodes which
increase in duration with time until AF is persistent [11, 76]. This is thought to oc-
cur for the following reasons: (1) Fibrosis increases with age [77, 78] and is strongly
associated with AF [37, 50], however, whether this occurs to a significant degree in
humans is still debatable [50]; (2) AF-induced functional remodelling [79, 80] and (3)
AF-induced structural remodelling [81, 50].
AF-induced remodelling is where the functional and structural properties of tissue
change in response to fibrillatory activity, usually in such a way to promote further
AF. For example, after a period sustained AF or rapid pacing the refractory period
is shortened and rate adaptation of the refractory period is impaired due to changes
in ion channel currents [79, 80]. This originally coined the term “AF begets AF” in
a study where AF-induced functional remodelling was demonstrated in goats which
were rapidly paced for as short as 24 hours [79]. AF-induced structural remodelling
has been shown to occur in animals models after longer periods of AF; this includes
gap-junctional remodelling [82, 83], however, whether it includes fibrosis is still de-
bated [84]. In humans, AF and fibrosis are highly correlated [50, 37]. Whether struc-
tural remodelling occurs in humans as a result of AF is still limited [80, 81, 50, 85].
Thus, whilst assumed to explain current observations of AF progression, the degree
to which AF actually begets AF in humans is unknown.
It is commonly thought that AF-induced remodelling and age-related increases in
fibrosis supports the notion that AF inexorably becomes worse [11]; paroxysmal AF
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will always progress to persistent AF and that fibrosis is an important factor in driving
this progression. However, a recent body of clinical observations now questions how
large this effect is in humans.
In contrast to previous population studies, Sugihara et al. [86] monitored AF pa-
tients continuously in a long term study (1031 cumulative patient-years, mean 3.2
years per patient) using dual chamber permanent pacemakers. Paroxysmal AF did
not always progress to persistent AF in this study, that is, some patients remained
paroxysmal for the duration of the long term follow-up and some patients even had
progressive reduction in AF episode duration. Some patients do not progress from
paroxysmal to persistent after as many as 22 years [37]. Veasey et al. [38] also used
continuous monitoring data to show that after a mean 7 year follow up, 35 % of pa-
tients that were initially classified as persistent AF using current clinical guidelines
were re-classified as paroxysmal AF. The average fibrosis burden increases with the
severity of AF [37]. Despite this, it has been shown that the time course of AF is seen
to vary significantly between patients with similar fibrosis burden: some patients pro-
gress rapidly from paroxysmal AF to persistent AF (on the order of months) whilst
other patients do not progress at all (measured over decades) [37]. Furthermore, pa-
tients with a high fibrosis burden can remain paroxysmal and those with low fibrosis
burden can be in persistent AF [37, 87, 88, 89].
These studies challenge the current view of how AF progresses. Although it has
been suggested that different pathological processes (diabetes, mitral valve disease
etc.) occurring in different patients may contribute to variability in AF progression
[90], there is no understanding of what causes the aforementioned clinical observa-
tions. To resolve these conflicting observations of AF progression and variability we
need a better understanding of how changes in myocardial structure affect wave-front
dynamics which determine the temporal patterns of AF.
1.4.4 Discussion
Curative therapies for AF are limited with single-procedure success rates as low as
40%. AF therapies are currently limited by a lack of mechanistic understanding in
what initiates and maintains AF. A greater understanding of how myocardial mi-
crostructure disturbs wavefronts to initiate and maintain fibrillatory activity may
identify novel sites for ablation to treat persistent AF.
AF progression is highly variable between and within individuals. Long stand-
ing views regarding AF progression and fibrosis need to be reconciled with recent
observations of patient variability. Once again, a greater understanding of myocar-
dial microstructure affects wavefront dynamics, in particular over a long timescale, is
required to address this apparent conflict in the literature.
To summarise, the mechanisms of AF in humans are not well understood. Abla-
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tion therapy has been limited by an inability to identifiy critical sites. How and why
AF progresses in time is not well understood. The microstructure of myocardium is
essential to both these clinical problems. Thus understanding how the microstructure
of myocardium affects wavefront dynamics is an important research problem. Thus
the majority of the work within this thesis attempts to address how uncoupling within
myocardial microstructure, for example by gap-junctional lateralisation and fibrosis,
affects the dynamics of electrical wavefronts.
1.5 The Heart as a Complex System
In this section we outline the approach we will take into investigating the relationship
between the structure of myocardium and wavefront dynamics in AF. Broadly speak-
ing, we take a complex systems approach. A complex system is a system consisting
of many interacting parts which exhibit some of the following characteristics: feed-
back, non-linearity, emergent phenomena, hierarchical organisation, spontaneous or-
der and phase transitions. The behaviour of a complex system in general cannot be
reduced by a purely reductionistic analysis of its constituent parts. This is because the
atomic components of the system (e.g., atoms, neurons, individual birds in a flock) in-
teract to give rise to phenomena at larger temporal and spatial scales, these phenom-
ena in turn can create meso-scale structures (e.g., vortices in superconductors, neural
networks, flocking in birds). These larger meso-scale structures can interact to give
rise to phenomena at yet larger temporal and spatial scales (e.g., superconducting
phase transitions, conciousness, predator-avoiding behaviour in flocks). In addition,
some complex systems can also have top-down feedback, for example, macroscopic
patterns of brain activity change the connectivity between neurons [91].
Complex systems are difficult to study as a result of the large number of con-
stituent components and their interactions; hierarchy of phenomena; feedback and
non-linearity. In particular, it is difficult to know how changing the system at any
level will influence the behaviour of the entire system. Mathematical and computer
modelling have become essential tools in studying complex systems. For example,
networks and graph theory have become prolific in studying cities [92], transmission
of infectious diseases [93] and social media [94]. Cellular automata have been used
to study excitable systems such as cardiac tissue [95, 96], chemical reactions [97] and
forest fires [98]. Agent based models have been used to study flocking behaviour in
animals [99], the immune system [100] and socio-economic behaviour [101]. The com-
monality in the approach to studying complex systems is simplicity. That is, to model
the most relevant constituent component of a system and the interactions between
them in a simplified but faithful manner, then to observe how the system behaves.
Simple models of complex systems are preferred because if a model has many para-
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meters it becomes as difficult to study and control as the actual complex system itself.
In addition, simplicity is also related to robustness – simpler models are less prone to
human error in implementation and are often easier to interpret.
The heart and the phenomena of cardiac arrhythmia can be viewed as a complex
system, as could any organ in principle. Let us solely consider the electrophysiolo-
gical properties of the heart. The expression and properties of ion channels are de-
termined at the genetic level, this determines the electrophysiology of the cell. At
the sub-cellular level, mitochondria and the sarcoplasmic reticulum govern calcium
cycling and energy management which modulate the action potential. At the level
of the cell, the distribution of gap junctions, cell size and action potential modulates
conduction. At the level of tissue, the arrangement and packing of cells as well as the
presence of fibrosis can modulate conduction. Re-entrant circuits and spiral waves are
an emergent macroscopic phenomena occurring at a much larger spatial and temporal
scale to which the cell operates. The rapid activity caused by re-entrant wavefronts re-
models the microscopic functional properties of tissue such as how ion channels are
expressed. Fibrillatory activity may also remodel the microscopic structural proper-
ties of tissue by redistributing gap junctions and potentially promotes fibrosis, which
in turn promotes the macroscopic fibrillatory activity.
In this thesis we have taken a complex systems approach where we have used a
simple model to investigate the relationship between myocardial microstructure and
wavefront behaviour, and how this gives rise to AF.
1.6 Mathematical Modelling of Cardiac Conduction
In this section we provide an overview of mathematical models of cardiac conduc-
tion. Mathematical modelling of the heart covers a wide range of methods which
encompass different levels of biological complexity [102, 103]. These different levels
of complexity span the modelling of single cells; 1-D cables of myocytes; 2-D sheets of
tissue; 2-D atrial surfaces of tissue taken from MRI images of the heart; 3-D volumes of
tissue taken from MRI images of the heart and even the inclusion of mechanical con-
traction. We restrict our review here to models of action potential propagation, that
is, cardiac wavefront dynamics and its relationship to the structure of myocardium.
Computer models of action potential generation and propagation have increas-
ingly been used to compliment experimental cardiac electrophysiology. This is be-
cause such models allow a quantitative description of action potential propagation
and can be used to test and generate hypotheses which are difficult to address exper-
imentally.
Models of cardiac conduction involve the propagation of action potentials in a net-
work or continuum of cells. In general, there are two categories of models of cardiac
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electrophysiology: biophysical and phenomenological.
Biophysical models incorporate the physiological processes directly, thus they
take into account cell membrane kinetics such as ion channel, exchangers and pumps;
intracellular calcium handling; and the diffusion of ions across membranes [103].
Some biophysical models also try to incorporate structural characteristics directly
such as the anatomy, coarse-grained scar or fibrotic tissue, and fiber direction using
MRI imaging or histology [104]. Biophysical models typically solve multiple coupled
differential equations, potentially on a complex spatial domain. As a result biophys-
ical models tend to be computationally cumbersome and require advanced differen-
tial equation solvers.
Phenomenological models incorporate the generic properties of cardiac tissue dir-
ectly. These properties always include: excitability, propagation and refractoriness,
but can also include other properties such as restitution and source-sink phenom-
ena. Phenomenological models sacrifice biophysical detail for faster computation and
clearer insights which may not be extracted from more complex models. For example,
using a large number of simulations to extract statistical or ensemble properties of
tissue [95, 96], analytic calculations on the behaviour of spiral waves [105, 106] and
phase-like transitions [95]. We note that approaches from both methods can be integ-
rated, for example, Siregar et al. [107] used a phenomenological model of propagation
on an anatomical model of a heart extracted using MRI.
We provide a summary of model types by how such models treat space, time and
state variables in Table 1.1. We will provide a more detailed review of phenomenolo-
gical models, but first we provide a brief overview of the mathematical basis of most
biophysical models.
Model Type Space Time State
Partial Differential Equations Continuous Continuous Continuous
Coupled Ordinary Differential Equations Discrete Continuous Continuous
Coupled Map Lattices Discrete Discrete Continuous
Cellular Automata Discrete Discrete Discrete
Table 1.1: Summary of model types.
1.6.1 A brief introduction to biophysical models
As this thesis is primarily concerned with a phenomenological model, we only provide
a brief overview of the basis of biophysical models. A more detailed review of such
models can be found in [104, 102]. At the cellular level, the mathematical modelling
of cardiac electrophysiology is largely derived from the work of Hodgkin and Hux-
ley, who created a model of neurons in 1952. The model describes the time-evolution
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of the transmembrane voltage, Vm, and different ionic currents through several non-
linearly coupled ordinary differential equations. The cell membrane can be thought
of as a capacitor with ion channels acting as resistors for current to flow across the
membrane. The time-evolution of the transmembrane voltage for a given cell is given
by:
dVm
dt
= −(Iion + Istim)
Cm
, (1.2a)
Iion =
∑
x
Ix, (1.2b)
where Iion is the sum of the individual ionic currents Ix through each ion channel,
pump and exchanger across the membrane. Istim is an externally applied stimulus
current and Cm is the membrane capacitance. The individual ionic currents are given
by Ohm’s law:
Ix = gx
∏
i
γi(Vm − VNernst,x), (1.3a)
dγi
dt
= αγi(1− γi)− βγiγi, (1.3b)
where gx is the maximal conductance of the ion channel x, γi represent gating vari-
ables, subscripted i, which describe the probability that a channel is open, VNernst,x is
the Nernst potential of the ion of type x which is the potential at which the concentra-
tion of ion x is in equilibrium across a membrane, αγi and βγi are voltage dependent
rate-constants governing the opening and closing rates of gates within ion channels.
The set-up and solution of these equations are shown in [108]. These equations consti-
tute a biophysical cell model and can be designed so that action potentials are elicited
when the transmembrane voltage reaches a threshold value.
These cell models can be coupled to a spatial domain in which currents can move
in space. One of the most common spatial models treats the myocardium as two spa-
tially continuous domains: intracellular space and extracellular space. This is known
as the bidomain model which describes current flow and the distribution of electrical
potential using the conservation of charge and current [109]. The model is based on
two Poisson equations which are derived from Maxwell’s equations and Ohm’s law:
∇ · (σi∇Φi) = βIm − Isi, (1.4a)
∇ · (σe∇Φe) = −βIm − Ise, (1.4b)
where i and e refers to the intracellular and extracellular space respectively, σ is the
conductivity tensor, Φ is the electric potential between a point and an infinitely far
reference point, β is the surface-to-volume ratio of a cell, Im is the transmembrane
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current density and Is is the externally applied stimulus current density. The trans-
membrane current density can be written as
Im = Cm
dVm
dt
+ Iion. (1.5)
If we assume that the anisotropy of the intracellular and extracellular space are the
same, that is, that the conductivity in the extracellular space is proportional to the
intracellular space the bidomain model can be simplified into the monodomain model
described by an effective conductivity tensor σ:
∇ · (σ∇Vm) = β(CmdVm
dt
− Iion). (1.6)
The monodomain model represents current flows through the intracellular space only.
1.6.2 Previous model studies of structural heterogeneity in AF
In this section we review recent studies using biophysical and phenomenological
models to understand how fibrosis and other structural changes effect AF.
In studies using the monodomain or bidomain model, fibrosis is normally im-
plemented as a local region with altered conduction velocity, anisotropy and action
potential characteristics [104]. For example, Kreuger et al. [110] extracted regions
of fibrosis from late gadolinium enhanced (LGE) MRI from a single paroxysmal AF
patient and used a monodomain model, where these regions were given slower con-
duction velocities and greater anisotropy ratios. Kreuger et al. [110] initiated a rotor
by providing a well-timed extra stimulus after a sinus rhythm beat, they found that
the presence of fibrosis modelled in this manner resulted in stable a rotor, whereas
without fibrosis the rotor was unstable.
Zahid et al. [111] also used LGE MRI to extract regions of fibrosis from twenty per-
sistent AF patients and used a monodomain model. In the model these regions were
also assigned slower conduction velocities and greater anisotropy ratios, but they
changed the action potential characteristics as well by changing ion channel prop-
erties to mimic the action potential found in fibrotic myocardium. Zahid et al. used
a decremental pacing protocol to induce AF in the model, they found that re-entrant
circuits between boundaries of fibrotic and non-fibrotic tissue maintained AF. This is
similar to the mechanism speculated by Peters et al. in [112] where by re-entrant cir-
cuit could occur at the interface between a region of localised enhanced anisotropy
and normal tissue.
Homogenising fibrosis onto a continuous domain removes the possible mechan-
isms by which micro-fibrosis can initiate as well as maintain AF. Many biophysical
models such as those described above require a pacing protocol on a re-modelled
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substrate to induce AF. Spach et al. [113, 114, 115] showed that micro-fibrosis changes
conduction characteristics such that a continuum approximation may not be valid.
This is because in the anisotropic, structural heterogeneous and poorly coupled state,
the stochastic nature of propagation is important as conduction is no longer smooth
and can be blocked in particularly poorly coupled regions .
We now look at some recent biophysical models which treat the myocardium as
being discrete by solving a discrete reaction-diffusion equation. This is where each
node in the reaction-diffusion equation represents a cell and the connection between
each cell is usually a resistive pathway described by a diffusion term. The following
models only consider the intracellular domain as they only take into account current
flow in the intra-cellular space. Tanaka et al. [116] used an atrial cell model. The
spatial domain and geometry of fibrosis was taken from a histological analysis of
a transmural slice of myocardium from heart failure sheep. Fibrosis was treated as
inert discrete elements. The study found that the activation frequency and dynamics
of wavefronts were controlled by the interaction between waves with heterogeneous
clusters of fibrotic patches of various sizes.
Comtois et al. [117] also used an atrial cell model. Fibrosis was represented as re-
gions of inert tissue. In this study, fibrosis was generated using a stochastic process by
randomly attaching new fibrotic patches to existing fibrotic patches. The study found
that propagation failure was highly dependent on the spatial pattern of fibrosis. The
authors surprisingly found that decreasing the resistivity of the tissue did not have a
strong effect on sensitivity to conduction block and heterogeneous propagation.
Alonso and Bar [118] used a phenomenological cell model, the Fenton-Karma
model. Heterogenous uncoupling in this study was represented by removing a frac-
tion of links randomly from a patch of tissue. Alonso and Bar found that re-entry
would occur when the fraction of links removed was around the percolation threshold
within the patch of tissue. This is because conduction is slowed and is only just able to
propagate within the patch of tissue such that the normal wavefront passes by and an
excitatory signal can escape the patch of uncoupled tissue to form a re-entry circuit.
We now look at models which explicitly take into account the cell size, packing
and geometry by modelling current flows on the sub-cellular level. Even the dis-
tribution of gap junctions have explicit spatial locations on the cell. The following
models only consider current flow in the intra-cellular space. As there is much more
detail being simulated, these models tend to simulate smaller regions, typically cen-
timetres, of tissue with a few hundred to thousands of myocytes. Jacquement and
Henriquez developed such a microsctructure model in [119]. They studied the im-
pact of microfibrosis and impaired sodium channel function on the electrogram, they
found that properties of the electrogram could elucidate the microstructural cause
of conduction wave slowing. Hubbard and Henriquez [120, 121] studied how mi-
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crostructural variations in cell arrangement and increased gap-junctional resistivity
influenced the spatial distribution of conduction delays and block. They found that
microstructural variations such as heteroenegity in cell shape and arragnement across
a poorly coupled boundary of tissue could result in uni-directional block as a result
of source-sink mismatch and therefore caused mirco-re-entrant activity. The size of
tissue simulated was 0.6 cm by 0.6 cm. Toure and Cabo [122] studied the mechanism
of conduction block by looking at two possible changes in microstructure: (1) cell geo-
metry quantified as the length-to-width ration and (2) the cell-to-cell gap junctional
conductance. Toure and Cabo [122] found that enhanced conduction anisotropy was
arrhythmogenic when the anisotropy was the result of reduced gap junctional con-
ductance as opposed to changes in cell geometry.
Generally these models are still complex. They do not allow easily for analytic
calculations, they simulate a small number of cells or only simulate short periods of
time. So we now look at the simplest models of cardiac conduction, cellular automata.
1.6.3 Cellular automaton models of AF
A cellular automaton (CA) model of cardiac conduction represents the myocardium
as a lattice of idealised “cells”, where each cell can be in one of several discrete states.
The discrete states approximate the functional behaviour of cardiac tissue, for ex-
ample, excitability and refractoriness. An update rule determines the future state
of each cell as a function of the present state of the cell and its neighbouring cells.
The cells which are considered neighbours are determined by a neighbourhood, the
geometry and size of which are specific to a model and lattice type (e.g., square,
hexagonal, irregular etc.).
First generation CA models were spatially homogeneous and often had three states:
resting, excited and refractory. The simplest update rule was for an excited cell to
transmit excitation to its neighbouring resting cells, the excited cell would then enter
a refractory state for a refractory period of time and then return to rest (see Fig. 1.13).
Such tissue dynamics for a homogeneous tissue model were initially proposed by
Wiener and Rosenblueth [123]. They concluded that non-excitable obstacles were ne-
cessary to sustain fibrillation. Greenberg and Hastings [124] proposed a CA model
which could produce rotors with and without non-excitable obstacles [125]. Spe-
cific initial conditions were required to form a rotor without a non-excitable obstacle.
For example, an initial line of refractory tissue to act temporarily as a region of uni-
directional block (see Fig. 1.14). Young and Starmer [126] also demonstrated that
a pair of precisely timed stimuli could initiate periodic rotor activity. These obser-
vations are consistent with continuous models of excitable media and physiological
experiments [127].
Other basic changes to these simple models include changing the lattice type
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Figure 1.13: An illustration of first generation cellular automaton models. a, A cell is initially excited
(white) at the center. The neighbourhood consists of the eight nearest neighbours shown at rest (grey),
known as the Moore neighbourhood of radius 1. b, After one time step the central excited cell has excited
all cells within the neighbourhood and becomes refractory (black). c, The time course of a cell once it
has been excited by an excited neighbouring cell.
[125, 128] and extending the neighbourhood to the next nearest neighbours [128, 129].
Barbosa [129] used an anisotropic neighbourhood to introduce an anisotropic spread
in excitation.
An important change to these spatially homogeneous CA models was the addition
of functional heterogeneity. Moe et al. [46] used a model where the refractory period
varied spatially and a relative refractory state was introduced which caused a latency
in the excitation process. They found that multiple wavelets of excitations sustained
fibrillatory behaviour in this model rather than spiral waves. The model predicted
that the stability of fibrillation is proportional to the size of tissue, this suggestion is
supported by the success of the Cox Maze procedure [130].
The simplicity of these models is associated with some disadvantages. The dis-
creteness of the lattice produced sharp wavefronts which are not observed in nat-
ural excitable media. The conduction velocity and wavefront morphology changed
drastically with the neighbourhood. Other problems of first generation CA models
are that they do not encapsulate other important properties of cardiac muscle tissue
[131]. Such properties include:
1. Action potential duration and conduction velocity restitution.
2. Source-sink phenomena. This results in conduction velocities which are inde-
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Figure 1.14: A spiral wave or rotor in a first generation cellular automaton model with a refractory
period of one time step. The four nearest neighbours define the neighbourhood in this model. The initial
condition is a line of excited (black) cells adjacent to a line of refractory (cross-hatched) cells which acts to
block excitation propagating in one direction. The centre of the rotor (outlined) stays fixed as a rotating
wavefront develops. Reproduced with permissions from [124]
pendent of wavefront curvature. Thus the critical mass phenomenon, in which
a critical amount of tissue needs to be excited for a wavefront to propagate, is
absent. This in turn results in the absence of spiral waves with excitable cores.
3. Spiral waves in first generation CA models do not meander whereas this phe-
nomena is observed in cardiac tissue [132].
4. Spiral waves in first generation CA models are stable whereas in biophysical
tissue models such patterns can break up into less organised behaviour [133].
This may be a consequence of criticism 1. [133].
Second generation CA models (see review by Saxberg and Cohen [128]) were con-
structed to address these problems. Saxberg and Cohen [128] proposed that action
potential duration and conduction velocity restitution could be directly accounted for
by making the action potential duration and conduction velocity dependent on the
excitation history of the cell. Gerhardt et al. [134] modified the update rule such that a
resting cell would require more than one excited neighbouring cell to excite, this intro-
duced wavefront curvature effects. Fast and Efimov [135] achieved curvature effects
by weighting the contribution of excited cells: neighbours further away contribute
less to the excitation process of a resting cell than do closer excited cells. Markus and
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Hess [136] removed artificially sharp wavefronts by randomising the position of a cell
within a unit square and using a circular neighbourhood. Thus the problems of first
generation CA models were overcome by extending the neighbourhood, adjusting
the threshold to excite and semi-randomising the lattice.
Weimar et al. [137] criticised second generation CA models for the computational
inefficiency associated with calculating distances between cells and weighting sums.
Instead they proposed a third generation CA model which simulated wave propaga-
tion as an approximation of the continuous reaction-diffusion equation. They do this
by applying a weighted neighbourhood in such a way as to approximate the oper-
ator: D∇2, where D is the diffusion coefficient, which represents the spatial diffusion
term of the reaction-diffusion equation. Weimar et al. [137] verified that the conduc-
tion velocity-wavefront curvature relationship is linear as expected from continuous
models of excitable media.
The CA models described so far attempt to provide computationally efficient ap-
proximations of spatially homogeneous excitable media. Cardiac muscle tissue is an-
isotropic and in diseased states highly heterogeneous, thus different rules have to be
used to take this into account. For example excitation through sporadically coupled
cells in fibrotic regions may no longer be well represented by applying an isotropic,
extended neighbourhood.
Bub et al. [138] proposed a structurally heterogeneous CA model to study the ef-
fect of varying cell-to-cell connectivity and cell density. This was done by randomly
perturbing the position of cells on a square lattice and introducing an excitation rule
which compared the number of excited cells to non-excited cells within an extended
neighbourhood of size r. This novel update rule introduced wavefront curvature and
captured the source-sink relationship involved in the action potential propagation
process. The model showed that as the cell-to-cell connectivity decreased the wave-
front behaviour changed from being planar to forming spiral waves until propagation
was eventually blocked.
Bub et al. [138] then studied heterogeneity in the form of randomly placed patches
of non-excitable obstacles [96] in the same model. As the size of the non-excitable
obstacles increased the planar wavefronts were uni-directionally blocked and re-entry
circuits thus formed around the obstacles. This behaviour occurred as a result of the
source-sink relationship and shows that the geometry of non-excitable obstacles and
the wavefront can interact to give non-planar behaviour. The model was adjusted to
incorporate pacemaker activity and the effect of fatigue, where cells become inactive
after a rapid period of activity, to model monolayers of embyronic chick myocytes
[138, 139]. The model was successful in reproducing the qualitative behaviour ob-
served in their isotropic cell culture preparations.
We note that attempts have been made to incorporate biophysical properties, such
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as the membrane potential, into CA models [107, 140, 141, 142]. These changes enable
the extracellular potential to be calculated from the model. This enables a comparison
with experimental electrograms and allows an investigation into how changes in tis-
sue properties affects the electrogram recording. However, to derive electrograms for
structurally heterogeneous models is non-trivial as the calculation requires treating
the conductivity as a tensor.
More recently, Spector et al. [143] introduced a self-described CA model which
tries to capture electrotonic effects, for example source-sink mismatch phenomena,
without using an extended neighbourhood. This is achieved by modelling the state
of the cell continuously by a variable analogous to the membrane voltage and using
an ordinary differential equation to describe current flow between cells as a result of
spatial differences in membrane voltage. As the state variable, membrane voltage,
is treated continuously the model is technically a coupled map lattice. If the mem-
brane voltage of a cell reaches a threshold value the cell undergoes a manually set
pre-programmed action potential sequence in which the membrane voltage increases
linearly, plateaus and decreases linearly back to threshold. So, the myocardium in
this model is a square lattice of cells coupled by resistors. Other physiologically relev-
ant phenomena are directly programmed into the model such as: conduction velocity
through modifying the gradient of depolarisation of the pre-programmed action po-
tential, and restitution by programming the action potential duration to be a function
of the diastolic interval. The model has primarily been used to study the electrogram
[144] and ablation strategies [44, 45] rather than heterogeneity in tissue properties.
1.6.4 Discussion
CA models, if implemented correctly, can reproduce the results of other types of
model [145, 96] and thus represent a computationally efficient and intuitive method
for investigating cardiac conduction. We propose that a natural progression of work
in this area would be an investigation into a CA model in which the anisotropic,
branching, cable-like structure of the myocardium is taken into account. Structural
heterogeneity due to this structure and its modification due to fibrosis and gap junc-
tional uncoupling could then be studied in a simplified CA model. The results can be
compared against other phenomenological model types, biophysical computer mod-
els and biological models. In addition to this, functional heterogeneity, such as a
spatially varying refractory period and noise in the excitation process, could be incor-
porated.
A novel investigation would be to use a CA model to study how the organisation
of wavefronts, in an anisotropic cable-like medium, are affected by heterogeneity in
tissue. The identification of specific regions of heterogeneity which result in destabil-
ising wavefronts would be of clinical interest if such regions could be identified in
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biological models. The major work of this thesis, Chapters 2-4, is concerned with the
introduction and study of a new CA model to investigate how structural heterogen-
eity in tissue affects wavefront behaviour and AF.
1.7 Predicting Vasovagal Syncope
In this section we outline the background to a smaller segment of work presented
in this thesis which concerns the prediction of fainting during a medical test known
as head-up tilt table testing. We performed an exploratory analysis on a previously
large unpublished data set of 377 head-up tilt tests (HUTT) which include up to 45
minute recordings of blood pressure and electrocardiogram (ECG) per test. We briefly
provide an overview of the background and recent work.
1.7.1 Vasovagal syncope
Syncope is the transient loss of conciousness, also described as “fainting”, which oc-
curs due to impaired blood flow to the brain. Syncope is a symptom, with many
different causes, as opposed to a specific pathological condition. Syncope is classified
by its cause for prognostic purposes into three broad categories: (1) Reflex (neurally-
mediated), (2) orthostatic hypotension and (3) cardiovascular [146]. Reflex syncope
refers to diverse group of conditions in which cardiovascular reflexes that are nor-
mally helpful in controlling blood circulation become intermittently inappropriate in
response to a trigger; this results in a reduction in heart rate (HR) and/or blood pres-
sure (BP), consequently reducing blood flow to the brain.
Vasovagal syncope (VVS) is a reflex type syncope which is mediated by emotion
or orthostatic, standing upright, stress. VVS is one of the most common causes of
syncope and is a benign condition which is characterised by a self-limiting episode
of systemic low blood pressure and sometimes low heart rate [147, 148]. VVS is a
frequent cause of hospital admissions and has an economical cost due to patient han-
dicaps resulting from several fainting episodes [149]. Thus the detection and early
diagnosis of vasovagal syncope is of importance.
The Bezold-Jarisch reflex has traditionally been thought to be the mechanism for
VVS [150]. We summarise the process as follows:
1. The patient assumes an orthostatic posture, for example, by standing or being
tilted.
2. The patient’s blood is redistributed in response to the orthostatic stress, blood
pools into the legs.
3. This decreases the rate of blood flow back to the heart, venous return.
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4. An increased heart rate, constriction of blood vessels and more forceful heart
contractions try to compensate the reduced venous return. This is a normal
response to orthostatic stress.
5. In VVS patients, the forceful heart contractions are thought to activate hyper-
sensitive cardiac receptors which increases parasympathetic tone and reduces
sympathetic tone 1.
6. The changes in tone result in a reduced heart rate and dilated blood vessels,
resulting in a low blood pressure.
7. As blood pressure falls, less blood reaches the brain until syncope occurs.
Some studies have challenged whether the Bezold-Jarisch reflex is in fact respons-
ible for VVS [151, 152], however, this is not important to the focus of the work presen-
ted in this thesis. We now discuss the clinical challenge regarding diagnosis of VVS.
1.7.2 Head-up tilt test
Head-up tilt testing (HUTT) is a medical procedure used to diagnose VVS. During the
HUTT a patient is strapped to a table which tilts to a near upright angle, the patient
is held in this position for up to an hour to try to reproduce syncope symptoms, this
forms the basis of the diagnosis. However, the HUTT can take up to an hour and is
stressful for the patient as it attempts to reproduce their syncope symptoms. Early
prediction of the HUTT outcome would reduce the time of the test and stress for the
patient. Reducing the time of the test would also increase efficiency and reduce costs
for healthcare providers, this is because it allows physicians to see patients at a greater
rate or to be able to spend time on other tasks. We provide a more detailed discussion
on HUTT in Chapter 5.
1.7.3 Time series analysis
During routine HUTTs an ECG is recorded to measure heart rate and blood pressure,
however, research centres sometimes measure additional signals during the HUTT
such as cerebral perfusion changes (e.g., concentration of oxyhaemoglobin) [153] and
transthoracic impedance [154]. A clinical challenge has been to reliably predict the
outcome of a HUTT, using time-series extracted during the test, much earlier than the
1Parasympathetic and sympathetic tone refers to the degree of activity of the parasympathetic and
sympathetic nervous system. The parasympathetic nervous system stimulates “rest-and-digest” activ-
ities, thus lowers heart rate and blood pressure; whereas the sympathetic nervous system stimulates
“fight-or-flight” activities, thus increases heart rate and blood pressure.
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patient’s syncope event. A review of this literature can be found in [155]. We provide
a summary of time-series measures which are commonly used in the literature.
RR intervals are the time between R-waves, which represent ventricular contrac-
tion, on the ECG. Hear rate (HR) can be extracted from RR intervals by taking inverse
of the RR interval and converting the units to beats per minute. Measures of HR
previously used in studies of syncope prediction include the HR mean, HR standard
deviation and HR kurtosis.
Another property measured is heart rate variability (HRV), this is the beat to beat
variation in RR intervals. One measure is from the power over particular bands in the
frequency spectrum of HR. The frequency spectrum of HR in healthy patients nor-
mally shows periodicity in the variation of HR, two peaks are normally observed: a
low frequency (0.04-0.15 Hz) due to the baroreflex 2 mechanism and a high frequency
(0.15-0.4 Hz) due to respiration.
Guidelines to standardise the measurement, interpretation and clinical use of HRV
were introduced in 1996 [156]. HRV can been computed by several measures and have
been used in syncope prediction [157, 158, 159]:
• pNN50: The fraction of consecutive NN intervals (RR interval between two nor-
mal sinus rhythm beats) that differ by more than 50 ms
• SDANN: The standard deviation of NN intervals
• RMSSD: The root-mean-square of the difference between consecutive NN inter-
vals
• LF/HF ratio: The power in the low frequency range (0.04-0.15 Hz) divided by
the power in the high frequency range (0.15-0.4 Hz)
The blood pressure time-series has similarly been analysed to extract measures
which may be relevant to VVS. One measure is that of baroreflex sensitivity (BRS),
this quantifies how much control the baroreflex has on heart rate. Another measure
extracted from BP time-series used in syncope prediction is pulse transit time (PTT)
which is the tame taken for a pulse waveform to travel a given path in the arterial
system.
Thus, to summarise, the most common measures used in syncope prediction are:
HR, HRV, BP, BRS and PTT. The studies used to establish this typically have around
or much fewer than 100 patients [157, 158, 159, 160, 161, 162, 163, 164]. No measure
has so far resolved in universal acceptance.
2The baroreflex is a negative feedback system which regulates blood pressure. Acute changes in
blood pressure are stabilised by activation or inactivation of baroreceptors by modulating sympathetic
activity and thereby making compensatory adjustments in heart rate and blood pressure.
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1.7.4 Discussion
We have seen that only a limited number of features have been selected for study and
so far these features have not been found to be clinically useful. We use a library of
over 7894 time-series analysis methods [165] to extract over 6000 time-series proper-
ties, also known as features, from RR intervals (time between heart beats) and blood
pressure (BP) signals recorded during a HUTT. These time-series analysis methods
are from a wide range of sciences and analyse various time-series properties: sum-
maries of autocorrelation, stationarity, wavelet decompositions, measures from non-
linear time-series analysis (e.g., correlation dimension estimates, fractal scaling prop-
erties), information theoretic measures (e.g., permutation entropy, sample entropy),
and others [165]. We apply machine learning methods to analyse these large number
of features to try to predict syncope early in the HUTT. This enables the use of data
mining methods to seek alternative features and combinations of features which may
be able to outperform the usual physiological measures in predicting the outcome of
HUTTs. Our study differs to previous studies by using a larger number of patients
and time-series features which consider a much wider set of time-series properties.
1.8 Structure of Thesis
This thesis is organised as follows. In Chapter 2 we introduce a new CA model of
cardiac conduction which incorporates the branching structure of myocardium. We
look at the overall macroscopic behaviour of the model as we change model para-
meters, such as the degree of transversal coupling. We find that the mean fraction of
time in AF of a simulation increases rapidly when the degree of transversal uncoup-
ling is lowered below a threshold. We analytically derive the threshold of transversal
uncoupling to tissue parameters.
In Chapter 3 we present a study of the microscopic mechanisms which drive the
macroscopic AF behaviours in the model. We also introduce a mean-field model
to identify which microscopic mechanisms are most prominent in driving AF in the
model. We find that structurally critical regions on the lattice and wavefront-wavetail
collisions sustain AF in the model.
In Chapter 4 we adapt the model to study patient variability in AF, AF progression
and address recent observations which suggest that mitochondrial DNA mutations
contribute to AF. The adapted model suggests that the slow, stochastic accumulation
of transversal uncoupling, which can occur as we age as a result of fibrosis and gap
junctional lateralisation, is sufficient to reproduce clinically observed patient variab-
ility in AF. We also show how dysfunctional cells in the model mimic cells with mi-
tochondrial dysfunction, as a result we provide a hypothesis to address how a small
number of mitochondrially dysfunctional cells can initiate an arrhythmia.
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In Chapter 5 we present a study where we use a highly comparative time-series
analysis tool [165], which consists of a large library of diverse time-series analysis
methods, to predict the outcome of head-up tilt tests using blood pressure and RR
interval signals. We use a classification algorithm, a linear support vector machine, to
achieve classification performances comparable to the literature.
In Chapter 6 we summarise the thesis. We contextualise each chapter in relation to
one another and this body of work overall. We then outline future work which could
develop from each chapter.
We provide additional figures and data from each chapter in a set of appendices,
with the same title as their respective chapter titles, at the end of the thesis.
Chapter 2
Cellular Automaton Model of Atrial
Fibrillation
Some of the material presented in this chapter has been published as: ”Simple model for identi-
fying critical regions in atrial fibrillation.” K. Christensen†, K. A. Manani†, and N. S. Peters.
Physical Review Letters 114.2 (2015): 028104. †Joint first authors.
The proposed mechanisms that initiate and maintain atrial fibrillation (AF) are di-
verse and not fully understood [90]. The relationship between the micro-architecture
of heart muscle tissue and the propagation of action potential wavefronts, that is, the
relationship between structure and dynamics, may be a key mechanism [59, 114, 120,
166, 167]. Rotating spiral wavefronts of excitation have been observed in isolated
cardiac tissue [132] and recently in human AF [74], suggesting critical regions for per-
sistence of AF. But why these rotating wavefronts should form and their relationship
to the underlying structure and its arrhythmogenic characteristics are unknown.
In this chapter we define a cellular automaton model of heart muscle tissue (myocar-
dium). The dynamics of the model describe the generation and transmission of ac-
tion potentials between cells. We study the dynamics of action potential wavefronts,
henceforth referred to as excitation wavefronts, on a lattice of cells where the cell-to-
cell connectivity is set to mimic the anisotropic branching structure of myocardium,
see Fig. 1.6. The model allows us to explore the relationship between structure and
dynamics. We find that this simple model is able to reproduce many clinically known
characteristics of AF, the most notable being: the increased risk of AF with increasing
structural heterogeneity and dysfunctional cells, occurrence of AF events of variable
frequency and duration, ability to terminate AF through ablation, absence of AF in
infants and patient variability. In addition, the model makes novel predictions about
the mechanisms underlying the arrhythmia.
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2.1 Introduction
Atrial fibrillation is a poorly understood arrhythmia where multiple excitation wave-
fronts are observed to propagate continuously in the atrial muscle tissue in an appar-
ently random manner [168]. The excitation wavefronts meander, divide and collide
with mutual extinction and re-initiation. This manifests in patients as episodes of vari-
able duration, from short self-terminating episodes (paroxysmal AF), which typically,
but not always (see Chapter 4), get longer with time to become self-sustaining (per-
sistent AF) [169]. The incidence of AF increases with age and is strongly associated
with the accumulation of fibrosis [52], however, the exact mechanisms underlying AF
are still not understood.
Ablating atrial tissue extensively and empirically via catheter electrodes may cure
AF in some cases [39, 72], but an inability to identify the specific regions critical to
the persistence of AF has resulted in failure to improve on disappointing clinical out-
comes. For example, the clinical success rate after one ablation procedure is 30% for
persistent AF and 60% for paroxysmal AF [62]. Thus, enhancing mechanistic under-
standing, identification of critical causative regions, and prediction of arrhythmic risk
for preventative strategies requires a novel approach.
Heart muscle cells are discrete and so it is natural to use cellular automata to
model activation wavefronts as was done in some of the earliest mathematical mod-
els of AF [46, 123]. These studies investigated the effect of heterogeneity in func-
tional parameters (e.g., refractory period) and macroscopic obstacles on the dynamics
of wavefronts. The studies showed that an increase in hetereogeneity in refractory
period resulted in greater wavefront complexity. Bub, Shrier and Glass devised cellu-
lar automaton models of cardiac conduction and experimentally compared the beha-
viour of the model to cardiac cell monolayers [138, 139]. Bub et al. have also investig-
ated the relationship between structural heterogeneity and the stability of activation
wavefronts in isotropically coupled tissue. In contrast, we have investigated the ef-
fects of anistropic structural heterogeneity in the underlying lattice of cells to mimic
the lateral uncoupling of myocardial strands by fibrosis or gap junctional uncoupling
[52].
The primary results of this chapter are that we find that with low levels of struc-
tural heterogeneity wave propagation remains planar. As the level of structural het-
erogeneity is increased beyond a threshold value, we observe spontaneous localised
disruption of propagation and progressive degeneration to fibrillation, either self ter-
minating or sustained. Hence, the model reproduces the observation that an increase
in structural anisotropy [52, 170], might spontaneously induce and sustain AF.
The simplicity of the model provides mechanistic insight into the initiation and
maintenance of AF. We can characterise and identify the composition of local regions
critical to the initiation and maintenance of AF and show that ablation of such critical
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regions may terminate AF. Furthermore, we predict the existence of a critical level of
heterogeneity beyond which AF occurs. Due to the simplicity of the model, we can
analytically calculate the risk of AF as a function of model parameters.
2.2 The Model
We represent the myocardium by an L×L rectangular lattice of cells, where L repres-
ents the system size. Each cell is connected to its longitudinal (horizontal) neighbour
with probability η = 1 and to its transversal (vertical) neighbour with probability
0 ≤ ν ≤ 1. This creates a lattice which mimics an anisotropic branching network of
interacting cells. Structurally, the substrate can be pictured as a set of aligned cables
of single cell thickness which are coupled to neighbouring cables with frequency ν,
see Fig. 1.6. The lattice structure is a 2D sheet, this is a valid first approximation
because the atrial muscle wall is thin, 2.5 mm [171] relative to the atrial surface area,
20 cm2 [172, 173]. However, one might extend the model to 3D by coupling adjacent
2D sheets of tissue.
To mimic the basic topological features of an atrium we apply periodic boundary
conditions vertically and open boundary conditions horizontally to the 2D lattice, pla-
cing the pacemaker cells along one of the open boundaries. This provides a cylindrical
topology which is a convenient substrate to study the evolution of wavefronts as our
focus is on investigating the effects of increasing anisotropic structural heterogeneity,
rather than the effects of atrial anatomy. Once the cell-cell connectivity is generated,
it remains static throughout a simulation. Thus structural properties are incorporated
into the lattice by the single variable ν.
We now discuss the dynamics of the model. The coordinated contraction of the
heart is a result of a regular propagating wavefront of excitation originating at the
heart’s natural pacemaker. The ionic currents which determine the excitation of a cell
(i.e., the action potential) are not explicitly considered in the model. In its simplest
representation, a cell may be in one of three states: resting (repolarised), excited (de-
polarising) or refractory. An excited cell at time t induces neighbouring resting cells to
become excited and itself becomes refractory at time t+1. The wavefront is a coherent
propagation of this excitation throughout the lattice.
A small fraction of randomly distributed dysfunctional cells can contribute to ar-
rhythmogenesis [174]. This motivates us to add a fraction δ of randomly chosen cells
in the lattice to be assigned as “dysfunctional”. These particular cells have a finite
probability, , of not exciting in response to an excited neighbour. A dead cell would
have  = 1, a partially dysfunctional cell would have 0 <  < 1. A more detailed
physiological interpretation of this parameter is provided in Chapter 4. For now, we
treat it as a free parameter which introduces noise into the excitation process.
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Cells along the left open boundary are pacemakers and self-excite at a fixed period,
T to mimic normal sinus rhythm. A summary of the lattice structure and dynamics of
the model is shown in Fig. 2.1. The parameters of the model are summarised in Table
2.1.
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Figure 2.1: Structure of the lattice and dynamics of the model. a-c, A connection is represented by a link
between two cells. Cells are always connected longitudinally and with frequency ν transversally. a-b,
A resting cell (black) will become excited (white) in the next time step if at least one of its neighbouring
coupled cells are excited. b-c, Once a cell is excited it will enter a refractory state (grey scale) for a
duration of time τ . d, The time course of a cell once it has been excited by an excited neighbouring
connected cell. Figure is reproduced from [1] under a CC-BY 3.0 license.
Parameter Symbol Model
Value
Physiological
System size L 1000 4-5 cm [172, 173]
Probability of transversal (vertical) connection ν 0-1 Unknown
Probability of cell being dysfunctional δ 0-0.05 0-0.05 [174]
Probability of dysfunctional cell not exciting  0.05 Unknown
Period of pacemaker cells T 500-1700 300-1000 ms
Refractory period τ 167-500 100-300 ms [175]
Depolarisation time ∆t 1 0.2-1.0 ms [176, 177]
Table 2.1: Parameters of the model and their physiological values. We use the physiological data to
determine the model values. The probability that a dysfunctional cell does not excite, , depends on the
biological mechanism, see Chapter 4. As far as the author is aware no such experimental data has yet
been collected to determine this. To the author’s knowledge statistics on the extent of micro-fibrotic or
gap junctional uncoupling in human atria does not yet exist, however, limited data does exist for the
goat [166].
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2.3 Fitting the Model Parameters
We now discuss how to fit the model parameters to physiological values. We indicate
physiological, that is, experimentally measured values using the prime superscript ”
′ “ . A healthy atrial area is L′ × L′ ≈ 20 cm2 [172, 173]. Atrial muscle tissue consists
of nearly cylindrical myocytes of length ∆x′ ≈ 100µm and diameter ∆y′ ≈ 20µm
packed in an irregular brick-wall like pattern, see Fig. 1.6 [93, 178]. The time taken
for a cell to depolarise, ∆t′ ≈ 0.6 ms, is much shorter than the refractory period, τ ′ ≈
150 ms. Sinoatrial nodal cells (i.e., pacemaker cells) self-excite at a range of periods
T ′ = 300-1000 ms. Without coarse-graining we obtain model values by dividing
length scales by ∆x′ and timescales by ∆t′. We coarse-grain the model as we aim to
gather statistics on the behaviour of a larger number of lattices, this is infeasible if we
simulate a L = 1000 lattice.
Translating real tissue values into the model yieldsL = L
′
/∆x′ = 1000. We coarse-
grain the model by taking ∆x′ → b∆x′, where b×b is the number of cells within a unit
of space in the model. As the conduction velocity θ′x = ∆x′/∆t′ ≈ 0.2 ms−1 is fixed we
also get ∆t′ → b∆t′. We take b = 5 which gives L = 200 and τ = τ ′/(b∆t′) = 50. The
evolution of the system varies depending on the fractions of transversal connections ν
and dysfunctional cells δ which are the only remaining parameters. Coarse-graining
the transversal connections gives: ν → 1 − (1 − ν)b as this is the probability that
a group of b cells have at least one transversal (vertical) connection between them.
Coarse-graining the fraction of dysfunctional cells give: δ → [1 − (1 − δ)b]b as this is
the probability that there is at least one dysfunctional cells in every cable in the group
of cells that will be coarse grained. We take the period of pacing to be T = T ′/(b∆t′) =
220 using T ′ = 660 ms. This coarse-graining procedure and scaling on the behaviour
of the model is discussed in detail in Sec. 2.7.
2.4 Model Behaviour
The wave behaviour in the model can be classified into three categories: (1) planar
wavefront behaviour, (2) single re-entrant circuit behaviour, and (3) multiple re-entrant
circuit behaviour, see Fig. 2.2a-c. The single and multiple re-entrant circuit beha-
viours are broad categories defined by the presence of wavefronts undergoing self-
sustaining circular motions. The re-entrant circuits in the model are much smaller in
scale than what is clinically referred to as a re-entrant circuits, normally considered
as being a macro-re-entrant circuit with a size on the order of the anatomy (e.g., the
pulmonary veins). A more appropriate term for the circular motions observed in the
model are micro-re-entrant circuits, however, for brevity we shall simply call them
re-entrant circuits.
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a b c
	 ν	>	ν	⋆ ν	≈	ν	⋆ ν	<	ν	⋆
Figure 2.2: Wave behaviours in the model. a, A planar wavefront. The wavefront is not smooth because
dysfunctional cells can block excitation in particular cables resulting in gaps with resting cells in the
wavefront. These resting cells in abutting the wavefront are then re-excited by excited cells in neigh-
bouring cables. These are stable for ν & 0.21. b, A single re-entrant circuit (yellow dashed box). These
occur when ν ≈ ν?. c, Mulitple re-entrant circuits (yellow dashed boxes). These occur when ν < ν?.
During a simulation the system can transition between these different types of wave behaviours.
The model also shows distinct types of temporal behaviour, see Fig. 2.3: (1) the
trivial case where there is only planar wavefront behaviour (i.e., sinus rhythm), (2)
events of finite duration of abnormal wave behaviour (i.e., paroxysmal AF), (3) ab-
normal wave behaviour occurring continuously (i.e., persistent AF). Thus the model
reproduces different clinically observed temporal patterns of fibrillatory behaviour as
occurs with AF.
The behaviour and temporal stability (i.e., the frequency and duration of AF events)
of these waves change with the fraction of transversal connections ν. When ν = 1,
mimicking neonatal tissue in humans and other mammals, we observe regular wave-
fronts for all δ, consistent with the rarity of AF observed in children. We now in-
vestigate the effect of structural heterogeneity (ν < 1). For simplicity, we consider a
fixed fraction of dysfunctional cells (δ = 0.05, similar to what is observed experiment-
ally [174, 179]) leaving the fraction of transversal connections, ν, as the only control
parameter.
For large fractions of transversal connections (ν & 0.21) we only observe planar
wavefronts. However, as ν is decreased, mimicking the onset of fibrotic interference
of lateral cell-to-cell coupling, the branching nature becomes more prominent and
circuits of activity may form spontaneously by wavelets of excitation leaking back
through the refractory wake of the wavefront, see Fig. 2.4a-c. The associated fibril-
lation may self-terminate, see Fig. 2.4d, or become persistent. Generally, the event
duration and frequency of AF events increase as ν is decreased, explored in detail in
Chapter 3.
Hence, the parameter space ν may be divided into a re-entrant circuit forming
range and a stable range in which no re-entrant circuits form, see Fig. 2.5. The fre-
quency of formation and the temporal duration of re-entrant circuits increases sharply
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Figure 2.3: The temporal behaviour of the model. Numerical simulation for a 200 by 200 system where
pacemaker cells activate periodically, the model is run for 10,000 time steps which is equivalent to 30
seconds real time. a, During sinus rhythm (SR, blue curve) the number of excited cells varies with the
same period as the pacemaker cells. When the number of excited cells exceeds a threshold (220, see
dashed gray line) it implies that the system is in fibrillation (AF, black curve). The system is defined
to return to SR when the system is below threshold for more than one normal sinus rhythm beat. b, a
rectangular electrode of size 1mm2 (10 x 10 cells) placed at the centre of the tissue is used to simulate
the electrogram. During fibrillation (black curve) the rate of the electrogram increases by a factor of 2-5.
c, the associated binary signal of the time series in a into periods of SR (blue filled area) and AF (black
filled area). The frequency and duration of AF events during a simulation are stochastic and depend on
model parameters such as the fraction of transversal connections ν.
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from zero as the fraction of transversal connections ν decreases below a threshold
value ν? ≈ 0.14. Only when ν is sufficiently small will the relevant path length of
the re-entrant circuits exceed the refractory period, which is a necessary condition to
sustain a circuit, see Fig. 2.4e. Decreasing ν results in re-entrant circuits forming and
disassociating more rapidly resulting in a fibrillatory state, see Fig. 2.5. This mimics
the natural onset of AF and its transition to paroxysmal and persistent atrial fibrilla-
tion. Moreover this is consistent with the increase of AF incidence with advancing
age. The critical regions forming a simple re-entrant circuit as displayed in Fig. 2.4e
are primarily responsible for the fibrillation observed in the model.
a b
c
d
e
a
c d
Figure 2.4: Initiation and self-termination of fibrillation in a simulation with L = 200, τ = 50,  = 0.05,
δ = 0.05, and ν = 0.18. See appendix Fig. A.1 for the full image and animation. The pacemaker cells
self-activate with a period of T = 220. a, A planar wavefront induced by pacemaker cells along the
left boundary a time t0 + 25. b, An opening occurs in the refractory wake (i.e, wave-break) and a wave
of excitation leaks back on itself. c, A re-entrant circuit forms as a result of this breakthrough. Hence,
the duration of this event is approximately 815 time steps. d, The re-entrant circuit self-terminates and
planar wave propagation resumes. e, A critical region which can induce a rotor. The dysfunctional
cell (dotted boundary) in the bottom cable may block the propagation wavefront. When the wavefront
in the top cable reaches the rightmost transversal connection, it induces activity in the bottom cable
that will also propagate retrograde. If the relevant path length (red line) of the circuit is greater than the
refractory period, the cell to the left of the dysfunctional cell will be in a resting state when the retrograde
wavefront arrives and a re-entrant circuit of activation forms. The re-entrant circuit terminates when the
dysfunctional cell blocks the retrograde wavefront. This is the simplest example of a critical region
which will induce fibrillation-like behaviour in the model. Figure is reproduced from [1] under a CC-BY
3.0 license.
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2.5 Characterising the Average Behaviour of the Model
We aim to characterise the average behaviour of the model quantitatively as we vary
different parameters. We study the aggregate behaviour of a sample of N simulations
where each simulation has a lattice that is probabilistically generated from the same
parameter values of ν and δ. Firstly, we will introduce the fraction of time that the
system is in AF (clinically referred to as the AF burden) as a macroscopic property of
the model. Secondly, we show how varying the fraction of transversal connections
changes the average behaviour of the model. We then elaborate on describing this
average behaviour analytically. Finally, for completeness we measure how the aver-
age behaviour of the model changes with the fraction of dysfunctional cells δ and the
probability that a cell does not excite . We define the system to be in ‘‘AF” when the
lattice contains non-planar wavefronts such that the number of excited cells exceeds
a threshold of L+ 20. This threshold is chosen by inspection of Fig. 2.3. The system is
defined to have returned to sinus rhythm from AF after more than one sinus rhythm
beat has occurred.
2.5.1 Risk of AF
An informative macroscopic property of a simulation is the fraction of time the system
is in AF:
tAF =
TAF
Ttot
, (2.1)
where TAF is the time that a particular simulation is in AF and Ttot is the total simu-
lation time. The sample average of tAF , henceforth referred to as the average time in
AF, is
〈tAF 〉 = 1
N
N∑
i=1
T
(i)
AF
Ttot
(2.2)
where T (i)AF is the time in AF of the ith simulation in the sample and we sum over each
simulation in the sample. If 〈tAF 〉 = 1 then all simulations in the sample underwent
persistent AF. If 〈tAF 〉 = 0 then no simulations experiences any AF. Any intermediate
value of 〈tAF 〉 implies a mixture of simulation behaviours, for example, some sim-
ulations in the ensemble do not fibrillate whilst others do. The variability in model
behaviour for a given sample forms the basis of study for Chapter 4.
We now wish to relate the average time in AF 〈tAF 〉 from Eqn.(2.2) to the probab-
ility that a simulation in the sample has AF. Hence we might think of this as being a
measure of AF risk Prisk. For a given value of ν we naively define the probability that
a simulation will have AF to be the fraction of simulations in the sample which had
AF:
Prisk =
NAF
N
(2.3)
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where NAF is the number of simulations in the ensemble which had AF.
It is only for a small range of ν such that a simulation only has paroxysmal AF for
the full time of the simulation. Most simulations either never develop AF or develop
persistent AF eventually. Thus we can write in the limit of a long simulation:
lim
Ttot→∞
TAF
Ttot
=
1 if simulation has persistent AF,0 if simulation does not have AF. (2.4)
We now show that in the limit of long simulation times that the sample average of tAF
is equivalent to Prisk. Only a small fraction of simulations tend to remain paroxysmal.
So we can expect:
lim
Ttot→∞
〈tAF 〉 = 1
N
N∑
i=1
lim
Ttot→∞
T
(i)
AF
Ttot
=
NAF
N
= Prisk. (2.5)
Thus the sample average of the fraction of time a simulation is in AF is an indirect
measure of the risk of AF provided the number of simulations which display only
paroxysmal behaviour is small. Thus we run simulations for a duration of time (Ttot =
106 time steps) that is much longer than the characteristic time-scale for persistent AF
to occur (typically ∼ 105 time steps), this is discussed in detail in Chapter 3. The
reason for measuring TAF rather than NAF directly is that the former provides more
information about the behaviour of the model. For example, the duration of AF events
influence TAF but not NAF .
The average frequency and duration of AF events are also of interest. We define
the frequency of AF events, fAF , for a single simulation as the number of AF events
divided by the total simulation time. We denote the mean duration of AF events for
a single simulation as dAF . The fraction of time in AF captures information about the
frequency and duration of events as we naively expect 〈tAF 〉 = 〈dAF 〉 × 〈fAF 〉. The
frequency and duration of AF events is explored in further detail when studying the
heterogeneity in behaviour between paroxysmal and persistent AF in Chapter 3.
2.5.2 Fraction of transversal connections
We now measure the average time in AF as we vary the fraction of transversal (ver-
tical) connections, Fig. 2.5. We observe that the system has a sharp transition from
planar wavefront behaviour to persistent AF as we reduce the fraction of transversal
connections below a particular value ν?. Simulations around the transition regions
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show a range of behaviours and are studied in more detail in Chapter 3.
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Figure 2.5: a, A phase diagram of the model with L = 200, τ = 50,  = 0.05, and δ = 0.05.
Pacemaker cells self-activate with a period of T = 220. As ν decreases from 1, a transition from
planar wavefronts (C) to a few self-terminating re-entrant circuits (B) occurs. As ν is decreased below
ν?≈1− (δL2)− 1τ ≈0.14 the system develops multiple self-sustaining re-entrant circuits (A). The red line
is the analytically calculated probability Prisk = 1 − [1−(1− ν)τ ]δL
2
of having at least one fibrillation-
inducing structure, see Fig. 2.4e. The solid blue circles represent the average duration that a system
displays non-planar wavefronts, averaged over 50 realisations of duration 106 time steps and error bars
represent one standard error of the mean. b-d, Realisations of systems with ν = 0.9 - planar behaviour,
ν = 0.2 - single self-terminating re-entrant circuit and ν = 0.15 - multiple self-terminating re-entrant
circuits. See appendix Fig. A.2 for full image. Figure is reproduced from [1] under a CC-BY 3.0 license.
In the next subsection we will try to predict the relationship between 〈tAF 〉 and the
fraction of transversal connections using the structure of the lattice. In particular we
aim to identify the fraction of transversal connections at which the transition occurs
ν?.
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2.5.3 Analytically calculating the risk of AF from structure
Figure 2.4 shows that a particular arrangement of transversal connections and dys-
functional cells can initiate and maintain a re-entrant circuit. We identify the risk of
developing AF in a particular simulation with the probability, Prisk, that the L × L
system has at least one portion of the re-entrant circuit as displayed in Fig. 2.4e. We
further highlight the part that determines whether this arrangement of cells is critical
in initiating AF in Fig. 2.6. If ` ≥ τ/2, these arrangement of cells and connections are
the simplest that can initiate a re-entrant circuit. Thus we call portions of lattice that
contain these arrangement of cells and connections “simple critical regions (or struc-
tures)”. Thus, we are tacitly assuming that a lattice will undergo AF if it contains at
least one simple critical region. We will see that even with such a strong assumption
we will get a good fit to the data.
We now calculate Prisk analytically. The probability that a transversal connection
exists is given by ν. The probability that a cell has at least one transversal connection,
pν , is the complement of having no transversal couplings, that is,
pν = 1− (1− ν)2 . (2.6)
Consider a particular cable, that is a row in the lattice, we label a cell by its distance
along the cable starting from the pacemaker cells. Given an arbitrary dysfunctional
cell i, let `i denote the distance (measured in number of links) from that cell to its
first neighbour to the right that has at least one transversal connection , see Fig. 2.6.
Hence, the probability that `i < `min
P (`i < `min) =
`min−1∑
`i=0
(1− pν)`ipν = 1− (1− pν)`min = 1− (1− ν)2`min , (2.7)
that is, the complement satisfies
P (` ≥ `min) = (1− ν)2`min . (2.8)
A re-entrant circuit may not form if the path length of the potential circuit is less than
the refractory period. That happens when `min = τ/2 (for even τ ) or `min = (τ − 1)/2
(for odd τ ). For simplicity we restrict ourselves to even τ and we find that
P
(
`i <
τ
2
)
= 1− (1− ν)τ . (2.9)
The average number of dysfunctional cells in a system is given by δL2. Prisk is the
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Figure 2.6: A simple critical structure. This particular arrangement of transversal connections and a
dysfunctional cell is able to initiate and maintain a re-entrant circuit. ` is the distance between a dys-
functional cell and a cell with at least one transversal connection (dotted line) to the right. This arrange-
ment of cells and transversal connections can be seen in the schematic of a critical region Fig. 2.4e where
` ≥ τ/2.
complement of all dysfunctional cells having li < τ2 , that is,
Prisk = 1−
∏
dysfunctional
cells
P (`i < `min) = 1− [1− (1− ν)τ ]δL
2
. (2.10)
This is equivalent to the probability that at least one dysfunctional cell has li ≥ τ2 .
We note that this equation is invalid for ν . 1/L as we know PRisk(ν . 1/L) ≈ 0
as no more cables are connected in this non-physiological regime. This occurs as we
tacitly assumed an infinite system size which meant we treated all dysfunctional cells
equally in their propensity to form a simple critical region.
We will now redo the calculation rigorously in a finite system. The presence of
boundaries means that dysfunctional cells closer to a boundary are less likely to have
a series of absent connections extending to the right and therefore less likely to form a
simple critical region. We note that a cell with index i is located along the ith column
of the lattice. The finiteness of the system implies that for a given dysfunctional cell
i, there is a maximum distance L− i to its first neighbour to the right that has at least
one transversal connection. Hence
P (`i ≥ `min) =

L−1∑
`i=`min
(1− pν)`ipν for `min ≤ L− i,
0 for `min > L− i,
=
(1− pν)
`min − (1− pν)L−i+1 for `min ≤ L− i,
0 for `min > L− i,
(2.11)
and we find that
P (`i < `min) =
1− (1− ν)
2`min − (1− ν)2(L−i+1) for `min ≤ L− i,
1 for `min > L− i.
(2.12)
A re-entrant circuit may not form if the path length of the circuit is less than the re-
fractory period. That happens when `min = τ/2, assuming τ is even. The probability
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that all dysfunctional cells have `i < τ2 is given by
∏
dysfct.
cells
P (`i < τ/2). Note, how-
ever, that only dysfunctional cells with with i = 1, . . . , L−τ/2 contribute with a factor
less than one, that is, dysfunctional cells located within a distance of τ/2 of the right
edge of the system do not have enough space to create a simple critical region. For
each column j = 1, . . . , L, the average number of dysfuncitonal cells is δL. We re-
mind the reader that i is the distance along the cable measured in number links and
is therefore equal to j. Hence, the risk that a system has at least one critical region is
given by
Prisk = 1−
∏
dysfunctional
cells
P (`i < τ/2)
= 1−
L−τ/2∏
i=1
[
1− (1− ν)τ − (1− ν)2(L−i+1)
]δL
, (2.13)
where the exponent δL comes from multiplying the probabilities over each dysfunc-
tional cell in a column (i.e., all cells have the same i) and the product is over each
column (i.e., across all i). Note that for ν = 1 and ν = 0, Prisk = 0 for all values of
δL 6= 0 and that Prisk = 0 when no dysfunctional cells are present, δ = 0. It is also
interesting to note that for 0 < ν < 1,
lim
L→∞
Prisk = 1, (2.14)
that is, the quite abrupt transition from normal heart rhythm to fibrilatory behaviour
seen when the fraction of transversal connections decreases below a critical value
is technically an effect of the system having finite size. Unusually, though, as we
will prove below, this finite-size effect disappear extremely slowly and hence it is
physically relevant for all system sizes and is even present for systems with an area
the size of the Earth.
2.5.4 Estimating the threshold for fraction of transversal connections ν
We define the threshold for the fraction of transversal connections as the value of ν?
where the slope of the graph of Prisk vs. ν is steepest. For simplicity, we consider the
result where boundary effects are ignored, that is,
Prisk = 1− [1− (1− ν)τ ]δL
2
. (2.15)
We are searching for the non-trivial ν? that solves ∂
2Prisk
∂ν2
= 0. We find that
∂Prisk
∂ν
= −δL2 [1− (1− ν)τ ]δL2−1 τ (1− ν)τ−1 . (2.16)
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Hence, ∂Prisk∂ν < 0 for 0 < ν < 1 implying that Prisk is a monotonic decreasing function
of ν. We find that
∂2Prisk
∂ν2
= −δL2 [1−(1− ν)τ ]δL2−2 τ (1− ν)τ−2 [(δL2−1) τ (1− ν)τ − [1−(1− ν)τ ] (τ−1)] .
(2.17)
Therefore,
∂2Prisk
∂ν2
= 0⇔ ν =
01 (2.18)
or that ν? satisfies the equation
(
δL2−1) τ (1− ν?)τ − (τ−1) + (1− ν?)τ (τ−1) = 0. (2.19)
We solve this equation with respect to 1− ν?:
1− ν? =
(
τ − 1
δL2τ − 1
)1/τ
≈ (δL2)−1/τ , (2.20)
that is
ν? ≈ 1− (δL2)−1/τ (2.21)
because to a good approximation, τ  1 and δL2τ  1. Setting δ = 0.05, τ = 50 and
L = 200, we estimate the threshold ν? where Prisk increases abruptly to be at
1− ν? ≈ 0.86⇔ ν? ≈ 0.14. (2.22)
The threshold approaches 1 like L−2/τ , that is, extremely slowly because τ = 50. For
example, the threshold reaches ν? = 0.63 for L = 5 × 1011, corresponding to an atria
with an area the size of the Earth. Hence, although the transition is technically a finite-
size effect, it is relevant for all physiological system sizes and only disappears when
L =∞.
Thus we can relate physiological tissue parameters to the threshold amount of
connectivity around which fibrillation occurs. Anti-arrhythmic drugs which prolong
the refractory period increase the wavelength of re-entry θ′ × τ ′, thereby reducing
the number of possible independent electrical wavefronts which can propagate in
the atrium. This reduces the complexity of the fibrillation. However, in addition
to this, our model also predicts by Eqn.(2.21) that prolonging the refractory period
τ → τ˜ > τ reduces the structure-related risk of inducing fibrillation by rendering
once arrhythmic regions, for ν < ν?(τ), non-arrhythmic, for ν > ν?(τ˜). This implies
that functional changes can render structurally arrhythmic regions non-arrhythmic
without actually modifying the structure.
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2.5.5 3D Sheet
We now calculate Prisk for multiple sheets. Consider w parallel sheets of size L × L.
Each sheet has periodic boundary conditions transversally and open boundary con-
ditions longitudinally. This results in a cylindrical topology with cylinder thickness
w. The probability that a cell has at least one transversal connection, pν , is the com-
plement of having no transversal connections, that is,
pν = 1− (1− ν)n , (2.23)
where n = 3 if a cell is at the surface and n = 4 if the cell is within the bulk of the
tissue.
The probability that an arbitrary dysfunctional cell, i, is a distance `i < `min be-
comes:
P (`i < `min) = 1− (1− pν)n`min . (2.24)
So the probability that all dysfunctional cells (on average δw(L−2)2) have `i < `min =
τ
2 is
Prisk = 1−
∏
dysfunctional
cells
P
(
`i <
τ
2
)
= 1−
[
1− (1− ν) 32 τ
]2δL2 [
1− (1− ν)2τ
](w−2)δL2
(2.25)
We show the curve for Eqn. (2.5.5) for δ = 0.05, τ = 50, w = 7 and L = 200 in Fig. 2.7.
We see that the predicted behaviour of the system is similar to that of a 2-D system
as shown in Fig. 2.5, that is, there exists a sudden transition in the risk of AF as the
fraction of transversal connections is reduced below a threshold.
2.5.6 Phase space of the model
In this section we will systematically vary the fraction of transversal connections ν, the
fraction of dysfunctional cells, δ, and the probability that a dysfunctional cell does not
excite, . We measure the average of the fraction of time in AF 〈tAF 〉. For completeness
we vary the model parameters to potentially non-physiological ranges to characterise
the model.
Figure 2.8 shows how 〈tAF 〉 varies with both ν and δ. We see that a transition
from planar wavefronts to fibrillation as we lower ν below some threshold ν? occurs
for all fraction of dysfunctional cells δ. For ν > 0.35 we only observe planar wave-
fronts independent of the fraction of dysfunctional cells. This suggests that structural
heterogeneity is a necessary condition for AF in the model. For a small fraction of
dysfunctional cells, δ . 0.1, there is good agreement between the predicted risk of AF
given by Eqns. (2.5.3, 2.5.4) and the simulations. This suggests that the simple critical
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Figure 2.7: The probability that a three dimensional substrate, that is, a cylinder with finite thickness,
develops AF, Prisk. The parameters are: δ = 0.05, τ = 50, w = 7 and L = 200. A sudden transition from
no AF to AF as the fraction of transversal connections is reduced below a threshold occurs, similar to the
2-D lattice.
regions are the most relevant factor in determining AF in this regime, however, for a
larger fraction of dysfunctional cells more complex critical regions and other mechan-
isms may be important in determining AF. We will show in Chapter 3 that including
the next simplest set of critical regions in the analytic calculation slightly increases the
risk of AF and ν?.
Figure 2.9 shows how the average fraction of time in AF changes with . The
probability that a dysfunctional cell does not excite introduces an additional timescale
into the model. This is because the number of time steps required before a critical
region initiates a re-entrant circuit and the lifetime of a re-entrant circuit are both
functions of . Indeed, we will show in Sec. 3.3.1.1 that the average waiting time to
initiate or self-terminate a simple critical regions with one dysfunctional cell is 1/.
Thus  is to some extent a free parameter which constrains the timescale of the model.
This relationship is explored in detail in Chapter 3.
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Figure 2.8: Phase diagram of the average fraction of time in AF 〈tAF 〉 as a function of connectivity ν and
dysfunctional cells δ,  = 0.05. The colour represents the value of 〈tAF 〉 for each value of δ and ν. At
each white point we measure 〈tAF 〉 from 50 simulations running for T = 106 time steps at that given ν
and δ. Linear interpolation is used to construct the contour map in regions where 〈tAF 〉was not directly
measured. The red line is the analytical prediction of the threshold ν? ≈ 1− (δL2)−1/τ .
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Figure 2.9: Phase diagram of the model as we vary connectivity ν and the probability that a dysfunc-
tional cell does not excite . We see that an order in magnitude change in  shifts the location of the
transition very slightly. We note that  does not appear in our analytic calculation of Prisk. This suggests
that new mechanisms in the model are involved in causing AF in the model. However,  changes the
timescales at which AF occur and therefore using a fixed simulation time Ttot may not be appropriate.
This is explored further in Chapter 3.
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2.6 Ablation: Proof of Concept
We provide a proof of concept for ablation in the model. By rendering the region
containing this structure unexcitable, mimicking ablation, we find that the re-entrant
circuit terminates and planar wavefronts reappear, representing a return to regular
cardiac rhythm, see Fig. 2.10. We find that ablation is only successful when the system
has a few critical regions which occurs just below ν?. This suggests that there may
only be a narrow window for the fraction of transversal connections in which ablation
is successful.
a b c
d e f
Figure 2.10: a, A re-entrant circuit due to a critical structure. b, An ablation is made by rendering a
20 × 20 section of tissue around the critical structure unexcitable (cross hatched red). c-f, The ablation
terminates the re-entrant circuit and the system returns to a planar wavefront phase. For clarity these are
100×100 sections of the 200×200 system, see appendix Fig. A.3 for full image and associated animation
found in supplementary materials of [1]. Figure is reproduced from [1] under a CC-BY 3.0 license.
This result suggests that ablation can terminate AF because it is modifying the
substrate to remove the trigger of AF, which in this case is a critical region which
can initiate and maintain a re-entrant circuit. However, whilst ablation can terminate
a re-entrant circuit, it does not necessarily terminate the cause of the AF in the first
place. This is because, as we will show in Chapter 3, not all regions in which re-
entrant circuits are maintained are the result of critical regions, the trigger of AF in
the model. In Secs. 3.3 and 3.4 we show that regions that are triggers of AF in the
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model can maintain AF, but not all regions which maintain AF trigger AF. Therefore,
the ablation of regions which maintain re-entrant circuits does not remove regions
which trigger AF, and thus fails to prevent the recurrence of AF. However, early on
during the initiation of AF, the re-entrant circuit is normally centred around the region
which triggers AF. This implies that if regions were ablated shortly after the initiation
phase of a re-entrant circuit, then the triggers of AF could be removed. We calculate
the timescales over which a re-entrant circuit remains around its triggering region in
Sec. 3.3.
2.7 Scaling
In this section we expand on the coarse-graining procedure introduced in Sec. 2.3.
We check that the behaviour of the model does not change with the scaling parameter
b, where b × b is the number of cardiac cells represented in a single coarse-grained
cellular automaton cell.
If each cellular automaton (CA) cell were to represent a cardiac cell then the lattice
size for the surface area of an atrium would be 1000 × 1000 CA cells. However, the
processing time for running a large ensemble of these simulations over multiple para-
meters is infeasible. We instead coarse-grain the model by letting a cellular automaton
cell represent multiple cardiac cells, see Fig. 2.11.
   = 2
Figure 2.11: The coarse graining scheme for b = 2. As there is at least one transversal connection between
a group of cells then they are vertically connected after the coarse graining procedure. Similarly a group
of cells are coarse-grained into a dysfunctional cell if there is at least one dysfunctional cell across each
row that belongs to that group.
There are different ways in which one might coarse-grain the fraction of dysfunc-
tional cells. If we require that a dysfunctional coarse-grained cell must be able to block
an excitatory signal from reaching its adjacent coarse-grained cells from all four ori-
entations (left, right, up, down) then we must consider all possible internal configura-
tions of dysfunctional cells and transversal connections which accomplishes this. This
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would be computationally intensive, analytically cumbersome and introduce aniso-
tropy in the probability that a dysfunctional cell does not excite. To retain the essential
AF mechanism observed in the model we require that a dysfunctional coarse-grained
cell simply be able to block longitudinal excitation wavefonts. This is achieved by
requiring that each row in the coarse-grained cell contains at least one dysfunctional
cell, [1− (1− δ)b]b.
We also want to preserve the time-scale of the phenomena in the model so that
the translation of times in the model to real time are not effected by coarse-graining.
The time-scale of phenomena in the model translated to real time are proportional to
1
T∆t
′ or 1 τ∆t
′, we know that τ → τ/b , T → T/b and ∆t′ → b∆t′, therefore under
coarse-graining the time-scale of the phenomena are already preserved (1T∆t
′ →
1

T
b b∆t
′ = 1T∆t
′) and we do not need to change  to preserve the time-scales of the
model. We emphasise that the coarse-graining procedures for δ and  are chosen to
preserve the primary mechanism of AF and time-scales observed in the model as well
as computational and analytic simplicity. In any case, we know the model behaviour
is preserved across large ranges of both these parameters as shown in Sec. 2.5.6.
If b = 1 then a single cell in the CA model is equivalent to a single cardiac cell
as the fundamental spatial scale is ∆x′ = 100µm, the length of a myocyte. As the
conduction velocity θ′x = ∆x′/∆t′ ≈ 0.2 ms−1 is fixed we also get ∆t′ → b∆t′. That
is, the fundamental timescale of the model (the time taken for a cell to depolarise
∆t′ ≈ 0.6 ms) also increases by a factor b. We had L = L′/∆x′ = 1000.
So the quantities in the model scale as
∆x′ → b∆x′, (2.26a)
∆t′ → b∆t′, (2.26b)
L → L
b
, (2.26c)
T → T
b
, (2.26d)
τ → τ
b
, (2.26e)
ν → 1− (1− ν)b, (2.26f)
δ → [1− (1− δ)b]b, (2.26g)
where we note that the parameters on the right hand side of these expressions are
the non-coarse-grained values, for example, L = 1000 on the right hand side of Eqn.
(2.26c).
We now vary b to see how this changes the behaviour of the model. The coarse-
grained values are shown in Table 2.2. As the coarse-graining changes the parameter
T we need to change the total duration of the simulation. This is because the timescale
of the phenomena in the model will be proportional to T/. Thus, as a rule of thumb
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we set the total simulation time to be on the order of Ttot ∼ T/ × 102 to ensure the
results are comparable.
Scaling Parameter b L T τ δ 
1 1000 1100 250 0.15 0.05
2 500 550 125 0.07 0.05
5 200 220 50 0.05 0.05
Table 2.2: Parameters of the model and scaled values.
We observe that the behaviour of the model is approximately the same for a range
of scaling parameters b, see Fig. 2.12. Thus we conclude that coarse-graining the
model does not have a significant impact on the dynamics of the model.
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Figure 2.12: The average fraction of time in AF 〈TAF 〉 versus fraction of transversal connections ν at two
different scaling parameters, b = 2 (red cross) and b = 5 (blue cross). The analytically calculated risk of
AF, Prisk (see Eqn. (2.5.3)), is also shown for the model parameters with scaling parameters b = 2 (red
line) and b = 5 (blue line). We see that Prisk is a good fit to the data across different scaling parameters.
2.8 Discussion
The incidence of AF increases with age and is strongly associated with structural
changes such as the accumulation of fibrosis and gap junctional uncoupling. Our
main objective was to gain insight into the mechanisms responsible for the initiation
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and maintenance of AF in this context using a phenomenological model. This deliber-
ately simple model includes basic properties of tissue architecture and electrical dys-
function, whilst excluding more complex electrophysiological properties normally
thought to be important in fibrillation such as the dispersion of refractoriness and
restitution. We do not conclude that dispersion of refractoriness and restitution are
not important in AF, but that it is possible to reproduce many clinically observed fea-
tures of AF without them. Namely, (1) the appearance of self-sustaining circulating
wavefronts, (2) the spontaneous initiation and termination of AF events akin to par-
oxysmal and persistent AF, (3) propensity to AF linked to structural heterogeneity
and (4) ablation in some instances terminating AF behaviour.
The most interesting aspects of this study are: (1) The mere simplicity of the
model. (2) The integration of simplified dynamics on a relevant discrete medium
mimicking the anisotropic branching architecture of heart muscle. (3) A single model
that reproduces multiple well known observed features of AF. (4) The spontaneous
emergence of AF (without external stimuli) when the transversal coupling is reduced,
mimicking fibrosis, beyond a threshold value. (5) Identification of local critical regions
initiating and maintaining AF. (6) Analytical tractable risk of AF. (7) The existence of
an analytically tractable threshold value of heterogeneity below which AF emerges,
providing insight into how to control the risk. (8) A targeted ablation procedure is
possible.
The model identifies specific targets for ablation based on the underlying struc-
ture of the myocardium. Patterned cultures of cardiac myocyte monolayers or car-
diac tissue slices could test the primary predictions of the model as stated above. If
the biological experiments agree with the model predictions then such targets within
a biological system might be characterised electrophysiologically or architecturally
with the aim of translating such insight into clinical applications thereby, hopefully,
improving the success rate of treating AF with ablation.
2.9 Summary
In this chapter we have:
• Introduced a new cellular automaton model of atrial fibrillation where the struc-
ture of the lattice mimics the anisotropic branching structure of heart muscle
tissue. We study the evolution of excitation wavefronts on this lattice.
• Characterised the models macroscopic behaviours as a function of model para-
meters. We observe a transition from planar wavefront behaviour to AF as we
reduce the fraction of transversal connections ν.
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• Used the average time in AF to quantify changes in model behaviour. We related
the average time in AF to the risk that a particular lattice develops AF.
• Derived the risk of AF, Prisk, analytically by considering particular arrange-
ments of connections and dysfunctional cells which initiate AF in the model.
We showed that Prisk fits the data well in a physiological range.
• Derived the fraction of transversal connections at which we observe the trans-
ition ν?. We extended the calculation to 3D where we still expect to observe a
sudden transition as a function of transversal connectivity.
• Provided a proof of concept that rendering regions of cells unexcitable, i.e., ab-
lation, can terminate AF in the model.
• Provided a phase diagram of the model, see Fig. 2.8. We see that the behaviour
of the model is robust over a wide range of values for the parameters ν, δ and .
• Introduced a coarse-graining scheme and show that the model behaviour is ro-
bust at a range of scales of coarse-graining.
• Discussed the potential physiological and clinical implications of the model.
In this chapter we have primarily presented a study on the average behaviour
of a sample of lattices as we change model parameters. However, lattices generated
from the same set of parameters can produce very different behaviours. In the next
chapter we study the microscopic behaviour of the model which determine whether
a lattice undergoes no, paroxysmal or persistent AF. By uncovering the microscopic
mechanisms of the models AF behaviour we also introduce methods of quantifying
and predicting the behaviour of a given lattice, for example the event duration and
frequency.
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Chapter 3
Microscopic Mechanisms and the
Dynamics of the Model
The duration of AF episodes clinically observed lie on a continuum with event dur-
ations spanning several orders of magnitude in time [37]. A range of factors (e.g.,
fibrosis, diabetes, structural heart disease, congestive heart failure) have been associ-
ated with the progression of AF from short lived episodes to apparently permanent
episodes. There are also many competing theories regarding the type of wavefront
activity which governs AF. How these proposed mechanisms dictate quantitatively
the temporal patterns of AF, such as the frequency and duration of events, are cur-
rently unknown.
In the previous chapter we showed how the average behaviour of a sample lattices
(e.g., the sample average of the fraction of time in AF) change with model parameters
without discussing the variability of behaviours shown within those samples. Of
particular interest, the previous chapter did not explain why AF event duration and
burden in the model can vary widely for simulated tissues with the same fraction of
transversal (vertical) connections.
In this chapter we study the microscopic mechanisms of AF initiation and main-
tenance. We find that local patterns of transversal connections and dysfunctional cells,
critical structures, can initiate AF by creating re-entrant circuits. AF maintenance
occurs by the further creation of re-entrant circuits by other critical structures and
wavefront-wavetail collisions. This leads us to characterise AF as a stochastic process
in which re-entrant circuits are probabilistically created and annihilated. This allows
us to predict quantitatively the macroscopic behaviour of the model and the temporal
patterns of AF events from microscopic mechanisms. Thus this chapter details the mi-
croscopic mechanisms which drive the average macroscopic behaviour and temporal
variability of the model introduced in the previous chapter.
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3.1 Introduction
The duration of AF episodes lie on a continuum with event durations which can span
several orders of magnitude in time from seconds to decades [37]. How the frequency
and duration of AF episodes are determined by the mechanisms of AF and modulated
by the structure of the myocardium is unknown. Linking myocardial structure and
the temporal behaviour of AF might provide new ways of classifying a patient based
on structural characteristics of their myocardium. This is in contrast to classifying a
patient by arbitrarily thresholding the time a patient has been in AF [180]. Conversely,
it may be possible to infer structural characteristics of a given patients’ myocardium
from the temporal history of AF.
We use the cellular automaton model of AF defined in the previous chapter. The
model uses a lattice which mimics the anisotropic branching structure of myocar-
dium which can be used to investigate the effects of structural heterogeneity (e.g.,
fibrosis and gap junctional uncoupling). We observe a range of event durations for
the same structural parameters (e.g., fraction of transversal connections), thus these
global characteristics do not directly determine the temporal patterns of AF.
We examine the microscopic mechanisms which initiate and maintain AF in the
model, in doing so we quantify the how temporal characteristics of AF relate to struc-
tural and functional properties of the myocardium. We find that AF initiation is
triggered by critical structures: specific arrangements of transversal connections and
dysfunctional cells which disrupt a planar wavefront to create a re-entrant circuit.
AF is then initially maintained by re-entry around the triggering critical structure.
However, re-entry around the triggering critical structure is too short lived to account
for the AF episode durations we observe. We find that AF is maintained by the cre-
ation and annihilation of further re-entrant circuits akin to a birth-death process. The
initial re-entrant circuit creates further re-entrant circuits by two mechanisms: 1) ac-
tivating other critical structures and 2) wavefront-wavetail collisions.
In case 1), we note that whether a critical structure can initiate a re-entrant circuit is
dependent on the orientation of the incident wavefront. For example, a mirror image
of the simple critical structure shown in Sec. 2.5.3 requires a planar wavefront form
the right, rather than left, to create a re-entrant circuit. Thus, not all critical struc-
tures can create a re-entrant circuit from the sinus rhythm wavefronts. These non-
triggering critical structures require triggering critical structures to create re-entrant
circuits to provide waveronts from the necessary orientation. Thus we must distin-
guish between critical structures which initiate AF, maintain AF or both.
In case 2), the accidental collisions between a wavefront and a wavetail can result
in a re-entrant circuit. In this case the re-entrant circuit is not determined by the
configuration of transversal connections and dysfunctional cells but by the dynamics
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of wavefronts. Thus, re-entrant circuits generated by wavefront-wavetail collisions
are not necessarily pre-determined by the structure of the local region unlike critical
structures. This has clinical consequences as it implies that ablating sites of re-entry
may not actually be modifying the atrial substrate to reduce the recurrence or severity
of AF in some cases.
Thus to determine the relative importance between these two competing mechan-
isms for AF maintenance we propose a mean-field model in the form of a stochastic
process. By studying this stochastic process we can analytically predict the time in
AF and AF event statistics that would be expected if critical structures were the only
fibrillatory mechanism. Thus we separate the various factors and mechanisms which
contribute to one or both of AF initiation and maintenance.
To summarise, we show that critical structures and the interactions between them,
along with wavefront-wavetail collisions determine the dynamics of AF in the model.
Consequently, we are able to quantitatively relate the temporal patterns of AF to the
underlying structure of the lattice.
3.2 Temporal Patterns of Atrial Fibrillation
In Chapter 2 we observed how the average behaviour of the model over a sample
of lattices changed with model parameters, in particular the fraction of transversal
connections ν. However, for a fixed ν we observe significant variability in behaviour
across a given sample of N lattices, see Fig. 3.1 where ν = 0.16. We see that even for
a fixed ν we can get a wide spectrum of AF behaviours. So whilst ν can predict the
general tendencies of the model, it does not explain the temporal patterns of AF for a
specific simulation.
We observe that as ν is lowered and passes below a threshold ν? that the propor-
tion of simulations which display AF increases, see appendix Fig. B.1. The AF event
duration and frequency increases overall, however, around the transition we observe
significant variability in the temporal behaviour of simulations. This is in agreement
with the clinical observation that patients with similar amounts of fibrosis can display
very different AF behaviours [37].
In Fig. 3.1, we show that it is possible for a simulation to have AF behaviour even
in the absence of simple critical structures. The fraction of time in AF as a function of
simple critical structures is shown in Fig. 3.2. This suggests that either other critical
structures exist or another mechanism contributes to AF initiation and maintenance
in the model. Consequently, in the following section we manually observe the be-
haviour of simulations at key periods such as the initiation of AF events and follow
their progression into either self-termination or persistence. We explore the structure
of the regions around which re-entrant wavefronts are observed and find other critical
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Figure 3.1: The number of excited cells against time illustrating the temporal AF patterns in the model.
Each panel refers to a simulation of duration of 107 time steps with L = 200, τ = 50,  = 0.05, and
δ = 0.05. Pacemaker cells self-activate with a period of T = 220. Each simulation has a different lattice
that is generated with a fraction of transversal connections of ν = 0.16 > ν? ≈ 0.14. The number of
simple critical structures n(1)cs varies between simulations, the superscript of one refers to the fact that
a dysfunctional cell only needs to not excite once for a re-entrant wavefront to be created. We see later
that other critical structures exist which require a dysfunctional cell to not excite more than once for
a re-entrant wavefront to be created. We find that even with no simple critical structures AF can be
observed.
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Figure 3.2: The fraction of time in AF versus the number of simple critical structures n(1)cs . This data is
pooled over 160 simulations with ν = 0.135, 0.14, 0.15, 0.16, 0.20 which were run for 107 time steps with
L = 200, τ = 50,  = 0.05, and δ = 0.05. Pacemaker cells self-activate with a period of T = 220. We see
that the number of simple critical structures is a good predictor of whether the simulation will display
a large fraction of time in AF, however, simple critical structures are not necessary for AF. We see in the
following section that other critical structures and mechanisms exist in the model.
structures and mechanisms of AF maintenance in the model.
3.3 Observing the Mechansims of AF in the Model
In this section we describe observations from manually inspecting simulations during
key periods such as AF initiation and its progression to persistence or self-termination.
We pay special attention in particular to those simulations which had no simple crit-
ical structures.
3.3.1 AF initiation
AF appears to be initiated when one or more dysfunctional cells disrupt the incoming
planar wavefront such that it causes wavebreak: the wave of excitation turns back
on itself through the refractory wake and establishes a re-entrant circuit. The local
arrangement of transversal connections and dysfunctional cells have to be arranged
in a specific way to allow wavebreak to occur and for a re-entrant circuit to be estab-
lished. We call such local arrangement of transversal connections and dysfunctional
cells “critical structure”. Critical structures can be categorised by the constituent ar-
rangement and number of transversal connections and dysfunctional cells. We can
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also compute temporal properties of the re-entrant circuits generated by critical struc-
tures from knowing the constituent arrangement and number of transversal connec-
tions and dysfunctional cells. We now provide categories of critical structures and the
temporal properties of the re-entrant circuits they create. These results are generalised
from visually inspecting AF initiation.
3.3.1.1 Primary simple critical structures
For simulations around or below the threshold, ν . ν?, we found the simplest critical
structure, described in Chapter 2 Sec. 2.5.3, which can initiate re-entrant circuits, see
Fig. 3.3. We call this a primary simple critical structure as only one dysfunctional cell
is required to not excite once to initiate a re-entrant circuit.
Figure 3.3: A primary simple critical structure. This particular arrangement of transversal connections
and a dysfunctional cell is able to initiate and maintain a re-entrant circuit. ` is the distance between a
dysfunctional cell and a cell with at least one transversal connection (dotted line) to the right.
We now compute the expected waiting time tinit for a primary simple critical
structure to be created when pacemaker cells produce planar wavefronts with period
T . A re-entrant circuit is generated when a particular dysfunctional cell in the critical
structure does not excite, that is, it disrupts the incoming wavefront. This occurs with
probability . So the probability that a re-entrant circuit is generated when the nth
wavefront passes the critical structure is given by a geometric distribution
P [n] = (1− )n−1. (3.1)
The expectation value of n is 〈n〉 = 1/, that is, on average we expect to see one re-
entrant circuit initiated after 1/ wavefronts. Thus the expected waiting time until we
observe a re-entrant circuit from such a structure is given by
〈tinit〉 = T

(3.2)
where the factor of T is due to dysfunctional cells being excited every T time steps,
set by the pacemaker period. For T = 220 and  = 0.05 we have 〈tinit〉 = 4400.
Hence, a system with a primary simple critical structure can be expected to go into
AF rapidly, that is, around 20 sinus rhythm wavefronts or simulated heart beats. We
note that this timescale is determined by the model parameter . The re-entrant circuit
self-terminates when the dysfunctional cell disrupts the circulating wavefront. For a
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circuit which contains k dysfunctional cells the probability that at least one of these
dysfunctional cells interrupt the wavefront is given by 1 − (1 − )k. The probability
that the re-entrant circuit terminates on the mth rotation of the wavefront is given by
P [n] = (1− )k(m−1)(1− (1− )k). (3.3)
This is also a geometric distribution. Thus the lifetime of the re-entrant circuit, 〈tcircuit〉,
is given by
〈tcircuit〉 = λ
1− (1− )m (3.4)
where λ is the pathlength of the circuit.
We note that Eqn. 3.3 is more general; it is the probability of initiating or termin-
ating a re-entrant circuit for any process that requires at least one of k dysfunctional
cells to not excite. For a single dysfunctional cell in a re-entrant circuit, k = 1, and a
pathlength equivalent to the refractory period, λ = τ = 50 we get 〈tcircuit〉 = 4400.
These events are clearly much shorter than what is observed. This suggests that the
mechanisms of AF maintenance are more complex. We compare these time-scales to
the event durations observed in the model in Sec. 3.5.3.
3.3.1.2 Secondary simple critical structures
In some simulations, in particular those without simple critical structures, we observe
second order or secondary simple critical structures initiate re-entrant circuits. The
second order simple critical structure is illustrated in Fig. 3.4. We call the structure
second order because it requires that the same dysfunctional cell not excite twice, oc-
curs with probability 2  , for the re-entrant circuit to be initiated. Hence such struc-
tures are not only rarer as they possess more constraints on the number of transversal
connections but are also rarer to initiate AF because they require a dysfunctional cell
not to excite more than once. The expected waiting time for such a structure to initiate
AF is
〈tinit〉 = T
2
, (3.5)
for T = 220 and  = 0.05 we get 〈tinit〉 = 88000 time steps, that is, 400 sinus rhythm
wavefronts or heart beats.
We now re-calculate Prisk with the second order critical structure included. The
probability that a transversal connection exists is given by ν. The probability that a cell
has at least one transversal connection, pν , is the complement of having no transversal
couplings, that is,
pν = 1− (1− ν)2 . (3.6)
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(1)
(2)
(1)	=	0
(2)		>	τ/2
a b
Figure 3.4: A schematic for second order simple critical structures. The dotted line represents the pres-
ence of at least one transversal connection, either up or down. a, We define the distance from a dysfunc-
tional cell to the first and second nearest neighbour to the right by `(1) and `(2) respectively. b, A second
order simple critical structure, these differ from simple critical structures in that they possess at least
one transversal connection on the initiating dysfunctional cell and require that`(1) = 0 and `(2) > τ/2.
This particular arrangement of transversal connections and a dysfunctional cell is able to initiate and
maintain a re-entrant circuit also. This arrangement of cells and transversal connections can be seen in
AF initiating regions in Fig.3.11b.
Given an arbitrary dysfunctional cell i, let `(1)i and `
(2)
i denote the distance (measured
in number of links) from that cell to its first and second neighbour to the right that
has at least one transversal connection, respectively. Previously, in section 2.5.1, we
neglected `(2)i and looked at `i = `
(1)
i . As the path length must be greater than the
refractory period we now require that `(1)i > τ/2 or alternatively `
(1)
i = 0 and `
(2)
i >
τ/2 for a dysfunctional cell to be part of a critical structure. Thus the probability that
a dysfunctional cell i does not belong to the start of a critical structure is:
P [Not Critical] = P (0 < `(1)i < τ/2) + P (`
(1)
i = 0, 0 < `
(2)
i < τ/2)
= (1− pν)
τ/2−1∑
`
(1)
i =1
(1− pν)`
(1)
i pν + pν
τ/2−1∑
`
(2)
i =1
(1− pν)`
(2)
i pν (3.7)
From the sum of a geometric series we can show that
pν
τ/2−1∑
`=1
(1− pν)` = 1− (1− ν)τ−2 (3.8)
so that Eqn. 3.7 becomes
P [Not Critical] = 1− (1− ν)τ−2. (3.9)
Following the same steps as in Sec. 2.5.1 we calculate the probability that at least one
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Figure 3.5: The risk of AF incorporating both first and second order simple critical structures. The model
parameters are L = 200, τ = 50,  = 0.05, and δ = 0.05. Pacemaker cells self-activate with a period of
T = 220. The blue crosses represent the average duration that a system displays non-planar wavefronts,
averaged over 50 realisations of duration 106 time steps and error bars represent one standard error of
the mean. Second order critical structures do not significantly change the risk of AF (red line) compared
to the analytic calculation of Prisk which neglects them (red line).
dysfunctional cell belongs to the start of a critical structure to be
P
(2)
Risk = 1− (1− (1− ν)τ−2)δL
2
. (3.10)
This is the original equation for PRisk but with τ → τ − 2. Thus for large τ we do not
expect that secondary simple critical structures change the risk of AF significantly, see
Fig. 3.5.
3.3.1.3 Complex critical structures
We call a critical structure complex if it requires more than one dysfunctional cell to
not excite in order for it to initiate a re-entrant circuit. Consider a cable with a dys-
functional cell. With first order simple critical structures we required that the first
transversal connection to the right of this dysfunctional cell had to exceed some min-
imum distance, ` ≥ τ/2. A transversal connection occurring at a distance shorter than
this would would provide an opportunity for a wavefront in an adjacent cable to re-
excite the primary cable without forming a re-entrant circuit. However, if additional
dysfunctional cells could block the wavefront from the adjacent cable from re-exciting
the primary cable then a re-entrant circuit could be established with a transversal con-
nection located further down the cable, see Fig. 3.6. The probability that such complex
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Figure 3.6: Complex critical structures, these require more than one dysfunctional cell to not excite
to establish a re-entrant circuit. a-b, Consider the incipient dysfunctional cell, which could have any
number of transversal connections (dotted gray line) depending on whether it will initiate like a first
order or second order simple critical structure, which has a transversal connection to the right which
is at a distance of ` ≥ τ/2. If intermediate transversal connections (black dashed lines) co-occur with
dysfunctional cells then these dysfunctional cells can block wavefronts from adjacent cables which may
have stopped the formation of a re-entrant circuit. c-d, These critical structures initiate AF in identical
ways to those shown in a and b, however, require that all intermediate dysfunctional cells occur on
one side. It is also possible to have a mixture between the structures shown in a-b and c-d, where
dysfunctional cells occur on the primary cable as well as adjacent to it. We can generalise the above
complex critical structures by having more intermediate dysfunctional cells, however, this decreases
their probability of initiating a re-entrant wavefront by a factor of  for each additional dysfunctional
cell.
critical structures initiate a re-entrant wavefront range from 2 to 5 and is determined
by the number of intermediate dysfunctional cells. Indeed, the probability of initi-
ation decreases by a factor of  and probability of termination increases by a factor of
 for each additional intermediate dysfunctional cell.
An additional complex critical structure relies on the wavefront arriving in a par-
ticular state. Consider τ even, if `(1)i = τ/2 − 1 < τ/2 then this dysfunctional cell
does not form a primary simple critical structure, but is very close to doing so. If the
excited wavefront in the neighbouring cable is lagging by one cell then the cell behind
the dysfunctional cell will be at rest by the time the excited wavefront returns from the
adjacent cable with the lagging wavefront, that is, 2`(1)i + 2 = τ time steps elapse by
the time the excited wavefront returns and a re-entrant circuit can be formed, see Fig.
3.7. The actual body of the critical structure could be complex, this does not matter.
The lag in the wavefront is caused by a dysfunctional cell disrupting the wavefront
earlier in the simulation. Thus another dysfunctional cell was required to not excite
for this structure to establish a re-entrant wavefront. Thus the distance between a
dysfunctional cell and a transversal connection can be shorter by one and still allow
the formation of a re-entrant circuit.
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Figure 3.7: A complex critical structure as a result of the state of the incident wavefront. We see that the
second cable has an excited cell which is lagging the excited cell in the first cable by one. This occurs due
to a dysfunctional cell interrupting that cable earlier in the simulation. The body of the critical structure
can mimic any of the critical structures seen previously. However, the transversal connection is located
so that the distance ` = τ/2 − 1 < τ/2 which would not normally allow a circuit to form. However,
this lag implies that the wavefront will travel a path (blue arrow) length of p = τ when it returns to
the dysfunctional cell, thus allowing a re-entrant circuit to form. The initial dysfunctional cell can have
any number of transversal connections (dotted gray line), this just effects the probability of initiating the
structure.
The critical structures shown in this section all required more than one dysfunc-
tional cell to not excite in order for a re-entrant circuit to be established. Thus these
more complex critical structures are expected to occur less frequently and to be shorter
lived. We do not calculate their exact contribution to the risk of AF, however, they
would increase the risk of AF by less than that of secondary critical structures and
therefore would not adjust the risk by much.
3.3.2 AF maintenance
We now discuss how, after an initial re-entrant circuit is generated, fibrillatory activity
is maintained. We observe AF event durations as short as a few time steps to as long
as the full duration of simulations 107 time steps. Thus we can infer that the presence
of the initial re-entrant circuit is not the mechanism by which AF is maintained.
3.3.2.1 Robust critical structure
In principle, it could be possible that a specific critical structures create re-entrant
circuits which are robust to standard mechanism of termination, disruption from a
single dysfunctional cell. Re-entrant circuits from such critical structures would be
longer lived because to terminate they require either multiple dysfunctional cells to
simultaneously not excite or must be out-paced by other higher frequency sources
of wavefronts such as a smaller critical structure. Figure-of-eight re-entry where two
circuits However, no such critical structures have yet been observed visually or are the
constituent arrangement of dysfunctional cells and transversal connections known
theoretically.
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3.3.2.2 Multiple re-entrant circuits
It is common to see a re-entrant circuit initiate at a specific region. This region then
emanates nearly concentric wavefronts out into the tissue. These much more frequent
wavefronts then create a re-entrant circuit to form elsewhere. AF is then maintained
by continuous creation and annihilation of re-entrant circuits akin to a birth-death or
branching process where re-entrant circuits give “birth” to further re-entrant circuits.
This idea is developed further into a mean-field model in Sec. 3.5. Thus despite
critical structures being short-lived they can create other re-entrant circuits such that
the process becomes much longer lived. The duration of an AF event is dictated by
the interplay between the creation and annihilation of re-entrant circuits.
We observe two mechanisms by which a re-entrant circuit can create further re-
entrant circuits: 1) critical structures and 2) wavefront-wavetail collisions. The factors
which promote these mechanisms for re-entrant circuit formation can differ. We sum-
marise these ideas regarding AF initiation, maintenance and termination in Fig. 3.8.
AF	initiation
Triggering	critical	structure	
AF	maintenance
Initial	
re-entry
circuit
Mechanisms	to	create	more	re-entry	circuits
Critical	structures
• Types:	Trigger,	non-trigger, simple,	complex
• Existence	depends	on	ν		δ,
• Probability	of	creating	re-entry	circuit	depends	on	
incident	wavefront orientation	and	frequency
Wavefront-wavetail collisions
• Collisions	occur	at	high	wavefront frequency
• Heterogeneous	wavetail promotes	re-entry
• Heterogeniety depends	on	 , , and	frequency
Re-entry	circuit
• Occurs	at	same	
location	as	
critical	
structure
Re-entry circuit
• Occurs	at	point	
of	wavefront-
wavetail
collision
AF	termination
Dysfunctional	cells	in	re-entry	circuit	do	not	excite,	interrupts	and	terminates	circuit
ν		δ		ε
ε
Figure 3.8: A schematic for how AF is initiated, maintained and terminated. A critical structure initially
triggers AF by creating a re-entrant circuit. The initial re-entrant circuit creates further re-entrant circuits
through two mechanisms: other critical structures and wavefront-wavetail collisions. These new re-
entrant circuits can create further re-entrant circuits by the same mechanism. AF termination occurs
when dysfunctional cells disrupt the re-entrant circuits.
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Critical structures
We must distinguish between critical structures which initiate AF, maintain AF or
both. All the critical structures shown in Sec. 3.3.1 initiate AF and can then maintain
a re-entrant circuit. However, we could consider the mirror image of these critical
structures so that they are inverted about the transversal axis. They would not initiate
AF from planar wavefronts arriving from the left, that is, from the pacemaker cells.
However, wavefronts arriving from the right (e.g., if another source of wavefronts
such as a re-entrant circuit is present) could be disrupted by these inverted critical
structures to create new re-entrant circuits. Thus these inverted critical structures can
contribute to AF maintenance but not AF initiation.
More generally, new re-entrant wavefronts could be generated by other critical
structures which only create new re-entrant circuits if wavefronts arrive from a par-
ticular direction. The re-entrant circuits generated by these critical structures have
a specific property: they only occur at fixed locations on the lattice where the crit-
ical structures are. Therefore these locations become potential candidates for ablation
therapy to either terminate AF or decrease its maintainability. We now show that
wavefront-wavetail collisions can create re-entrant circuits in principle anywhere on
the lattice.
Wavefront-wavetail collisions
Re-entrant circuits produce wavefronts at higher frequencies than pacemaker cells
thus reducing the distance between a wavefront and the wavetail of the antecedent
wave. The waves become increasingly heterogeneous in time due to dysfunctional
cells not exciting. This causes wavefronts to take more tortuous paths to excite the
tissue, this effect compounds until the wavefronts propagating in the local region are
more heterogenous then they were at the start of a re-entrant circuit, see Fig. 3.9.
A wavefront can collide with the wavetail of the antecedent wave. If the wavetail
is spatially heterogeneous this can result in wavebreak of the wavefront which can
result in the formation of a re-entrant circuit, see Fig. 3.10.
The pacing period during sinus rhythm is long (i.e., low frequency), therefore,
we do not observe wavefront-wavetail collisions initiating AF. These collisions do
however contribute to the persistence of AF by creating re-entrant circuits. We have
not systematically studied the factors which might effect whether wavefront-wavetail
collisions result in the creation of re-entrant circuits. This is left for future work.
However, from inspection it appears that wavetail heterogeneity would promote the
creation of re-entrant circuits. Therefore local regions with a greater number dysfunc-
tional cells and lower transversal connectivity, which promote wavetail heterogeneity,
would be expected to encourage the creation of re-entrant circuits through wavefront-
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Figure 3.9: At the start of a re-entrant circuit we see more uniform wavefronts which take less tortuous
paths compared to approximately 1500 time steps later. The number of excited cells as function of time
for this simulation is shown below the snapshots of the lattice, the red line is the time of the snapshot.
The streaks are imprints of wavefronts being blocked by dysfunctional cells which resulted in excited
cells attempting to re-enter but being blocked by refractory tissue, the streaked regions are now refract-
ory when the wavefronts from the re-entrant circuit arrive. The wavefronts being less uniform and the
paths they take become more tortuous in time. This results in patches of heterogenous refractory tissue
belonging to wavetails. This heterogeneity promotes the formation of new re-entrant circuits during
wavefront-wavetail collisions.
wavetail collisions. This is consistent with the observations in Sec. 3.4.3 where regions
which we expect contained re-entrant circuits from wavefront-wavetail collisions had
less transversal connectivity and more dysfunctional cells than expected.
The regions where wavefront-wavetail collisions give rise to new re-entrant cir-
cuits could be modulated by the location of the source of the initial wavefronts, the
structure of the lattice and whether dysfunctional cells do not excite in some particular
order. Whether wavefront-wavetail interactions which give rise to re-entrant circuits
which are structurally determined is explored in Sec. 3.4.5.
We do not know to what extent each mechanism (i.e., critical structures and wavefront-
wavetail collisions) contributes to the creation of re-entrant circuits. This would be of
clinical significance as the re-entrant circuits created by these two mechanisms have
different relationships to the underlying structure in which they exist. Critical struc-
tures generate re-entrant circuits at a fixed location in the tissue due to the underly-
ing structure, whereas wavefront-wavetail collisions could in principle generate re-
entrant circuits anywhere. Therefore, if the objective of ablation is to reduce the re-
currence and propensity to maintain AF then it would be natural to target re-entrant
circuits created by critical structures rather than wavefront-wavetail collisions. The
mean-field model in Sec. 3.5 and tracking re-entrant circuits explicitly in Sec. 3.4
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Figure 3.10: The initiation of a new re-entrant circuit when a wavefront collides with a patch of refractory
tissue belonging to a wavetail of a different wavefront. At t=0 to t=17 a wavefront emitted from the
central re-entrant circuit collides with the wavetail of the antecedent wavefront. From t=32 to t=60, the
surrounding waves are able to turn through the wavebreak, however, they collide with new wavefronts
generated from the central re-entrant circuit. From t=1109 to t=1180 we observe that when the central re-
entrant circuit has terminated the wavefronts can now successfully re-enter from the wavebreak caused
by the wavefront-wavetail collision resulting in a new re-entrant circuit.
attempts to address which mechanism is dominant in the model.
3.3.3 Discussion
Through manual observation we found that AF initiation was caused by particular
local arrangements of transversal connections and dysfunctional cells, critical struc-
tures, that created re-entrant circuits. We categorised the simplest set of these critical
structures by looking at their constituent transversal connections and dysfunctional
cells. It is likely that there exist more complex critical structures, however, as the more
complex these structures becomes the less likely they are to to initiate a re-entrant cir-
cuit or even to exist on the lattice.
With the addition of more critical structures we see small perturbations in the
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risk of AF. The predicted risk of AF, derived from the probability of there being at
least one primary simple critical structure, over-estimates the actual risk of AF, see
Fig. 3.5. This may be due to the stability of paroxysmal AF events throughout a
simulation lifetime for these smaller values of ν where AF persistence appears rarer,
see appendix Fig. B.1. This is to be expected as we assumed in the calculation of Prisk
that a simulation with a critical structure would develop persistent AF rapidly. As
we move up the transition we see that the risk of AF is under-estimated by the same
probability Prisk, this implies the overall lattice is more prone for AF to persist. This
may be due to the more complex critical structures which trigger AF as well as those
that maintain AF which are not accounted for in the Prisk derivation. It might also
be the case that wavefront-wavetail collisions are more likely to produce re-entrant
circuits for smaller ν, but we have not shown this.
AF maintenance in the model appears to be driven by the creation of re-entrant cir-
cuits by other critical structures (which may be unable to initiate AF) and wavefront-
wavetail collisions. To establish the relative importance in maintaining AF between
these two mechanisms we formalise the stochastic process we expect from a lattice
containing only a finite number of critical structures and we neglect spatial effects,
hence we develop a mean-field model. We will discuss this in Sec. 3.5. The underlying
structure around the re-entrant circuit would be different if the circuit were created
by a critical structure or wavefront-wavetail collisions. So we also track re-entrant
circuits explicitly to look at the structure of the underlying lattice to detect which
mechanism might be prominent, see Sec. 3.4. Establishing the mechanisms which
create re-entrant circuits has biological implications regarding how AF is maintained,
but also clinical implications regarding the ablation of re-entrant circuits.
AF termination occurs in the model through the action of dysfunctional cells dis-
rupting the re-entrant circuits. Thus we have presented the mechanisms which gov-
ern AF in this cellular automaton model. Consequently we can generate hypotheses
regarding the relationship between myocardial structure and the dynamics of AF
which in turn has implications for clinical therapies. We will discuss the clinical im-
plications of these results in more detail in Sec. 3.7.
In Sec. 3.5 we develop and study the mean-field model. However, before we do
this we study systematically the regions where re-entrant circuits form in the model
using automated methods rather than manually tracking the model.
3.4 Re-entry Tracking
We investigate the structure of the lattice around the regions where we observe re-
entrant circuits. We develop an algorithm that allows us to automatically track re-
entrant circuits and the corresponding structure of the tissue. The automated tracking
3.4. RE-ENTRY TRACKING 103
of re-entrant circuits is a useful tool which allows us to:
1. Highlight specific regions which sustain re-entrant circuits allowing us to char-
acterise regions by their structure and correlate them with the behaviour of sim-
ulations.
2. Gather a large number of samples of regions where re-entrant circuits has oc-
curred for statistical analysis of the structure.
3. Show that a re-entrant circuit is always present during AF in the model.
4. Observe structures which cannot be categorised by inspection. These are stud-
ied individually to generate insight into how AF is initiated and maintained.
5. Estimate the number of critical structures on a lattice from the wavefront dy-
namics. This is used when comparing the CA model to the mean-field model.
3.4.1 Algorithm
We now define the re-entrant circuit tracking algorithm. We select an excited cell i
and note which cell excited cell i in the previous time step, cell j. We then repeat
this for cell j and look at which cell excited it and so on. If the procedure results in a
chain which re-visits cell i we know that this is a closed loop in which cells have re-
excited themselves. We could rephrase this as repeatedly asking “who excited who?”
until either we find that the excitation originated at the pacemaker cells or the excited
cell in question, in which case we have found a re-entrant circuit, see Algorithm 1.
If an excited cell had more than one cell excite it in the previous time step then the
algorithm selects one cell at random. We search through all excited cells to detect
re-entrant circuits.
3.4.2 Structures observed from automated re-entry tracking
We use the previously defined algorithm to re-visit the simulations in Sec. 3.2 and
extract the local structure around regions where re-entrant circuits were observed.
We show a selection of regions identified using the algorithm defined above in Fig.
3.11. The duration of the simulations were 107 time steps with parameters L = 200,
τ = 50,  = 0.05, and δ = 0.05. There were 160 simulations in total, 32 for each ν, for
the range of ν = 0.135, 0.14, 0.15, 0.16, 0.20.
We obtain the regions around which re-entrant circuits occur by using the re-
entrant tracking algorithm during 1) a time segment from the start of AF events and
2) a random time segment during an AF event. The time segments are of 100 time
step duration. For case 2) we randomly sample 50 time segments for each AF event.
We run the re-entrant tracking algorithm over segments of 100 time steps, as opposed
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Algorithm 1 Re-entrant circuit detection algorithm
1: Consider an excited cell, let us index it by i
2: procedure FINDPREVIOUSEXCITEDCELL(i)
3: Return the index of the cell, let us call this j, which excited cell i. If more than
one cell excited cell i then choose uniformly randomly between these cells.
4: end procedure
5: procedure FINDREENTRYCIRCUIT(i)
6: j:=i
7: for index = 1 to 3τ do . Search a finite number of cells into the past.
8: Append j to a list L
9: j := FindPreviousExcitedCell(j)
10: if j = i then cell i belongs to a re-entrant circuit
11: Return TRUE, List of indices of cells in the circuit L
12: end if
13: end for
14: Return FALSE
15: end procedure
to running the algorithm for the entire simulation, because running the alternative
would result in impractical simulation times (i.e., order of a month per simulation).
Tracking only the start versus a random time segment of an AF event allows us to
study the differences in regions contributing to AF initiation and maintenance re-
spectively. To prevent double counting re-entrant circuits we filter out re-entrant cir-
cuits which have a centre of mass within two CA cells vertically and ten CA cells from
their respective centres. To analyse the underlying structure of the re-entrant circuit
we study a rectangular segment of the lattice which is one CA cell larger than the
re-entrant circuit in both it’s width and height.
We group these observed structures by the categories defined in Sec. 3.3.1: first
order, second order, simple, complex and uncategorised critical structures. Many
regions are variants of those found previously by inspection. There are also many
structures which are uncategorised, by which we mean we cannot by inspection of
the structure alone deduce how they could initiate or in some cases even maintain re-
entrant circuits. We investigate how the uncategorised structures influence abnormal
wave behaviour by placing them in tissue that does not fibrillate and observe if AF
arises in those simulations, see Sec. 3.4.5.
3.4.3 Statistical properties of observed re-entrant circuits
We now look at the summary statistics of the sub-regions in which re-entrant circuits
occurred over the 160 simulations described in the previous section. We show the stat-
istical characteristics of the structures observed through tracking re-entrant circuits in
Figs. 3.13 and 3.12. We see that for all regions where re-entrant circuits occur that
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Figure 3.11: A sample of regions where re-entrant wavefronts were observed in the model. We extract
the full structure around the observed re-entrant wavefront (bold black borders), dysfunctional cells are
in red. a, Regions observed in simulations which had at least one simple critical structure. It is clear
that many of these are variants of the simple critical structure that we suggested in Chapter 2. b, Second
order simple critical structures. They are characterised by the presence of a transversal connection on
the initiating dysfunctional cell and are discussed in more detail in Sec. 3.3.1.2. c, Complex critical
structures, these regions require more than one dysfunctional cell to not fire in order to initiate a re-
entrant circuit. d, Regions observed in simulations with no simple critical structures. It is not clear how
such regions could initiate AF. When such regions are isolated and placed in tissue that never fibrillated,
no further fibrillation occurs. So it is clear that these are not triggers of AF.
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the fraction of transversal connections 〈ν〉, averaged over these regions, is lower than
expected and the fraction of dysfunctional cells 〈δ〉, averaged over these regions, is
greater than expected. This suggests that re-entrant circuits do indeed occur in regions
with specific structural properties, this may challenge the idea that re-entrant circuits
could form anywhere through wavefront-wavetail collisions or that such events are
rare in the parameter space we observed. Alternatively, wavefront-wavetail collisions
may only give rise to re-entrant circuits in regions with lower connectivity.
To assess the importance of wavefront-wavetail collisions in driving AF against
the competing mechanism of critical structures we develop a null model that only
includes the latter mechanism. We can estimate the upper limit on the number of
critical structures using the re-entrant tracking algorithm and try to predict properties
of the cellular automaton simulation such as time in AF using the null model. We
do this in the following section where we define a mean-field model of the cellular
automaton model.
Let us look solely at the regions obtained when sampling from the start of AF
events, see Fig. 3.12, thus quantifying the number of AF initiating regions on the
lattice. We observe that a large fraction of the regions contained critical structures.
This suggests that critical structures are the primary mechanism of AF initiation in
the model. It also suggests that the uncategorised regions do not tend to initiate AF.
In contrast, when we look at regions obtained when sampling randomly during
AF events, see Fig. 3.13, we observe that the majority of these regions could not be
categorised into any of the types of critical structures listed in Sec. 3.3.1. This could be
due to other complex structures, however, this is unlikely as these occur more rarely
on the lattice than simple structures. Instead, it is more likely to be that wavefront-
wavetail collisions form re-entrant circuits around regions which do not contain crit-
ical structures. This further reinforces the suggestion above that wavefront-wavetail
collisions may only give rise to re-entrant circuits in regions with lower connectivity.
We speculate that this may be because lower connectivity and more dysfunctional
cells would encourage heterogeneous wavetails which in turn makes it more likely
for a wavefront-wavetail collision to create a re-entrant circuit. Another observation
is that, as expected, we see that the number of observed regions with re-entrant cir-
cuits increases as the fraction of transversal connections is reduced.
3.4.4 Temporal behaviour and observed re-entrant circuits
In this section we study whether or not the number of critical structures in any given
category correlated with temporal behaviour, that is, the time in AF, the number of
AF events, the mean and median AF event duration.
Looking solely at the regions obtained when sampling randomly during AF events
we see that the strongest correlate with all temporal measures is the total number of
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Figure 3.12: The frequency of critical structures found from regions with re-entrant circuits sampled
from the first 100 time steps of AF events. The duration of the simulations were 107 time steps with
parameters L = 200, τ = 50,  = 0.05, and δ = 0.05. There were 160 simulations in total, 32 for each
ν, for the range of ν = 0.135, 0.14, 0.15, 0.16, 0.20. For each type of region we list 〈ν〉 and 〈δ〉 over those
regions. In contrast to sampling randomly from an AF event we see that most regions appear to be some
form of critical structure. This confirms that critical structures play a more important role in initiating
AF. The average connectivity 〈ν〉 in these regions is lower than expected. The density of dysfunctional
cells 〈δ〉 in these regions is larger than expected.
regions containing a re-entrant circuit and uncategorised regions, see Fig. 3.14. This
implies that simulations which spend more time in AF also tend to have more dis-
tinct regions which support re-entrant circuits and do not contain the most common
critical structures. Thus we can rule out the idea that a small number of robust re-
entrant circuits maintain AF in the model at these parameters. It might be the case
that a small number of robust re-entrant circuits perpetually create new short lived
re-entrant circuits. However, this would require monitoring the re-entrant circuits for
their full life time and so is left for future work.
When looking solely at the regions obtained when sampling from the start of AF
events (i.e., the AF initiating regions) we see that the number of critical structures, in
particular first and second order, correlated with the time in AF, see Fig. 3.14. We
see that the greater number of first order critical structures the more likely the time
in AF is large compared to the total number of regions. As the number of triggers
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Figure 3.13: The frequency of critical structures found from regions with re-entrant circuits sampled
from random 100 time step segments of AF events. The duration of the simulations were 107 time steps
with parameters L = 200, τ = 50,  = 0.05, and δ = 0.05. There were 160 simulations in total, 32 for
each ν, for the range of ν = 0.135, 0.14, 0.15, 0.16, 0.20. The majority of regions could not be categorised
into known critical structures. For each type of region we list 〈ν〉 and 〈δ〉 over those regions. The average
connectivity 〈ν〉 in these regions is lower than expected. The density of dysfunctional cells 〈δ〉 in these
regions is larger than expected. This suggests that critical structures may not play a significant role in
maintaining AF relative to wavefront-wavetail collisions.
increase, in particular first and second order critical structures, the AF duration and
frequency increases. We study the relationship between the number of AF initiators
and the temporal dynamics of AF in a mean field model in Sec. 3.5.
3.4.5 Uncategorised structures and AF
In this section we look at the uncategorised regions obtained from the first 100 time
steps of an AF event and from randomly sampling 100 time step segments of AF
events. We insert these regions into the centre of a lattice which did not fibrillate, sim-
ulation 17 at ν = 0.20 (see appendix Fig. B.1). We then run a simulation for a period
of 106 time steps to observe if the system now goes into AF. This establishes whether
a specific uncategorised region initiates AF. We took all uncategorised regions from
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Figure 3.14: Temporal measures of AF behaviour versus the number of different types of critical struc-
tures, r is the pearson correlation co-efficient and p is the p-value under the null hypothesis that there is
no correlation. a, Start of AF events. b, Random segment of AF events.
segments taken at the start of AF and 48 random uncategorised regions from the ran-
domly sampled segments of AF for each of the fraction of transversal connections (15
for ν = 0.20), obtained in Sec. 3.4.3. We find that approximately half of uncategorised
regions taken from the start of AF segments do not initiate AF, whereas the majority of
uncategorised regions taken from randomly sampling AF segments do not initiate AF
within 106 time steps. This suggests the majority of uncategorised regions observed
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Figure 3.15: The number of uncategorised regions which initiated AF. a, We take all uncategorised re-
gions at random from each ν from Sec. 3.4.3 where we sampled re-entrant circuits from the start of AF
events and insert it into a lattice which does not fibrillate. We quantify how many of these uncategorised
regions initiate AF in simulations of duration 106 time steps. We see that approximately half of these
uncategorised regions initiate AF, other than for ν = 0.2. b, We take 48 uncategorised regions at random
from each ν (15 for ν = 0.20) from the Sec. 3.4.3 where we randomly sampled re-entrant circuits from AF
events and insert it into a lattice which does not fibrillate. We quantify how many of these uncategorised
regions initiate AF in simulations of duration 106 time steps. In contrast with the uncategorised regions
from the start of AF events, we see that for each ν that almost all of the uncategorised regions do not
initiate AF.
during AF events, not at the start of an event, do not initiate AF. Thus these regions
are likely to be the result of wavefront-wavetail collisions as opposed to critical struc-
tures. Some uncategorised regions do however initiate AF, however, these are likely
to be more complex critical structures and we leave the study of these for future work.
3.5 A Mean-Field Model of Atrial Fibrillation
3.5.1 Definition
In Sec. 2.5 we have shown that a finite number of simple critical structures can initi-
ate fibrillation in the model. These structures are spatially localised and can sustain a
re-entrant circuit. Whilst a critical structure sustains a re-entrant circuit it emits wave-
fronts radially into the surrounding tissue. We might consider AF in the model to be a
stochastic process where a finite number of critical structures turn on and off (i.e., pos-
sess a re-entrant circuit around them or not) with some probability determined by the
frequency of wavefronts propagating across the lattice and the probability that a cell
does not excite . This is a form of spatio-temporal birth-death process where persist-
ent AF occurs when the probability for the “birth” of a re-entrant circuit is larger than
or equal to the probability of its “death” so that at least one re-entrant circuit is always
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Figure 3.16: Schematic of the reduction of the cellular automaton model to a mean-field model. Critical
structures can sustain a re-entrant circuit. An active particle represents a structure which contains a re-
entrant circuit and an inactive particle represents a structure which does not, but can, contain a re-entrant
circuit. Inactive particles can become an active particle when excited by a wavefront. Consequently,
an inactive particle has a probability pbirth of becoming active every T or Tre−entry time steps where
Tre−entry is the period of a re-entrant circuit.
present. We will formalise this idea to construct a null model where AF is driven only
by critical structures and compare this with the temporal statistics (e.g., frequency and
duration) of AF in the cellular automaton model. As we neglect spatial components
from the original model, this null model does not possess wavefront-wavetail colli-
sions as a mechanism to generate re-entrant circuits. This allows us to assess whether
such a stochastic process driven purely by critical structures is responsible for the
temporal behaviour of the original model.
We construct a mean-field (i.e., no spatial component) description of the model by
considering a system which is composed of N particles, where each particle repres-
ents a critical structure, which can be active or inactive. An active particle represents a
critical structure which contains a re-entrant circuit and an inactive particle represents
a structure which does not, but can, contain a re-entrant circuit, see Fig. 3.16. Thus
we reduce the original model to a system of N particles, that is, N critical structures.
The system is in AF if there is one or more active particles, otherwise the system is in
sinus rhythm (SR).
When there are no active particles (i.e., there is no re-entry) each inactive particle
has a probability pbirth =  of becoming active every T time steps (i.e., pacemaker
cells emit wavefronts with period T and each wavefront provides one opportunity for
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a structure to initiate re-entry). When a structure sustains a re-entrant circuit it also
emits wavefronts periodically with a period determined by the size of the structure.
Thus when there are multiple structures which possess re-entrant circuits then there
are multiple periodic emitters of wavefronts. These multiple wavefront emitters may
trigger re-entry around other structures which at the time do not possess re-entrant
circuits. To determine the period and lifetime of these circuits we require further
knowledge about the size of the circuit and the number of dysfunctional cells that
these structures contain as well as their relative locations.
For simplicity we assume all the structures are identical (i.e., the particles are
identical) in the sense that they emit wavefronts at the same period, have the same
birth and death probabilities, and that their spatial positions can be neglected. Thus
once there are one or more active particles each inactive particle has a probability 
of becoming active every Tre-entry time steps. The smallest and simplest structures
would sustain a re-entrant structure with a period of Tre-entry = τ .
We can describe the system as a Markov chain. We define the state of the chain at
time t, St, by the number of active particlesNa(t) at time t: St = Na(t) = {0, 1, 2, ..., N}.
We denote the number of inactive particles by Nb(t). We are interested in how the
number of active particles evolve over time. This can be analytically treated once we
compute the one step transition matrix given by Pij , this describes the probability that
the system goes from having i active particles to j active particles in one time step.
Let p be the rate that an inactive particle becomes active and let q be the rate that an
active particle becomes inactive:
p =
 T , if Na = 0,
τ , if Na > 0,
(3.11a)
q =

τ
, (3.11b)
we note that this simple picture assumes that a critical structure only has one dys-
functional cell.
We now calculate the one step transition matrix Pij . We remind the reader that
when the system is in state i there are i active particles. Consider the case when the
system transitions from a state with i active particles to a state with j active particles
where j ≥ i, that is, the system ends up with more or the same number of active
particles than the previous time step. There are i active particles and N − i inactive
particles. Let Na→b denote the number of particles which go from active to inactive.
For Na to stay constant or increase requires that Nb→a ≥ Na→b. We sum over the joint
probability of k active particles becoming inactive with a compensating N − j + k
inactive particles becoming active such that the new state has j active particles:
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Pij =
min{i,N−i}∑
k=0
(
i
k
)
qk(1− q)i−k
(
N − i
j − i+ k
)
pj−i+k(1− p)N−j+k,
=
min{i,N−i}∑
k=0
B(i; k, q) · B(N − i; j − i+ k, p), (3.12)
where B(N ;n, p) is the probability of n successful Bernoulli trials out ofN trials where
the probability of success is p, that is, the binomial distribution. Combinatorial factors
appear within the sum to account for the different ways the k active particles can be
chosen to become inactive and for the ways in which the remaining inactive particles
can be chosen to compensate this loss of active particles.
The sum starts at k = 0 and is truncated either when killing more particles would
result in the inability of the remaining pool of inactive particles to compensate for the
loss of active particles, k ≤ N − i, or when we have summed over all active particles,
k = i. By the same argument, we find the same formula applies for j < i however,
the sum begins at k = i− j.
We check that the analytically derived transition matrix Pij is correct by simulat-
ing the above defined stochastic process directly and measure the transition matrix
numerically Pˆij as described in [181]. For  = 0.05, T = 220, τ = 50, N = 3, Ttot = 106
time steps we obtain 100 estimates of Pˆij and look at the mean 〈Pˆij〉 and standard
error of the mean sˆeij :
Pij =

0.9993 0.0007 0.0000 0.0000
0.0010 0.9970 0.0020 0.0000
0.0000 0.0020 0.9970 0.0010
0.0000 0.0000 0.0030 0.9970
 , (3.13)
〈Pˆij〉 =

0.9993 0.0007 0.0000 0.0000
0.0010 0.9970 0.0020 0.0000
0.0000 0.0020 0.9970 0.0010
0.0000 0.0000 0.0030 0.9970
 , (3.14)
sˆeij =

0.1116 0.0001 0.0000 0.0000
0.0001 0.2455 0.0004 0.0000
0.0000 0.0003 0.2232 0.0001
0.0000 0.0000 0.0004 0.1227
× 10−15. (3.15)
We see that the numerically observed transition matrix 〈Pˆij〉 is consistent with the
analytically calculated transition matrix Pij . Thus we can be confident in using Pij to
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predict quantities of interest about the Markov chain (e.g., fraction of time in AF).
3.5.2 Risk of AF
We will now use the null model to compute the fraction of time in AF for a particular
simulation. From the theory of Markov chains we can compute the mean time that
the system is in a given state from the stationary distribution computed from the
transition matrix. We compute the stationary distribution of states pi ∈ RN from the
leading eigenvector of the transition matrix. pii is the proportion of time the chain is
in state i. From this we can predict the time in AF from the stationary distribution,
that is, 1− pi0, the time the system is in SR.
As the number of particles increases, corresponding to an increase in the number
of critical structures in the tissue, the time in AF increases, see Fig. 3.17a. As the time
in AF is computed from the transition matrix we do not have an analytic expression
relating the time in AF to the number of critical structures. However, by inspection of
Fig. 3.17a we guess that the functional form of the fraction of time in AF against the
number of critical structures is 1 − aebN . Thus by plotting 1 - fraction of time in AF
against the number of critical structures on a log-linear scale we can ascertain whether
our guess is correct, Fig. 3.17b shows a good fit to the data when there are more
than 3 critical structures. Hence the fraction of time in AF is related to the number
of critical structures in the mean-field model through an approximately exponential
relationship.
We now check to see if we can reproduce the curve for the risk of AF using the
mean-field model. We run 48 cellular automata simulations for a range of ν around
the transition and measure the number of critical structures present by inspecting the
lattice. We use the measured number of critical structures to compute the fraction of
time in AF expected from the mean-field model and use this to compute the mean-
field mean time in AF, see Fig. 3.18. The mean-field model shows similar behaviour to
the actual model around the transition. However, the mean-field model underestim-
ates the fraction of time in AF. This could be due to the number of critical structures
for a given lattice being underestimated or the fact that the mean-field neglects other
mechanisms which could cause persistence of AF such as wavefront-wavetail colli-
sions.
We now estimate the number of critical structures on a given lattice dynamically
using re-entry tracking on a set of cellular automata simulations. We sample all AF
events in a given simulation and look at 50 time points within each AF event for a
period of 100 time steps and look for re-entrant circuits using our re-entry tracking al-
gorithm to produce an estimate for the number of critical structures. We then compare
the fraction of time in AF as a function of the estimated number of critical structures
with the mean-field model, Fig. 3.19. The same functional form could arguably be fit
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a b
Figure 3.17: The fraction of time in AF, 1 − pi0, as a function of the number of critical structures in the
mean-field model. We run 50 Markov chain simulations for 106 time steps for different values of number
of critical structures. For each chain we measure the fraction of time in AF. a, The proportion of time
in AF tends to one as the number of critical structures increases. We compare the fraction of time in
AF predicted directly from the transition matrix (red circle) with the fraction of time in AF measured
from directly simulating the stochastic process (black crosses), standard error too small to see at this
scale. We also show a curve (black dashed line) described by 1 − aebN fitted to the data, with a = 3.5
and b = −0.6842. As expected, the two agree as the analytically derived transition matrix is nearly
identical to the numerically measured transition matrix obtained from simulating the stochastic process.
b, We suspect the functional form of the fraction of time in AF against the number of critical structures
is 1 − aebN . This intuition is confirmed by plotting 1 - fraction of time in AF against the number of
critical structures on a log-linear plot. However, for small numbers of critical structures the fit is poor.
For more than twelve critical structures the typical AF event time is a large fraction of the simulation
time, hence, we have a ”finite time” effect that leads to the apparent discrepancy between the numerical
and theoretical values.
to the numerical data (Fig. 3.19b), however, the mean-field model now over-estimates
the fraction of time in AF. This could be due to shorter lived critical structures (i.e.,
more complex structures) triggering AF in the CA model which are not included in
the mean-field model.
The results obtained so far do not rule out the mean-field model as a qualitative
explanation of the behaviour of the model. The mean-field model is able to repro-
duce similar behaviour around the transition, however, does not exactly reproduce
the fraction of time in AF or its variability as seen in the cellular automaton model.
This could be due to the absence of spatial effects, such as wavefront-wavetail colli-
sions, in the mean-field model. Thus from looking at the fraction of time in AF we
cannot conclude whether the fundamental mechanism determining the temporal be-
haviour of AF in the model is due to multiple spatially fixed critical structures or other
dynamical mechanisms such as wavefront-wavetail collisions.
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Figure 3.18: The average fraction of time in AF/Risk of AF as a function of fraction of transversal connec-
tions ν for the cellular automaton model and the mean-field model. We show the analytically calculated
Prisk considering only first order simple critical structures (light blue), the results of 48 cellular automata
simulations for a period of 106 time steps (dark blue crosses), the mean-field estimates of the fraction of
time in AF for each of the 48 simulations looking at first and second order critical structures oriented to
the right (red crosses), and both right and left (black crosses). The mean-field model shows similar qual-
itative behaviour of a transition around ν? = 0.14, however, underestimates the mean time in AF. This
suggests that number of critical structures estimated by looking directly at the lattice is underestimated
or other mechanisms cause AF to last longer than expected.
3.5.3 Mean event time
We will now use the null model to compute the mean duration of an AF event. We
wish to calculate
T [n] = Pr[Sn = 0|S0 = 0, {S1, S2, ..., Sn−1} ≥ 1], (3.16)
or to phrase it pictorially:
SR0 → AF1 → AF2 → ...→ AFn−1 → SRn (3.17)
where the subscript refers to time. However, this requires computing all possible
paths from state i = 0 to state i = 0 in n steps.
Another option is to compute the mean recurrence time of state i = 0 which is
given by 1/pi0. However, the mean recurrence time includes recurrence times of zero,
that is when the system goes from state i = 0 to i = 0 in one time step, hence, does not
provide an estimate for the mean event duration. Hence, the mean recurrence time
drastically underestimates the mean event duration because it includes the SR→ SR
transition in computing the mean of the time taken to return from state i = 0 to i = 0.
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Figure 3.19: The fraction of time in AF as a function of estimated number of critical structures found
through re-entry tracking. We run 32 cellular automata simulations for a period of 107 time steps for a set
of ν = 0.135, 0.14, 0.15, 0.16, 0.20 around the transition. We use re-entry tracking to estimate the number
of critical structures for each cellular automata simulation and use this estimate to calculate the time in
AF using the mean-field model for comparison with a direct measurement with the fraction of time
in AF. a, The fraction of time in AF increases rapidly with the estimated number of critical structures,
however, the mean-field model (black crosses) appears to over-estimate the measured time in AF (blue
circles). This suggests that the re-entry tracking algorithm counted many structures which may have
been short lived. We fit the function 1 − aebN to the data (red line) by observing the best straight line
visually in b. We get a = 1 and b = −0.14. b, We look at 1-Fraction of Time in AF for the measured data
to see if we observe a straight line indicating exponential behaviour. The mean-field model does not
provide a good fit to the data, however, it is possible to fit a straight line which suggests an exponential
relationship between the observed number of critical structures and the fraction of time in AF. However,
the significant spread in the measured data restricts us from drawing any strong conclusions.
This limitation can be overcome by manually setting the probability of going from
state i = 0 to i = 0 to zero, re-normalising the first row of the transition matrix, and
then computing the mean recurrence time to state zero.
A simpler quantity to calculate is as follows. Let us assume that the system has
been running for a long enough time that it has settled into its equilibrium distribution
pi. Then let us assume that the system is in AF, that is, i > 0. The probability that the
system is in state i, i.e., has i particles, is then given by
p˜ii =
pii∑N
j>0 pij
. (3.18)
The probability that the system goes from an AF state (i > 0) to SR (i = 0) in one
time-step is then given by
PAF→SR =
∑
i>0
p˜iiPi0. (3.19)
Thus the probability that the system does not go into SR for n− 1 time-steps and then
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enters SR on the nth time-step is given by
(1− PAF→SR)n−1PAF→SR. (3.20)
This is true because we assume the system is in the equilibrium distribution, therefore,
the probability PAF→SR is constant. We see that n follows a geometric distribution.
This implies that the expectation and standard deviation of the event duration are
given by
E[n] =
1
PAF→SR
(3.21a)
σ[n] =
√
1
PAF→SR
. (3.21b)
For the sake of comparison with the original model we can either use these equations
or measure the mean event duration from simulating the Markov chain directly. We
observe that the mean event duration increases exponentially with the number of
critical structures in the mean-field model, Fig. 3.20.
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Figure 3.20: The mean AF event time as a function of the number of critical structures from the mean-
field model. We run 50 Markov chain simulations for 106 time steps for different values of number of
critical structures. For each chain we measure the mean event duration. So for each value of number of
critical structures we have the measured mean of the mean event duration over 50 simulations (black),
the standard error is too small to see at this scale, and the prediction (red circle) from Eqn. (3.21b). a,
The strong agreement between the numerical and theoretical predictions for the mean event duration
suggests that the approximation used to analytically calculate the mean event duration are valid. We also
show a curve (black dashed line) described by a(ebN − 1) fitted to the data, with a = 260 and b = 0.609.
b, On a log-linear scale we observe a straight line which suggests that the relationship between the mean
event duration and the number of critical structures is approximately exponential. For more than twelve
critical structures the event time is large a fraction of the simulation time, hence, we have a “finite time”
effect that leads to the apparent discrepancy between the numerical and theoretical values. We see that
the mean event time grows exponentially with the number of critical structures.
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Figure 3.21: The mean AF event time as a function of estimated number of critical structures found
through re-entry tracking. We run 32 cellular automata simulations for a period of 107 time steps for a set
of ν = 0.135, 0.14, 0.15, 0.16, 0.20 around the transition. We use re-entry tracking to estimate the number
of critical structures for each cellular automata simulation and use this estimate the mean AF event time
using the mean-field model for comparison with a direct measurement with the mean AF event time. a,
The fraction of time in AF increases rapidly with the estimated number of critical structures, however,
the mean-field model (black crosses) appears to over-estimate the measured time in AF (blue circles).
This suggests that the re-entry tracking algorithm counted many structures which may have been short
lived. We fit the function a(ebN − 1) to the data (red line) by observing the best straight line visually
in b. We get a = 900 and b = 0.22. b, We look at 1-Fraction of Time in AF for the measured data
to see if we observe a straight line indicating exponential behaviour. The mean-field model does not
provide a good fit to the data, however, it is possible to fit a straight line which suggests an exponential
relationship between the observed number of critical structures and the fraction of time in AF. However,
the significant spread in the measured data restricts us from drawing any strong conclusions.
3.6 Deviations from the Mean Field
In Figs. 3.19 and 3.21 we show attempts to fit the mean-field model to the cellular
automaton model. We see that the mean-field model qualitatively reproduces the
main behaviours of the model: (1) a sudden increase in the average time in AF as
we decrease the fraction of transversal connections, (2) the increase in average time
in AF with the number of critical structures and (3) the increase in the average event
duration with the number of critical structures.
However, it is apparent that by neglecting spatial effects (e.g., wavefront-wavetail
collisions) and the variability in the critical structures (e.g., the number of dysfunc-
tional cells) that the mean-field model is unable to quantitatively reproduce the mac-
roscopic properties of the cellular automaton simulations.
We could improve these experiments by only tracking the number of trigger-
ing critical structures, as this would be a more faithful estimate to the number of
”particles“ used to represent the number of critical structures in the mean-field model.
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3.7 Discussion
The structural parameters of the model, such as the fraction of transversal connec-
tions, are not sufficient to explain the differences in macroscopic temporal patterns
of AF between simulations. Thus the goal of this chapter was to describe the micro-
scopic mechanisms which drive the macroscopic behaviour of the model, that is, the
mechanisms of AF initiation and maintenance. In doing so we sought to explain the
variability in AF event duration that is observed both clinically and within the model.
Through manual observation we establish that the mechanism of AF initiation in
the model is caused when a wavefront is disrupted by one or more dysfunctional
cells not exciting within a specific local configuration of transversal connections (crit-
ical structures). This triggers an initial re-entrant circuit. This initial re-entrant circuit
results in a train of high frequency wavefronts propagating across the lattice. Dur-
ing this period the initial re-entrant circuit can self-terminate by the action of a dys-
functional cell and the fibrillation consequently terminates, or the initial re-entrant
circuit can create additional re-entrant circuits. The perpetual creation and annihila-
tion of re-entrant circuits determine the perpetuation of AF in the model. After the
incipient re-entrant circuit, further re-entrant circuits are created by two mechanisms:
(1) other critical structures and (2) wavefront-wavetail collisions. Thus, to under-
stand the factors that determine AF event duration we need to understand how AF
is perpetuated by these two mechanisms. Factors that promote the existence (e.g.,
low fraction of transversal connections) or activation properties (e.g., high frequency
of incident wavefronts) of critical structures would increase AF event duration. To
establish what factors promote wavefront-wavetail collisions to produce re-entrant
circuits would require us to isolate this effect from those of critical structures, this is
left for future work.
In the case of other critical structures perpetuating AF we note that critical struc-
tures which initiate AF can be distinct from critical structures involved in AF main-
tenance. This is because whether or not a critical structure can initiate a re-entrant
circuit can depend on the direction of the incident wavefront. So critical structures
can exist which do not produce re-entrant circuits from wavefronts emanating from
the direction of the pacemaker cells, but, once AF is established and wavefronts em-
anate from a different direction these critical structures may now be able to produce a
re-entrant circuit.
In an analysis of the regions which supported re-entrant circuits we found that
during AF initiation, the most of the regions were indeed the critical structures which
we found through inspecting the simulations. We found that in all cases, the trans-
versal connectivity was lower than expected and the number of dysfunctional cells
was greater than expected in regions which supported re-entrant circuits. During AF
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maintenance, however, the majority of regions could not be categorised into any of
the most common critical structures. This suggests that wavefront-wavetail collisions
could produce re-entrant circuits in regions which are unable to initiate re-entrant
circuits alone.
We developed a mean-field model to simulate what we would expect if only a
fixed number of critical structures were to drive AF. This in part can inform to what
extent non-structural mechanisms of AF maintenance (e.g., wavefront-wavetail col-
lision) are important. The mean-field model was able to qualitatively reproduce the
behaviour of the cellular automaton model (e.g., a sudden transition in AF burden as
we decrease the fraction of transversal connections, that is, as the number of critical
structures increases). Variability in AF event duration was determined by the number
of critical structures in the mean-field model. However, the mean-field model system-
atically over-estimated the expected AF event duration as a function of the number
of critical structures and the estimate became increasingly worse as the number of
critical structures increased. This may be due to (1) the number of critical structures
is over-estimated as not all re-entrant circuits are located at regions which trigger AF
and (2) the mean-field model treats all critical structures as being able to trigger AF
which is not true. This suggests that wavefront-wavetail collisions, rarer critical struc-
tures and the orientation of wavefronts are important in determining the perpetuation
of AF.
Thus this chapter has explored the mechanisms which determine AF initiation and
maintenance in the model. The model shows how AF would behave if it were gov-
erned purely by the interaction between tissue architecture and dysfunctional cells.
The clinical implications of this are that triggers of AF are spatially localised and are
therefore suitable targets for ablation. Also, that re-entry occurs at both regions which
are structurally special and due to accidental effects of wavefront dynamics. Thus,
during fibrillation, it is difficult to ascertain if ablating a re-entrant circuit is destroy-
ing a region which actively promotes re-entry versus a region which is an unfortunate
bystander to wavefront dynamics. Such regions may be distinguished by examin-
ing the local tissue architecture and determining whether the transversal connectivity
here is lower than what would be expected.
3.8 Summary
In this chapter we have demonstrated the importance of specific microscopic mech-
anisms in determining the macroscopic behaviour of the model. Specifically we have:
• Shown that the temporal patterns of AF is highly variable even for systems with
the same fraction of transversal connections ν. We sought to explain this.
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• Observed that AF initiation occurs due to the creation of a re-entrant circuit
around localised patterns of connectivity and dysfunctional cells (critical struc-
tures).
• Categorised different types of critical structures based on their constituent dys-
functional cells and transversal connections.
• Described an algorithm to detect re-entry wavefronts. We then used this to ex-
tract the local structure of regions which contained re-entry wavefronts.
• Characterised regions which contained re-entry wavefronts. These regions had
fewer transversal connections and more dysfunctional cells than expected.
• Calculated the risk of fibrillation Prisk taking other critical structures into ac-
count. We found this had little effect.
• Observed that AF maintenance occurs due to the creation of further re-entrant
circuits through other critical structures and wavefront-wavetail collisions.
• Described a stochastic process to explain the behaviour of the model in terms of
interacting critical structures.
• Formalised a null model from this stochastic process using the theory of Markov
chains. We calculate the time in AF and AF event duration from the null model.
• Compared the cellular automaton model with the null model. We found that
the null model could qualitatively reproduced the original model.
• Discussed that deviations from the null model could be due to non-triggering
critical structures and wavefront-wavetail collisions.
• Discussed factors which promote AF perpetuation on the basis of the observed
mechanisms of AF maintenance.
• Discussed the potential physiological and clinical implications of the model.
Chapter 4
Patient Variability in AF and AF
Progression
Some of the material presented in this chapter has been published as: “Myocardial architecture
and patient variability in clinical patterns of atrial fibrillation.” K. A. Manani, K. Christensen,
and N. S. Peters. Physical Review E 94.4 (2016): 042401.
Section 4.5, concerning mitochondrial dysfunction and arrhythmia, forms the basis for an
additional publication.
The progression of AF with age, from short self-terminating episodes to persist-
ence, varies considerably between individuals and is poorly understood. An inability
to understand and predict variation in AF progression has resulted in less patient-
specific therapy. Variability in AF burden between patients with similar fibrosis is
also not understood. Furthermore, it has recently been shown that a small number of
myocytes with dysfunctional mitochondria, which accumulates with age, can cause
arrhythmia. It is not clear how a small number of dysfunctional cells can cause an
arrhythmia which interrupts the behaviour of the whole organ. Likewise, it has been
a challenge to relate the microstructural features of heart muscle tissue (myocardium)
with the emergent temporal clinical (macroscopic) patterns of AF.
In this chapter we modify the previously described cellular automaton model to
show how variation in AF behaviour arises naturally from microstructural differences
between individuals. We show that the stochastic nature of progressive transversal
uncoupling of muscle strands (e.g., due to fibrosis or gap junctional remodelling), as
occurs with age, results in differences in AF episode onset time, frequency, duration,
burden and progression between individuals. This is consistent with clinical observa-
tions. The uncoupling of muscle strands can cause critical architectural patterns in the
myocardium which anchor micro-re-entrant wavefronts and thereby trigger AF. We
show that it is the number of local critical patterns of uncoupling as opposed to the
average global uncoupling that determines AF progression. This insight may eventu-
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ally lead to patient specific therapy when it becomes possible to observe the cellular
structure of a patient’s heart.
Finally, we propose two mechanisms of how the dysfunctional cells of the model
might mimic mithocondrially dysfunctional myocytes and use an adapted model to
show how a small number of abnormal cells can result in arrhythmia. Thus the model
provides a hypothesis for a unifying mechanism to explain: AF variability within a
patient (i.e., in time), between macro-structurally similar patients (i.e., same global
fibrosis burden) and the association between ageing, arrhythmia and mitochondria.
4.1 Introduction
A key challenge in the mathematical modelling of diseases is to link microscopic vari-
ation in individuals (e.g., genetic, metabolic or tissue structure) to variation in disease
outcomes (e.g., the occurrence, recurrence or persistence of AF). In this chapter we
show how variation in microstructure affects the behaviour of AF, suggesting a single
mechanism for the origin of clinically observed variability of AF behaviour.
Atrial fibrillation is characterised by the apparently random propagation of mul-
tiple activation wavefronts in atrial muscle tissue (myocardium). This gives rise to
AF episodes of variable duration. It is thought that short self-terminating episodes
typically become longer with time until they no longer spontaneously terminate. Cur-
rent clinical guidelines (ACA/AGA/ESC) define AF by the episode duration as par-
oxysmal (< 7 days), persistent (> 7 days), long-standing persistent (> 1 year) and per-
manent (clinical decision to not treat) [180]. However, AF episodes lie on a continuum
of durations. The natural history of AF is usually discussed using this classification
scheme which by its technical definition allows for progression of paroxysmal to per-
sistent but not the reverse. However, this classification scheme is problematic in cases
where episodes lasting longer than 7 days terminate and are followed by episodes
shorter than 7 days which is observed to occur frequently in patients [38]. Indeed,
Sugihara et al. [86] could not consistently apply these clinical guidelines to their con-
tinuously monitored patients because AF episode durations were observed to remit
from more than 7 days to less than 7 days. Thus, they defined a different classification
scheme based on AF burden (fraction of time in AF) to describe and quantify their
observations rather than an arbitrary 7 day cut-off to categorise patients.
It has been proposed that AF induces atrial electrophysiological changes (e.g., ac-
tion potential duration shortening) and microstructural changes (e.g., fibrosis or gap
junctional uncoupling), which promote further AF. This self-perpetuation has been
coined “AF begets AF” [79]. Whilst fibrosis promotes AF, the quantitative relation-
ship and the mechanism by which fibrosis promotes AF is not fully understood [51].
Sugihara et al. [86] monitored AF patients continuously in a long term study (1031
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cumulative patient-years, mean 3.2 years per patient) using dual chamber permanent
pacemakers. Progression to persistent AF was not always observed, that is, some pa-
tients remained paroxysmal for the duration of the long term follow-up and some pa-
tients’ AF burden could remit from 100 % to less than 100 % and relapse to 100% again.
Indeed it has been observed that some patients do not progress from paroxysmal to
persistent after as many as 22 years [37]. Veasey et al. [38] also used continuous mon-
itoring data to show that after a mean 7 year follow up, 35 % of patients that were
initially classified as persistent AF using current clinical guidelines were re-classified
as paroxysmal AF. It has also been shown that the time course of AF is seen to vary
between patients with similar fibrosis burden: some patients progress rapidly from
paroxysmal AF to persistent AF (on the order of months) whilst other patients do
not progress at all (measured over decades) [37]. Furthermore, patients with a high
fibrosis burden can remain paroxysmal and those with low fibrosis burden can be in
persistent AF [37, 87, 88, 89].
Thus we have the following recent clinical observations: (1) AF burden does not
inexorably increase and can even spontaneously decrease implying that not all pa-
tients appear to progress to persistent AF, (2) persistent AF can remit to paroxysmal
AF, (3) the common conception that fibrosis correlates with AF progression needs to
be reconciled with the observed variability in AF burden for patients with similar
levels of fibrosis. Individually and collectively these studies challenge the current
view of how AF evolves. Although it has been suggested that different pathological
processes (diabetes, mitral valve disease etc.) occurring in different patients may con-
tribute to variability in AF progression [90], there is no understanding of what causes
the aforementioned clinical observations.
The incidence of AF increases with age and is strongly associated with the accu-
mulation of fibrosis [51]. In addition, arrhythmias in general become more prevalent
with age [182]. It has been suggested that this could be due to mitochondrial dys-
function in myocytes, as well as fibrosis, which increases with age [183]. Baris et al.
[174] recently showed that a small number of randomly distributed mitochondrially
dysfunctional myocytes in the presence of fibrosis increased arrhythmia incidence in
mice.
The clinical patterns of AF are studied in the domain of populations on long time-
scales (months to years), whereas the microstructure of myocardium is often studied
in wet labs within the domain of cellular electrophysiology on short time-scales (form
seconds to hours). These two vastly different timescales cannot be related experi-
mentally. Similarly, many models of AF are computationally intensive due to their
complexity. As a result only short time periods (seconds or minutes) has been invest-
igated. Thus, these models cannot address questions pertaining to the long timescales
of the disease progression. Previous work by Chang et al. [184] has explored the two
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timescales by modelling AF as a simple binary process which flips between normal
sinus rhythm (SR) and arrhythmia at patient specific rates. However, this study does
not relate the microscopic origins of variability in clinical observations.
We use a cellular automaton model of AF to link the two time domains. The model
is specifically designed to address the hypothesis that the stochastic nature of trans-
versal uncoupling is an important factor in the temporal patterns of AF. We model
a patient by simulating patient specific tissue using a simple stochastic process, and
then assess the resulting temporal AF patterns.
We propose that mitochondrially dysfunctional myocytes can behave like dys-
functional cells in the model. We show that the behaviour of the original model is
preserved after modifying model dysfunctional cells to mimic mitochondrially dys-
functional myocytes. Thus the model provides a mechanism to explain how a small
number of dysfunctional cells can give rise to arrhythmia. Namely, the interaction
between mitochondrially dysfunctional myocytes with the correct patterns of fibrosis
can initiate micro re-entrant circuits.
In this chapter we propose that the clinically observed variability in AF progres-
sion can be caused by a single process, the progressive stochastic accumulation of
cellular uncoupling. Using the model we show that different time-courses of AF can
occur between patients despite a similar degree of macroscopic transversal cellular
uncoupling. Consequently, the model provides a simple unifying explanation to the
above observations, namely that (1) the time-course of AF progression can vary sig-
nificantly between patients, (2) persistent AF can remit to paroxysmal AF, (3) macro-
structurally similar myocardium can show very different AF behaviour due to these
microstructural differences and (4) a small number of mitochondrially dysfunctional
myocytes can promote arrhythmia.
4.2 Progressive Uncoupling: Modifications to the Model
In this section, we describe how we change the model to study patient variability and
AF progression. In the original model the structure of the lattice remained fix for the
whole duration of a simulation. We now remove transversal (vertical) connections
during a simulation to mimic the progressive uncoupling that is thought to occur in
humans [37]. So a given lattice and its change in structure and wavefront behaviour
in time represents the evolution of a particular ”patient“.
The initial conditions for each “patient” are created by assigning the same num-
ber of transversal connections (identical initial ν) but at different random positions.
Next the accumulation of cellular uncoupling is implemented by reducing ν (e.g., to
mimic the progression of fibrosis or gap junctional uncoupling). To do this, we run
simulations for a period of T = 4.3× 107 time steps in the computer model and trans-
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versal connections are removed at a rate of one connection every nine thousand time
steps. We note that the actual rate at which transversal uncoupling accumulates in
humans is unknown and may differ between patients. Hence, the rates used in the
model are set to be identical between simulated ”patients“ with the aim of capturing
the generic phenomenon of the accumulation of uncoupling over time thought to oc-
cur frequently in humans [37]. We observe the dynamics of excitation wavefronts as
the transversal uncoupling accumulates in the tissue. All other model parameters are
set to physiological values as described in Sec. 2.3: L = 200, τ = 50,  = 0.05, and
δ = 0.05. Pacemaker cells self-activate with a period of T = 220.
4.3 Temporal Patterns of AF burden and Patient Variability
We ran 32 simulations with the same initial fraction of transversal connections distrib-
uted randomly in each simulated tissue. This represents 32 simulated “patients” with
the same fraction, but with differing spatial distributions, of transversal connections.
We start at ν = 0.25 where all the simulated heart muscle tissue are in sinus rhythm
(SR) but as we lower ν by removing transversal connections one by one, fibrillation
may emerge. The number of excited cells can be used to determine when the system
is in fibrillation and hence gives the associated AF burden which we define as the
amount of time in AF divided by the total observed time. We define paroxysmal and
persistent AF in the model using a similar scheme to Sugihara et al. [86] based on AF
burden. We call periods of AF burden being 1-99% paroxysmal AF and AF burden of
100% persistent AF.
The time-course of four particular simulated “patients” are shown in Fig. 4.1.
Patient A undergoes what would be considered the standard progression from par-
oxysmal AF, with low AF burden, to persistent AF, with maximal AF burden. Patient
B, however, shows isolated short-lived episodes of paroxysmal AF with a sudden
cross-over to persistent AF. Hence, Patient B lacks a gradual progression from par-
oxysmal AF to persistent AF. Patient C also had a few isolated episodes of paroxysmal
AF before entering a much more disordered relapsing-remitting phase between par-
oxysmal and persistent AF with different AF burdens compared to Patient B. Patient
D underwent a sudden transition from sinus rhythm to persistent AF, but has phases
of sinus rhythm interrupting persistent AF during the time-course of the disease.
These four “patients” are archetypes of the time-course of AF observed in the 32
simulations (see App. C.1-C.5 for all 32 simulations). In addition to the variability in
the progression to persistent AF we note that the onset of AF occurs at significantly
different amounts of uncoupling, that is, fractions of transversal connections.
Furthermore, we observe that AF activity tends to change suddenly. That is, the
frequency and duration of AF episodes change rapidly rather than gradually with
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Figure 4.1: AF burden varies with time, calculated from the time in AF in a sliding window of 5 × 106
time steps for four different “patients”. Each simulation begins with an initial fraction of transversal
connections of ν = 0.25 and is reduced to ν = 0.13 by removing one transversal connection every
9000 time steps, mimicking progression of uncoupling over a simulated time period of 4.3 × 107 time
steps. a, Patient A develops paroxysmal AF for ν . 0.188 which eventually develops into persistent
AF at ν . 0.138. b, Patient B develops short lived episodes of AF for 0.206 . ν . 0.238 and a sudden
transitions into persistent AF ν ≈ 0.206. This relapses into paroxysmal AF three times before remitting
back into persistent AF at ν ≈ 0.166. c, Patient C shows a phase of relapsing-remitting paroxysmal to
persistent AF for a considerable period of time until AF becomes persistent at ν ≈ 0.159. d, Patient
D shows isolated short lived episodes of AF and a sudden transition into persistent AF ν ≈ 0.164.
Remission back into sinus rhythm occurs twice (ν ≈ 0.156 and ν ≈ 0.145) before AF becomes persistent.
The transversal dashed lines are values of fractions of transversal connections at which simulations are
re-run without progressive uncoupling, that is, with a fixed fraction of transversal connections (see Fig.
4.2).
progressive uncoupling (see Fig. 4.2). This is consistent with the clinical observation
that macrostructurally similar myocardium (e.g., quantified by the global fibrosis bur-
den) show very different AF characteristics [37]. The frequency and duration of AF
events are different in each simulated patients.
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Fraction of Transversal Connections ν
Figure 4.2: Seven snapshots at ν = 0.220, 0.206, 0.178, 0.172, 0.160, 0.156 and 0.131 of variability in
event duration (given as a fraction of the simulation time 1.2 × 107 time steps), number of AF events
and AF burden for repeated simulations as a function of fraction of transversal connections. We re-
run the simulations shown in Fig. 4.1 for 1.2 × 107 time steps starting from particular values of the
fraction transversal connections (see vertical dashed lines in Fig. 4.1) in which at least one of the four
simulations showed non sinus rhythm behaviour. Note that we see variability both within a ”patient“
as the time-course of AF progresses as well as between ”patients“. These three observables of event
duration, number of AF events and AF burden are seen to vary significantly between real patients as
well [86].
4.4 Critical Regions and Patient Variability
In addition, unlike clinical studies, we can identify the microscopic origins of the ob-
served behaviour. The differences in the behaviour of these simulations are explained
to a large degree by the number of localised critical regions with specific architectural
patterns of coupling observed in the simulated tissues.
In the model we detect these critical regions by detecting complete loops of wave-
front activation, that is, re-entrant circuits. We measure the number of initiating crit-
ical regions by re-running the simulations for each patient; when a re-entrant circuit
forms we render all cells in the circuit unexcitable, a form of ablation, for the re-
mainder of the simulation and reset the system to sinus rhythm. The number of initi-
ating critical regions is taken to be the number of ablations that occurred during the
full simulation. For the range of fraction of transversal connections reported here the
number of ablations are not large enough to promote fibrillatory behaviour.
However, these critical patterns of uncoupling might also be determined structur-
ally as these local patches of tissue have connections and dysfunctional cells arranged
in a configuration which allows the formation of pinned micro-re-entrant circuits [95],
see also Sec. 3.4.2. These regions are characterised by large contiguous regions of un-
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coupled cells akin to the obstructive fibrosis found to promote AF in goats [55].
We observe that the first occurrence of AF coincide with the (chance) emergence
of the first critical structure at ν = 0.188, 0.238, 0.228 and 0.177 for Patient A, B, C and
D, respectively, see Fig. 4.3a-d. Furthermore, the number of these critical regions vary
between patients despite having the same fraction of transversal connections (macro-
scopic measure), see solid black line in Fig. 4.3a-d. It is the variation in the number of
these critical regions that causes the variability in the observed AF behaviour shown
in Fig. 4.1 and 4.2, see Fig. 4.3e (see also full set of 32 “patients” in the appendix, Fig.
C.5 ).
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Fraction of Transversal Connection ν
Figure 4.3: a-d, Accumulation of initiating critical regions (black curve) versus the fraction of vertical
connections for patients A-D. The onset of AF in each patient coincide with the first appearance of a
critical region. As uncoupling progresses (the fraction of vertical connections is reduced), the number
of initiating critical regions increases. e, The average AF burden for each “patient” as a function of
the number of critical regions. The standard deviations and standard error are too small to be seen at
this scale. The differences in the accumulation of critical regions between patients better predicts the
variability in the AF behaviour observed.
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4.5 Mitochondria, Ageing, and Arrhythmia
In this section we discuss how the cellular automaton model of AF provides mech-
anistic insight into another factor relating to arrhythmia progression and variability:
mitochondrial dysfunction in ageing.
The incidence of arrhythmia increases with age [182]. As the heart ages it ac-
cumulates cells with severe mitochondrial dysfunction due to mitochondrial DNA
(mtDNA) mutations [183]. Baris et al. [174] recently reported that as few as 0.5% of
cardiomyocytes with dysfunctional mitochondria promoted cardiac arrhythmia dur-
ing ageing in mice. A comparable number of dysfunctional cells are in seen in aged
human hearts [185] which suggests that a similar mitochondrial-driven phenomenon
may result in arrhythmia in elderly human populations. However, the exact mech-
anism(s) by which mitochondrially dysfunctional cells contribute to arrhythmia are
currently unknown.
Baris et al. [174] showed that in a population of mutant mice, which accumu-
late mtDNA mutations in cardiomyocytes faster than a wild type group, had a much
greater incidence of arrhythmia with age. After a sufficient number of mtDNA muta-
tions, the mitochondria in that given cell becomes dysfunctional (e.g., impaired cal-
cium handling and electron transport chain function). They observed a small number
of mitochondrially dysfunctional cells which are thought to be randomly distributed
in the myocardium. Both groups of mice developed fibrosis with age, and, import-
antly, the amount of fibrosis between the two groups were the same. We note that
in the wild type mice no mitochondrially dysfunctional cells were observed for the
full lifetime of the mice (18 months). Thus, this is strong indication that the increased
number of mitchondrially dysfunctional cells promoted the arrhythmia. The study
gives rise the following question: how can a small number of randomly distributed
dysfunctional cells result in an arrhythmia which impacts the whole organ?
Khrapko et al. [186] speculate the following mechanism. Arrhythmia was greatly
enhanced when the mice were aged and under stress. The arrhythmias were short-
lived and therefore are unlikely to be driven by re-entrant circuits, this leaves ectopic
mechanisms whereby non-pacemaker cells generate abnormal wavefronts. Ectopic
beats are initiated by after-depolarisations, this is where a cell goes through additional
phases of depolarisation and re-polarisation during a preceding action potential. Mi-
tochondrially dysfunctional cells are known to sustain after-depolarisations. How-
ever, after-depolarisations need to overcome a problem known as source-sink mis-
match in order to generate and propagate a new wavefront. The after-depolarisation
of a single cell would not be able to provide enough current (i.e., too little source) to
the cells in its neighbourhood (i.e., too much sink) to cause them to initiate an action
potential. Khrapko et al. [186] suggests that this is overcome by increasing source: 1)
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under stress conditions a greater number of cells undergo after-depolarisations and 2)
mitochondrial dysfunctional cells under stress emit toxic metabolites [187] to neigh-
bouring cells encouraging more after-depolarisations. It is unknown whether the pro-
posed mechanisms by Khrapko et al. to overcome source-sink mismatch would in fact
work. Additionally, this mechanism neglects the large fibrosis burden in these aged
mice and does not explain the modest increase in arrhythmia for the affected mice at
rest. However, we note that this modest increase relative to wild type did not achieve
statistical significance in the study by Baris et al [174].
We propose two alternative mechanisms where the interaction between dysfunc-
tional cells and fibrosis creates micro-re-entrant circuits and does not require after-
depolarisations to propagate. We note that micro-re-entrant circuits in our model can
be short lived, therefore, cannot be ruled out as a mechanism against the observation
that the arrhythmias in the mice were short-lived. We can map the phenomenon onto
the cellular automaton model. In the original model dysfunctional cells stochastic-
ally interrupt incoming wavefronts. We discuss two hypothetical scenarios of how
mitochondrially dysfunctional myocytes might do this.
Scenario/mechanism 1: After-depolarisations, which occur after a preceding wave-
front has already passed, stochastically result in cells being unexcitable later than they
would have without the after-depolarisation. This unexcitable cell can interrupt the
incoming wavefront, particularly at high frequencies, and be excitable by the time a
retrograde wave appears allowing the formation of a re-entrant circuit as discussed
in Sec. 3.3. An additional stochastic after-depolarisation could further terminate the
circuit.
Scenario/mechanism 2: This is where a spontaneous action potential occurs in the
absence of any external stimulation or wavefront. Mitochondrial dysfunction results
in abnormal calcium handling in a myocyte [188]. Abnormal calcium handling can
result in stochastic spontaneous calcium release which can generate action potentials
[16]. These action potentials may not propagate as a result of source-sink mismatch.
This again would stochastically produce an unexcitable cell which could interrupt
an incoming wavefront and allow the formation of a re-entrant circuit. We note that
atrial fibrillation is associated with an increased rate of spontaneous calcium release
in cardiomyocytes [189].
These mechanisms are not mutually exclusive and it is possible that both may con-
tribute to arrhythmia. We note that mechanism 1 requires high frequency wavefronts
for the dysfunctional cell to interrupt the incoming wavefronts, thus at low frequen-
cies we would not expect this mechanism to create re-entrant circuits and therefore
arrhythmia. Mechanism 2 is consistent with the observation that some mice in the
study of Baris et al. [174] showed arrhythmia in resting conditions. Also, both of these
mechanisms and indeed in the original model the probability of initiating a re-entrant
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circuit is proportional to the frequency of the incoming waves. This may explain the
increased incidence of arrhythmia in the stressed mice.
4.5.1 Dysfunctional cells as spontaneous abnormal activity
We modify the behaviour of dysfunctional cells in the original model to mimic mech-
anism 2. Hove-Madsen et al. [189] measured calcium waves, a form of calcium release
which can initiate action potentials, occurring at a rate of 2.8± 0.5mm−1s−1 in AF pa-
tients versus 1.1 ± 0.3mm−1s−1 in patients without AF. Converting the units to the
model with no coarse graining gives a range of rates of 6−18×10−5∆x−1∆t−1 where
∆x = 100µm (one myocyte length, that is, one CA cell) and ∆t = 0.6ms (time to
depolarise, that is, one model time step) are the fundamental space and timescales
of the model. When we coarse-grain such that each CA cell represents b × b cells we
get the following rate: 6− 18× 10−5 × b2[b∆x]−1[b∆t]−1, where [b∆x] and [b∆t] is the
length of a CA cell and duration of a model time step respectively. For b = 5 we get
a rate of calcium waves of 1.5− 2.5× 10−3 per CA cell per model time step. Thus, in
this alternative model dysfunctional cells have a probability of self-exciting without
propagating a wave of  = 1.5− 2.5× 10−3. This is in contrast to the dynamics of the
original model where a dysfunctional cell has a probability of not exciting in response
to neighbouring excited cells of  = 0.05.
We repeat the experiment in Sec. 2.5 and measure the mean time in AF over a
sample of 48 simulations as a fraction of transversal connections over for this altern-
ative implementation of dysfunctional cells. The fraction of transversal connections
are fixed during the simulation and we investigate two different values for the fraction
of dysfunctional cells, δ = 0.01 and 0.05. We find that the behaviour of the original
model is preserved, see Fig. 4.4. We show the number of excited cells as a function
of time for a random sample of 16 of the 48 simulations for ν = 0.1, 0.175, 0.25 and
δ = 0.05 in the appendix, Sec. C.2.
We now discuss the observations of Baris et al. with respect to the simulations.
The wild type mice had no mitochondrially dysfunctional cells (δ = 0) and showed
no arrhythmia with age, the model also shows no arrhythmia in the absence of dys-
functional cells. The young mutant mice have dysfunctional cells (0 < δ < 0.05) but
low levels of fibrosis so that little to no arrhythmia is observed (ν > ν?), the model
also shows no arrhythmia when fibrosis burden is low ν?. The older mutant mice
have dysfunctional cells (0 < δ < 0.05) and higher levels of fibrosis (ν . ν?), the cel-
lular automaton model shows arrhythmia in the presence of dysfunctional cells and
when the amount of fibrosis is above a threshold. Thus, we show the results of Baris
et al. [174] can be reproduced by a cellular automaton model which takes into account
the most basic features of myocardium. Specifically we show that a small number of
dysfunctional cells interacting with regions of uncoupling (e.g., due to fibrosis) can
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Figure 4.4: The mean time in AF for the alternative implementation of dysfunctional cells. The model
parameters are L = 200, τ = 50,  = 2× 10−3, T = 220 and δ = 0.05 (blue cross) or δ = 0.01 (red cross).
The simulation time was 106 time steps. There were 48 simulations for each ν and the error bars show
one standard error of the mean. The analytically derived risk of AF, Prisk (see Eqn.(2.5.3)), is shown for
δ = 0.05 (blue line) or δ = 0.01 (red line). The behaviour of the original model is preserved: a cross-
over to persistent AF as the fraction of transversal connections is reduces. As expected the analytically
derived risk of AF better fits the simulated results for lower fractions of dysfunctional cells δ, this is
because Prisk only accounts for simple critical structures which are more prominent for lower δ.
trigger short lived arrhythmic events. The duration of the event is determined by the
interaction between the number of dysfunctional cells and fibrosis.
4.6 Discussion
The progression of AF and its variability is poorly understood. Fibrosis, among other
factors, is known to be important. However, the reason why so much heterogeneity
in AF behaviour occurs in patients with similar fibrosis burden is not known. In ad-
dition to this, insights from studies in cardiac tissue slices (short timescales) have yet
to be reconciled with the clinical patterns of AF development (long timescales). We
bridge this gap using computational modelling and identify how structural charac-
teristics of myocardium and uncoupling alone can give rise to patient variability. We
note that the variability in the simulated patients is strictly due to specific architec-
tural patterns of transversal uncoupling between cells. Fibrosis is one mechanism
of cellular uncoupling. An additional mechanism of uncoupling is gap junctional
remodelling, whereby the passive high resistance pathways between cells are redis-
tributed to enhance anisotropic conduction and may result in the failure of action
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potential propagation [190, 191, 192]. Indeed, gap junctional remodelling is known to
be arrhythmogenic [193].
We show that a simple model of heart muscle tissue can display the clinically ob-
served variability in AF progression. This variability originates from the chance oc-
currence of critical regions characterised by poor transversal connectivity. The model
reproduces clinical observations: variability in AF episode onset time, frequency, dur-
ation and progression. In addition to this, the model provides mechanisms to explain
recent experimental observations in which only a small number of mitchondrially
dysfunctional cells in the presence of fibrosis, both of which accumulate with age, are
shown to be arrhythmogenic.
Thus we show that a single pathological mechanism, namely the interaction between
uncoupling and dysfunctional cells, can result in patterns of AF observed clinically.
Specific architectural patterns of uncoupling rather than the global uncoupling (e.g.,
total fibrosis burden) were observed to drive AF. Thus, our work suggests that the
tissue microstructure is essential in determining the time-course of AF in a given pa-
tient. This is a first step in relating structural features of myocardium, greatly studied
in a basic science context, to patterns of AF in patients, studied in a clinical context.
When experimental access to in vivo tissue microstructure becomes available in the
future insight from this work might potentially lead to patient-specific therapy.
4.7 Summary
In this chapter we have shown that the model is able to provide unifying mechanistic
insights into multiple phenomena regarding patient variability in atrial fibrillation.
Specifically we have:
• Introduced a modification of the cellular automaton model of atrial fibrillation
where we progressively remove transversal connections with time.
• Demonstrated that all the clinical patterns of AF are reproduced in the model.
• Demonstrated variability in AF episode frequency, event duration and AF bur-
den within and between patients.
• Shown that this variability is linked to the number of initiating critical regions
in the simulated tissue.
• Shown that the model behaviour is preserved when changing implementation
of dysfunctional cells to mimic mitochondrially dysfunctional cells.
• Shown that model generates hypotheses to explain experimental observations
regarding mitochondrial dysfunction, ageing and arrhythmia.
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• Discussed how these results generate a single hypothesis demonstrating how
structure and cellular dysfunction can result in AF variability within a patient
in time, between patients with similar fibrosis burden and how a small number
of dysfunctional cells cause arrhythmia.
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Chapter 5
Syncope Prediction using Highly
Comparative Time-Series Analysis
Syncope is the transient loss of conciousness, also described as “fainting”. Vasovagal
syncope (VVS) is one of the most common causes of syncope and is a benign condi-
tion which is characterised by a self-limiting episode of systemic low blood pressure
[147, 148]. Head-up tilt testing (HUTT) is a medical procedure used to diagnose VVS.
During the HUTT a patient is strapped to a table which tilts in an attempt to repro-
duce syncope symptoms which forms the basis of the diagnosis. However, the HUTT
can take up to an hour and is stressful for the patient as it attempts to reproduce their
syncope symptoms. Early prediction of the HUTT outcome would reduce the time of
the test and stress for the patient.
In this chapter we provide an exploratory analysis of a large, unpublished HUTT
data set. We use a library of over 7894 time-series analysis methods [165] to extract
over 6000 time-series properties, also known as features, from RR intervals (time
between heart beats) and blood pressure (BP) signals recorded during a HUTT. We
apply machine learning methods to analyse these large number of features to try to
predict syncope early in the HUTT.
5.1 Introduction
Vasovagal syncope is a frequent cause of hospital admissions and has an economical
cost due to patient handicaps resulting from several fainting episodes [149]. Thus the
detection and early diagnosis of vasovagal syncope is important. During a HUTT,
the ECG, heart rate (HR, extracted from the ECG), and blood pressure are recorded.
During VVS there is a marked sudden fall in blood pressure and an associated fall in
heart rate, often resulting in syncope. As the diagnosis of VVS is contingent upon re-
producing the patient’s VVS symptoms the test can last up to an hour and is stressful
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for the patient. Generally, there are no visually discernible features of the heart rate
or blood pressure signal early on to allow a diagnosis to be made early in the test.
Thus automated syncope prediction has the potential to reduce the time of the test
and stress on the patient.
Sensitivity and specificity are common performance metrics of a diagnostic test
or predictive algorithm. Sensitivity is the proportion of positives that are correctly
classified as being positive. Specificity is the proportion of negatives that are correctly
classified as being negative [194].
During a HUTT if a patient does not faint after some period of time a pharmacolo-
gical agent, such as nitroglycerin (GTN) or isoproterenol, is administered to provoke
a faint. This can increase the sensitivity of the test whilst leaving the specificity un-
changed [195, 196]. We note, that syncope prediction results depends on which phar-
macological agent is used to provoke syncope: Alberola et al. showed that increased
HR two minutes after tilt-up (long before GTN administration) was not predictive of
syncope in HUTTs using GTN whereas this measure was predictive in other protocols
[197].
We summarise only recent studies on HUTT outcome prediction which use GTN
as a provocative agent, as the data reported in this work uses GTN, in Table 5.1. The
two studies which reported high specificity and sensitivity [198, 199] had the majority
of predictions made within 3 minutes of syncope which is not ideal for shortening the
test or providing early syncope detection. In addition the sample size for [199] is relat-
ively small with 43 patients. Together, this suggests that the outcome of the HUTT can
be easily predicted within 3 minutes of syncope, however, robust predictions before
syncope symptoms occur do not exist.
There are a wide range of syncope prediction studies which use a range of proto-
cols and different pharmacological agents other than GTN to provoke syncope [200,
201, 202, 203]. These studies contain typically less than 200 patients total, some as
low as 28. The sensitivity and specifity in these studies, with sample sizes more than
100, is typically between 50-70 %. In each of these studies the features extracted are
related to changes or trends in BP and HR (e.g., a steady decrease in blood pressure)
and measures of blood pressure variability (BPV) and heart rate variability (HRV).
Thus previous studies are limited by either relatively small sample sizes or are re-
stricted to predicting syncope within only a few minutes or even after VVS symptoms
have already begun. The features used in these studies also try to extract information
from the same physiological properties, namely changes in baseline and variability in
HR and BP.
In contrast, the number of patients used in this analysis varies from 229 to 309 and
a much larger number of features are investigated. We use a library of time-series
analysis methods [165] to extract a large number of time-series features, over 6000,
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Study Features Sample size Results
Aleberola et al. 2005 [197] Early HR increase 117 Negative result
Virag et al. 2007 [198] HR, BP trends. HRV, BPV 1,115 Sn = 95%, Sp = 93%
Couceiro et al. 2014 [199] Stiffness and reflection
index, left ventricular
ejection time, HR change,
pulse arrival time
43 Sn = 100%, Sp = 92%
Klemenc and Strumbelj 2015
[204]
HRV and baroreflex sens-
itivity
105 Negative result
Table 5.1: Recent studies on syncope prediction using GTN. Negative result implies that the study was
unable to predict syncope or equivalently distinguish between positive and negative test outcomes.
The two with positive results could only predict syncope after symptoms had begun and were within
3 minutes of syncope [199], limiting the potential for early syncope prediction. Sn - sensitivity, Sp -
specificity.
from RR intervals and BP signals. We present an exploratory analysis where we have
used machine learning methods to predict syncope based on these large number of
time-series features.
5.2 Head-up Tilt Test Protocol and Data Acquisition
The data was acquired at Hammersmith Hospital, Imperial College Healthcare NHS
Trust in the Syncope Prediction Study under the team of Phang Boon Lim from the
years 2012 to 2014 and is currently unpublished. The ’Italian protocol’ [195] was used:
1. Stablisation phase: Patient lies horizontally (i.e., 0◦) on the table for at least 5
minutes.
2. Passive phase: Table tilted to 60◦ for 20 minutes.
3. Provocation phase: Administer a 400 µg oral spray preparation of nitroglycerin
(Nitrolingual) and continue test for a further 15 minutes.
4. Test interruption: Patient returned to horizontal when the protocol is completed
in the absence of syncope (test negative) or syncope symptoms reproduced (test
positive when syncope occurs with decreased blood pressure, heart rate or both).
The application of nitroglycerin is used to provoke syncope. This has been shown
to increase the sensitivity of the test whilst leaving the specificity unchanged [196].
Throughout the HUTT blood pressure is continuously monitored using digital
photoplethysmography with a Finapres™ and the ECG is recorded using a three-lead
body-surface ECG.
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5.3 Data Summary
For each patient we have a BP and ECG time-series of duration 5 to 40 minutes
sampled at 1 kHz. The HUTTs were conducted at Hammersmith Hospital between
the years of 2013 and 2015. There are 371 patients aged between 18 to 90 years (mean
age 45 years, standard deviation 22 years). Patients who had a prior tilt test, were
enrolled in other device or drug studies, or were pregnant were excluded. There are
238 positive tests and 133 negative tests.
As we aimed to predict the outcome of HUTT tests, we extracted a 5 minute time
segment of the ECG and BP before the initial tilt (interval between t = 0 minutes to
t = 5 minutes from start of test) and a 5 minute segment prior to the administration
of nitroglycerin (interval between t = 20 minutes to t = 25 minutes from start of test).
Thus we sought to predict syncope at two extremes: the earliest 5 minute segment and
the latest 5 minute segment where the outcome cannot be easily predicted by inspec-
tion, see Fig. 5.1. For the latest 5 minute segment, for positive tests, we only analysed
patients given GTN as: (1) this provides a well defined fiducial time to segment from,
thus allowing comparison between patients, (2) is earlier than the onset of syncope
symptoms or visual cues in the time-series. We extract RR intervals from the ECG.
So in summary we have for each patient two 5 minute recordings of RR intervals
and BP signals which have been filtered as described in Sec. 5.4 below. Each time
series is labelled by the outcome of the test: negative and positive. Examples of both
classes of RR interval and BP time-series are shown in Fig. 5.2.
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Figure 5.1: The full time series for HR and BP for 35 minutes of the test. The two five minute segments of
time-series used for analysis is highlighted between the red dotted lines. The first segments corresponds
to the five minutes before tilt. The second five minute segment corresponds to five minutes prior to GTN
administration. We can see in the positive test that there is a sudden drop in BP and HR when syncope
occurs (1900 secs). These two examples were selected at random.
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Figure 5.2: Blood pressure and RR interval time series segments from three patients in each of the two
classes: negative (red) and positive (blue). The time-series are grouped by the period of recording also
as early and late. The blood pressure segments are 5 seconds long and the RR interval segments are 75
seconds worth of heart beats. The two examples were selected at random. Axes omitted as the amplitude
is in arbitrary units, we are only interested in the morphology of time-series here.
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5.4 Pre-processing
5.4.1 ECG and extracting RR intervals
The ECG was bandpass filtered with a third order Butterworth filter between 1 and 40
kHz with a downsample factor of 10 to eliminate baseline wander and high frequency
noise. RR intervals were then extracted from the ECG using the Pan-Tompkins QRS
detection algorithm [205]. Segments of noisy signal and ectopic beats were manually
removed.
5.4.2 Blood pressure
The BP was bandpass filtered with a second order Butterworth filter between 0.3 and
150 kHz with a downsample factor of 10 to eliminate baseline wander and high fre-
quency noise. Segments of noisy signal were manually removed.
5.5 Methods
5.5.1 Highly comparative time-series analysis
We use a highly comparative time-series analysis (HCTSA) tool which consists of
a library of time-series analysis methods and data visualisation tools developed by
Fulcher et al. [165]. We summarise the methods here, the details of the methods are
published in [165] and the software written in MATLAB is publicly available 1.
The library of time-series analysis methods are a collection of 7894 algorithms
which take a single time series as an input and return a single real valued number as
an output. We call this output a time-series feature. These time-series analysis meth-
ods are from a wide range of sciences and analyse various time-series properties:
summaries of autocorrelation, stationarity, wavelet decompositions, measures from
non-linear time-series analysis (e.g., correlation dimension estimates, fractal scaling
properties), information theoretic measures (e.g., permutation entropy, sample en-
tropy), and others [165].
For each time series, the HCTSA tool computes a vector of 7894 features. These
features are normalised using an outlier-robust sigmoidal normalizing transform [165]
so that the features are comparable. So for N time-series we obtain a data mat-
rix of size N × M where M is the number of features calculated by applying vari-
ous different time-series analysis methods to each time-series. As there are 371 pa-
tients and 7894 time-series analysis methods in the library of methods we find that
N = 371 and M = 7894, depending on the data set, for each of the early and late 5
1https://github.com/benfulcher/hctsa
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minute time series segments. We also combine the features of both the RR intervals
and BP for a single patient thus giving M ≈ 15, 788 in this case.
Some time-series analysis methods may produce special values such as infinity or
a NaN2, for example, if a time series is too short for a particular time-series method
to be applied. We remove these features from the data matrix if they contain at least
one special value across a given dataset. We also remove a time series from the data
matrix which contain 20% or more special values. Thus we are left with a reduced
data matrix with no special values in any entry.
We then apply standard machine learning and statistical methods to this data mat-
rix such as: (1) Clustering methods to observe if patients can be clustered in a mean-
ingful way based on their time-series, (2) Dimensionality reduction methods to com-
press the data using information across all features in preparation for classification,
(3) Classification methods to see if we can distinguish between positive and negative
tests and thereby predict syncope early.
5.5.2 Principal component analysis
Principal component analysis (PCA) is a commonly used statistical procedure to trans-
form a set of possible correlated features into a set of linearly independent principal
components which are linear combinations of the input features [194]. The transform-
ation is defined such that the data has the greatest variance along the first principal
component, the data has the next greatest variance along each successive principal
component under the constraint that it is orthogonal to previous principal compon-
ents. We can thus use PCA to reduce the current large number of features, due to the
large number of time-series analysis methods, to a smaller number of features. This
is achieved by selecting a smaller number of principal components which still cover
a large amount of variance of the data.
For the sake of preliminary analysis PCA allows us to project the data into a lower
dimensional space to: (1) visualise the data along the first two principal components
to look for obvious clustering, (2) reduce the number of features to make syncope
prediction less prone to over-fitting.
5.5.3 Clustering and classification
Clustering is used to automatically order the data by similar classes of patients and
time-series analysis methods. We used average linkage clustering, as implemented
using the linkage function from MATLAB’s Statistics Toolbox 3. Clustering requires
a distance or similarity measure to quantify the distance or similarity between two
2NaN - Not a Number. An erroneous output.
3MATLAB 2014b
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Actual class
Positive Negative
Predicted class
Positive TP FN
Negative FP TN
Table 5.2: A contingency table or confusion matrix. The entries report the number of true positives (TP),
true negatives (TN), false positives (FP) and false negatives (FN).
objects. The distance between two time-series is taken as the euclidean distance
between the vectors formed from the time-series analysis methods acting on those
time-series (i.e., a pair of row vectors in the data matrix). The distance between two
time-series analysis methods is taken as the correlation as based on the mutual in-
formation between the vectors formed from applying the operation across all the
time-series (i.e., a pair of column vectors in the data matrix). This is because sim-
ilarity between two time-series analysis methods is determined by how correlated
they are on their outputs rather than the by the actual output values themselves. We
clustered time-series analysis methods (i.e., the columns) in addition to time series
(i.e., the rows) because this can provide insight into which physiological variables the
predictive features are representing.
Syncope prediction is achieved using classification algorithms (classifier for short),
that is, we try to classify time series into one of the two labels defined by the outcome
of the test: negative or positive. Thus, if we are able to make a successful classification
of the time-series as either positive or negative prior to the syncope event, we are in
fact predicting the event. As we wish to predict syncope before symptoms or visual
cues appear, we restrict the classification task to positive tests which required GTN.
This is because we can reliably obtain a five minute segment before the instant GTN
is administered to consistently analyse a period before syncope occurs.
Performance measures for classifiers are normally defined as some combination
of variables found in a contingency table or confusion matrix (see Table 5.2) which
tabulates the number of true positives (TP), true negatives (TN), false positives (FP)
and false negatives (FN).
The accuracy is the proportion of correct of predictions. However, this is an in-
appropriate measure here as it does not distinguish whether the algorithm produces
a large number of false positives or negatives. Accuracy is also more difficult to in-
terpret in the context of imbalanced classes (e.g., the data set contains more positive
samples than negative samples). Broadly speaking, in medical classification a low
number of false positives and false negatives is desirable. Therefore, sensitivity (Sn)
and specificity (Sp) are preferred performance measures and are defined by:
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Sn =
TP
TP + FN
, (5.1)
Sp =
TN
TN + FP
. (5.2)
The sensitivity is the proportion of positive samples that are correctly identified
and the specificity is the proportion of negative samples that are correctly identified.
Both measures are bounded between 0 and 1 where a good classifier would score
highly on both measures. A classifier which labels all samples as positive or negat-
ive would score 1 on one of these measures and 0 on the other. A classifier which
randomly allocated class labels as positive or negative with 50% probability would
score 0.5 on both measures on average; this is independent of whether the data set
has imbalanced classes.
Thus we report the full confusion matrix, sensitivity and specificity in measuring
the performance of our classifiers.
5.6 Results
We present the results of this exploratory analysis in three sections: (1) we show data
matrices ordered by hierarchical clustering to show any initial structure in the data,
(2) we use PCA to compress the data, (3) we show the performance of various classi-
fiers in predicting syncope. Each section contains data on both the early and late five
minute time segment.
5.6.1 Data matrices and clustering
There are four groups of data: early RR intervals, late RR intervals, early BP signals
and late BP signals. Within each group we have two labels determined by the outcome
of the test: positive and negative. The data matrices produced by the HCTSA tool
represent the output of applying time-series analysis methods (the columns of the data
matrix), scaled between 0 and 1, to a time series (the rows of the data matrix).
We present the data matrix for each group of data where we order the time-series
by test outcome (Fig. 5.3) and by clustering the time-series along the rows and oper-
ations along the columns using hierarchical clustering (Fig. 5.4) as discussed in Sec.
5.5.3. Clusters along the rows would be observed as bands of rows of similar colours,
the time series in these bands would be considered to be closely related. Similarly
clusters along the columns would be observed as bands of columns with similar col-
ours.
If there exists a marked difference between BP and RR interval time series between
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HUTT positive and negative patients that is measurable across a group of time-series
analysis methods in the library, then we would expect some clustering by arranging
the rows of the data matrix by HUTT outcome. However, Fig. 5.3 shows that this
is not the case. This does not imply that one or more features that are predictive
of HUTT outcome, that is, features that vary by HUTT outcome do not exist as this
would not be visually discernible from the data matrix. We apply other statistical and
machine learning methods to explore this possibility in Secs. 5.6.2 and 5.6.3.
After applying hierarchical clustering methods we observe that that some patient
groups appear different from others, see Fig. 5.4, however, we leave such an investig-
ation for future research and focus on syncope prediction in this chapter.
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Figure 5.3: The data matrix for each of the four time-series groups. Patients are groups into negative
(red bar along left side row) and positive (blue bar along left side of row). The output is the value of a
time-series analysis method after it has been renormalised. No distinct differences between positive and
negative groups can be seen visually.
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Figure 5.4: The data matrix for each of the four time-series groups. Patients and time-series features are
hierarchically clustered using average linkage clustering. This means that two time-series or operations
adjacent to each other in the data matrix are more closely related than time-series or operations further
away in the data matrix. The output is the value of a time-series analysis method after it has been
renormalised.
5.6.2 Principal component analysis
As the number of features is much larger than the number of time-series we require a
method for reducing the number of features to use for classification tasks. We apply
PCA to each time-series group. We also concatenate the data matrices of BP signals
and RR intervals so that each row of the concatenated data matrix represents one
patient and the columns represent the features of both BP and RR interval time-series.
We find that the first one to ten principal components contain the majority of the
variance of the data, see Fig. 5.5. This suggests that we could reduce the number of
features from thousands to the order of tens when constructing a classifier. As a first
step, selecting the principal components which contain the majority of the variance
of the data would be a sensible choice to build a classifier from. Intuitively, this is
because if the variation in the data is due to the differences in HUTT outcomes, then a
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boundary between two groups of data points in principal component space can easily
be calculated [194].
We show the distribution of the data projected on the first two principal compon-
ents in Fig. 5.6. If there were differences between the time series from different HUTT
outcomes in principal component space we would expect to see a degree of clustering
between points within a given HUTT outcome. The differences in the distribution of
points along the first and second principal components suggests that there are differ-
ences between time series taken from negative and positive HUTTs (e.g., Fig. 5.6 a, b,
d, e, f). Early RR intervals appeared to be the least distinctive.
5.6.3 Syncope prediction by classification
We use a weighted linear support vector machine (SVM) as the classification algorithm
implemented using the templateSVM and fitcecoc function from MATLAB’s Stat-
istics Toolbox. Linear SVMs are a commonly used classification algorithm whereby a
linear decision boundary (represented by a hyper-plane) is constructed between two
classes of data points such that the distance between the boundary and nearest data
points are maximised [194]. However, the linear decision boundary normally is cre-
ated by a so-called “soft margin” such that a certain tolerance of misclassified points
close to the boundary are allowed. Data points on one side of the boundary are clas-
sified as being of one type, whereas, data points on the other side are classified as
being of the other type. As there are more positive outcomes then there are negative
outcomes we weight the outcomes inversely proportional to their relative frequencies
when training the classifier. This is to prevent the classifier from being over-fitted to
positive outcomes [206]. Hence, we are using a weighted SVM.
We use k-fold stratified cross validation with 10 folds. This is where we split the
data into 10 sub-sets as evenly as possible where the proportion of positive and neg-
ative samples is the same in each sub-set as the total dataset. Nine subsets are used
to train the classifier and we test the performance on the remaining subset. We do
this for all 10 subsets to generate 10 confusion matrices and therefore 10 sensitivity
and specificity values. We report the mean and standard error of the performance
measures over the 10 subsets.
The classification results using the first 10 principal components are shown in
Table. 5.3. BP signals taken five minutes prior to GTN administration appeared to
give the highest sensitivity (0.62 ± 0.05) and specificity (0.65 ± 0.06). We see that the
results are similar to those reported in the literature without having performed ad-
ditional fine tuning (e.g., regularisation, SVM kernels to create non-linear decision
boundaries). The early time-series group did not provide joint sensitivities and spe-
cificities significantly above 0.5. Hence, for these results any predictive capability of
syncope appears to be restricted to much later in the HUTT.
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Figure 5.5: The amount of variance along each principal component for each time-series group. The
inset figures show the cumulative variance by adding successive principal components. The first one to
ten components contain a large amount of variance of the data relative to the remaining components.
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Figure 5.6: The time-series features projected along the first two principal components for each time-
series group. Negative and positive test outcomes are labelled as red and blue respectively. A sample of
time-series are shown in a-d. The distribution of the two principal components for negative and positive
outcomes are shown on the top and right of each figure.
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Time-series group TP FP TN FN Sn Sp
RR Early 9.6± 0.7 4.5± 0.05 0.8± 0.06 4.8± 0.5 0.55± 0.04 0.52± 0.06
BP Early 1.2± 0.9 5.3± 0.05 8.6± 0.09 5.5± 0.5 0.57± 0.04 0.51± 0.04
BP and RR Early 1.1± 0.7 5.3± 0.03 7.5± 0.06 4.4± 0.3 0.60± 0.03 0.45± 0.03
RR Late 6.5± 0.5 3.2± 0.06 7.9± 0.04 5.3± 0.7 0.45± 0.03 0.62± 0.07
BP Late 9.0± 0.7 3.0± 0.05 5.5± 0.07 5.6± 0.5 0.62± 0.05 0.65± 0.06
BP and RR Late 6.5± 0.6 2.2± 0.05 6.2± 0.06 5.0± 0.5 0.51± 0.05 0.70± 0.06
Table 5.3: The mean and standard error of the performance of the weighted SVM classifier using the first
10 principal components. TP, FP, TN and FN are in terms of patients. Sn - sensitivity, Sp - specificity.
Nonetheless, these results forms the basis of future work to achieve greater pre-
dictive power using the aforementioned “fine tuning” methods and different dura-
tion segments of the time-series. For example, longer segments may prove to be more
predictive. We also note, that by selecting the time segment five minutes prior to
GTN administration we deliberately avoid segments of the time-series which clearly
indicate a positive result visually. Other studies do not do this and include those
time-segments and consequently achieve much higher specificity and sensitivity as a
result, but are of limited practical use [198, 199].
Greedy forward feature selection, whereby a subset of informative features are
created by iteratively adding individual features with the best accuracy on a train-
ing dataset to a growing subset of features [194], provided no improvement on these
results (not shown).
5.7 Discussion
The head-up tilt test is a diagnostic test for vasovagal syncope which can take up to an
hour and attempts to reproduce syncope symptoms in patients, hence it also stressful
for the patient. Predicting the outcome of the test prior to the onset of a patient’s
symptoms would reduce the time of the test and stress for the patient. In this chapter
we present an exploratory analysis where we apply a novel time-series analysis tool
to a large, privately acquired head-up tilt test time-series dataset.
We segment blood pressure and RR interval signals into two 5 minute segments:
the first five minutes whilst the patient is supine and another five minute segment is
taken 20 minute later prior to the administration of a nitroglycerin. We extract over
6000 time-series features for each of the four groups: BP early, BP late, RR early, RR
late. The library of features contains a range of methods from the scientific literature
on time-series analysis [165]. This provides a data matrix for each time-series group
where we are able to apply standard methods in machine learning: clustering, prin-
cipal component analysis and classification.
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Clustering patients by their time-series features showed that additional structure
exists within the data independent of the test outcome. However, as this is not imme-
diately relevant to syncope prediction this is left for a future investigation. We used
principal component analysis to reduce the large number of time-series features to
ten principal components which contained the majority of the variability within the
data. We then used the 10 principal components in training a weighted support vector
machine classifier. We found that the specificity and sensitivity was greatest for the
late BP signal and overall the results were comparable to previous studies without
having explicitly selected and fine-tuned methods to the domain problem. We also
did not perform more advanced fine tuning by trying to select from a set of classifi-
ers or using more sophisticated methods (e.g., boosting, bagging, regularisation, SVM
kernel methods). Thus, achieving results comparable with the literature, using time-
segments much earlier from the syncope event unlike the best performing studies,
suggest that these are promising results to develop further.
Future work would involve incorporating further patient meta-data to under-
stand the structure shown by clustering. Feature selection algorithms could be used
to identify which particular time-series properties are predictive of syncope. Clas-
sification results could be improved by: (1) testing against and comparing multiple
classifiers, (2) using other machine learning techniques such as regularisation, kernel
methods, bagging or boosting [194], (3) use a different length of time segment, and (4)
incorporate more specific time-series features tailored for VVS from other studies.
5.8 Summary
In this chapter we have used highly comparative time-series analysis tool to predict
syncope in head-up tilt tests. We achieved similar results to those made by others in
the literature without using domain specific features. Specifically we have:
• Processed a privately unpublished dataset for use with the HCTSA tool.
• Split the time-series into groups for syncope prediction by classification by seg-
menting five minute intervals from the start and later in the test.
• Extracted over 6000 features from each time-series group using the time-series
analysis engine.
• Used hierarchical clustering to identify clusters of patients.
• Used principal component analysis to reduce the number of features from thou-
sands to ten.
• Used a weighted support vector machine on each time-series group. We could
achieve a joint sensitivity of 0.62 and a specificity of 0.65.
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Chapter 6
Summary and Future Work
And now we are free... I will see you again... but not
yet... not yet!
— JUBA
In this chapter we provide an overview of the thesis, summarise the key findings
and outline future work. We first discuss the major theme of this thesis regarding
the modelling of atrial fibrillation and then summarise the shorter study on syncope
prediction.
6.1 Cardiac Structure and Wavefront Dynamics in
Atrial Fibrillation
Atrial fibrillation is the most common abnormal heart rhythm affecting 35 million
people worldwide and is predicted to double in incidence within the next two to
three decades [30, 32]. AF is a poorly understood arrhythmia where multiple excita-
tion wavefronts are observed to propagate continuously in atrial muscle tissue in an
apparently disorganised manner. The excitation wavefronts meander, divide and col-
lide with mutual extinction and re-initiation. This manifests in patients as episodes
of variable duration, from short self-terminating episodes (paroxysmal AF), which
typically, but not always [86], get longer with time to become self-sustaining (per-
sistent AF) [169]. During AF the atria mechanically quiver and do not contract in
coordination. This causes inefficient transport of blood around the body. The lack of
coordinated contraction also results in pooling of blood in the atria, which increases
the risk stroke [33].
Ablating atrial tissue extensively and empirically via catheter electrodes may cure
AF in some cases [39, 72], but an inability to identify the specific regions critical to
the persistence of AF has resulted in failure to improve on disappointing clinical out-
comes. For example, the clinical success rate after one ablation procedure is 30% for
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persistent AF and 60% for paroxysmal AF [62]. Thus, enhancing mechanistic under-
standing and the identification of critical causative regions is required to improve
ablation therapy.
Another clinical conundrum is related to patient variability in AF and AF progres-
sion. It is commonly thought that AF-induced remodelling and age-related increases
in fibrosis supports the notion that AF inexorably becomes worse [11]; paroxysmal AF
will always progress to persistent AF and that fibrosis is an important factor in driv-
ing this progression. However, a recent body of clinical observations now questions
how large this effect is in humans [38, 86, 37].
In Chapter 1, we argued that this could be explained by understanding how the
myocardial micro-structure affects AF. We argued that the relationship between the
micro-structure of heart muscle tissue and the dynamics of excitation wavefronts
may provide a key mechanism for the initiation and maintenance of AF. Thus in
subsequent chapters, we explored the relationship between the micro-structure of
heart muscle tissue and wavefront dynamics using a simple mathematical model.
We showed how understanding this relationship could address the two clinical chal-
lenges outlined above.
6.1.1 Chapter 2: Cellular automaton model of AF
In Chapter 2, we introduced a new cellular automaton model of heart muscle tissue
where the structure of a lattice of cells mimics the anisotropic branching structure
of myocardium. We used the model to explore the relationship between the micro-
structure of myocardium and the dynamics of action potential wavefronts.
We represent the myocardium by a rectangular lattice of cells. Each cell is connec-
ted to its longitudinal (horizontal) neighbour and to its transversal (vertical) neigh-
bour with probability 0 ≤ ν ≤ 1. For ν < 1, this creates a lattice which mimics
an anisotropic branching network of interacting cells. Structurally, the substrate can
be pictured as a set of aligned cables of single cell thickness which are coupled to
neighbouring cables with frequency ν. We used the simplest model of cell kinetics
to mimic the action potential so that a cell may be in one of three states: resting (re-
polarised), excited (depolarising), or refractory. An excited cell causes neighbouring
coupled resting cells to become excited. Thus the wavefront is a coherent propagation
of this excitation through the simulated tissue. We randomly select cells in the lattice
to be assigned as “dysfunctional” such that the overall fraction of dysfunctional cell is
δ = 0.05. These particular cells have a finite probability, , of not exciting in response
to an excited neighbour. Thus two parameters characterised the structure of the lat-
tice: the fraction of transversal connections ν and the fraction of dysfunctional cells δ,
which we fixed for most of this study.
We characterised the macroscopic behaviour of the model as a function of struc-
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tural heterogeneity, specifically the fraction of transversal connections. We observed
that as we reduced the fraction of transversal connections below a threshold, the spon-
taneous initiation and maintenance of re-entrant circuits occurred, see Fig. 2.5. We
found that specific configurations of transversal connections and dysfunctional cells,
which we call critical structures, were responsible for initiating re-entrant circuits. We
showed that the probability of the occurrence of the simplest critical structure on a
lattice was a good predictor of AF risk. Thus, the simple model reproduced many
clinical observations, namely: the increased risk of AF with increasing structural het-
erogeneity and dysfunctional cells, occurrence of AF events of variable frequency and
duration, ability to terminate AF through ablation, absence of AF in infants and pa-
tient variability.
The most interesting aspects of the study were: (1) the mere simplicity of the
model; (2) the integration of simplified dynamics on a relevant discrete medium mim-
icking the anisotropic branching architecture of heart muscle; (3) a single model that
reproduces multiple well known observed features of AF; (4) the spontaneous emer-
gence of AF (without external stimuli) when the transversal coupling is reduced,
mimicking fibrosis, beyond a threshold value; (5) identification of local critical regions
initiating and maintaining AF; (6) analytical tractable risk of AF; (7) the existence of
an analytically tractable threshold value of heterogeneity below which AF emerges,
providing insight into how to control the risk; and (8) a targeted ablation procedure
is possible.
The model identifies specific targets for ablation based on the underlying struc-
ture of the myocardium. Patterned cultures of cardiac myocyte monolayers or cardiac
tissue slices could test the primary predictions of the model. If the biological experi-
ments agree with the model predictions, then such targets within a biological system
might be characterised electrophysiologically or architecturally. Thus insight from
the model could be translated to clinical applications thereby, hopefully, improving
the success rate of treating AF with ablation.
6.1.2 Chapter 3: Microscopic mechanisms and model dynamics
In Chapter 3 we investigated the microscopic mechanisms which governed the mac-
roscopic behaviours we observed in Chapter 2. Understanding the microscopic mech-
anisms which drive AF behaviour was required to: (1) explain why two lattices with
the same tissue parameters (ν, δ and ) could produce very different AF behaviour; (2)
characterise critical regions structurally to propose ablation targets; and (3) propose
and study a mean-field model.
Through manual observation of AF simulations, we found that perpetual creation
and annihilation of re-entrant circuits drove AF in the model. We found that critical
structures could initiate re-entrant circuits of excitation which circulate the structure.
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We categorised critical structures by how they initiated re-entrant circuits, we did
this by observing simulations during the initiation of re-entrant circuits. We then
modified the risk of AF to take into account more complex critical structures which
were neglected in the calculations shown in Chapter 1; the end result of this was
a very small increase in the critical fraction of transversal connections at which AF
behaviour suddenly increases.
We developed a re-entrant circuit tracking algorithm to extract the local structure
around regions which contained re-entrant circuits. We did this for a large number
of simulations and assigned each region a category defined by the types of critical
structures which were inspired from manually observing simulations. We found that
regions which contained re-entrant circuits had a lower fraction of transversal connec-
tions and higher fraction of dysfunctional cells than would be expected. This seems
intuitive as regions of less coupled tissue is known to promote re-entry and provides
a basis for proposing these sites as ablation targets. However, we were unable to
categorise many of these regions into the predefined classes of critical structures we
observed. Indeed, we found that the majority of these uncategorised regions could
not initiate AF, ruling them out as triggers of AF in the model. Thus, we found that
an alternative mechanism of re-entrant circuit initiation was important in the model:
wavefront-wavetail collisions. We showed the wavefront-wavetail collisions were an
important mechanism by developing a mean-field model which neglects wavefront-
wavetail collisions.
We developed a mean-field model by modelling a stochastic process inspired by
the cellular automaton model: a lattice is just a discrete number of regions which
either contain re-entrant circuits or do not. A region containing a re-entrant circuit
can trigger a re-entrant circuit around any of the other regions which do not con-
tain a re-entrant circuit. From this idea, we modelled the process as a Markov chain
and computed the transition matrix – describing how the number of re-entrant cir-
cuit containing regions change in time. From the mean-field model we computed the
AF burden and other temporal AF statistics. The mean-field model reproduced the
qualitative behaviour of the model, such as a sudden increase in the AF burden as
the fraction of transversal connections is reduced, however, it did not reproduce the
temporal AF statistics from the cellular automaton model. This again, highlights the
importance of wavefront-wavetail collisions, however, shows they are not a necessary
condition for the models main behaviours.
Thus this chapter showed that AF in the model was driven by critical structures,
which are structurally determined, and wavefront-wavetail collisions which is not
purely determined by structure. This work implies that the triggers of AF are struc-
turally determined and could be ablated to prevent recurrence of fibrillation.
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6.1.3 Chapter 4: Patient variability in AF and AF progression
In Chapter 4 we used the cellular automaton model to address a broad range of ap-
parently disconnected clinical challenges regarding patient variability. Traditionally,
it has been thought that: (1) AF inevitably progresses from paroxysmal to persist-
ent AF [11], and (2) that this is a result of AF-induced remodelling and age-related
increase in fibrosis [11]. However, recent clinical observations have challenged both
of these statements. Continuous monitoring studies using dual chamber pacemakers
have shown that AF burden varies widely in time and that persistent AF patients can
even remit to paroxysmal AF [86, 38]. Also, whilst average fibrosis burden is correl-
ated to severity of AF [37], there is significant variability within those averages, so
that patients with a high fibrosis burden can remain paroxysmal and those with low
fibrosis burden can be in persistent AF [37, 87, 88, 89]. Tangential to this, recent obser-
vations have shown that a small number of mitochondrially dysfunctional cells can
cause arrhythmia in mice [174] and this number is similar to that found in aged hu-
man myocardium [183]. How a small number of dysfunctional cells could cause an
arrhythmia is not understood.
We modified the original cellular automaton model by progressively removing
transversal connections one at a time, to mimic the age-related progressive uncoup-
ling (e.g., fibrosis and gap-junctional lateralisation). We found that the simulated pa-
tients also displayed inter-patient and intra-patient variation in AF progression. Some
simulated patients would progress to persistent AF in time, others would remit and
relapse between paroxysmal and persistent AF, whilst some would start and remain
in persistent AF, and others would remain paroxysmal throughout. We quantified
this variation through measuring AF burden, onset time, event frequency, and event
duration.
We considered another modified cellular automaton model to better mimic the be-
haviour of dysfunctional cells. In this version of the model dysfunctional cells could
spontaneously depolarise, for example as a result of abnormal calcium handling, but
not propagate this excitation due to source-sink mismatch. We kept the fraction of
transversal connections fixed. We found the behaviour of the original cellular auto-
maton model was preserved, that is, dysfunctional cells in combination with regions
with a reduced fraction of transversal connections drove AF through re-entrant cir-
cuits.
Thus we showed that a single pathological mechanism, namely the interaction
between uncoupling and dysfunctional cells, can result in patterns of AF observed
clinically. Specific architectural patterns of uncoupling rather than the global uncoup-
ling (e.g., total fibrosis burden) were observed to drive AF.
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6.2 Vasovagal Syncope and Head-up Tilt Tests
Syncope is the transient loss of conciousness, also described as “fainting”, which oc-
curs due to impaired blood flow to the brain. Vasovagal syncope (VVS) is a reflex
syncope which is mediated by emotion or orthostatic, standing upright, stress. VVS
is one of the most common causes of syncope and is a benign condition which is char-
acterised by a self-limiting episode of systemic low blood pressure and sometimes
heart rate [147, 148]. VVS is a frequent cause of hospital admissions and has an eco-
nomical cost due to patient handicaps resulting from several fainting episodes [149].
Thus the detection and early diagnosis of vasovagal syncope is of importance.
Head-up tilt testing (HUTT) is a medical procedure used to diagnose VVS. During
the HUTT a patient is strapped to a table which tilts to a near upright angle, the patient
is held in this position for up to an hour to try to reproduce syncope symptoms, this
forms the basis of the diagnosis. If syncope symptoms are reproduced, the HUTT is
positive, otherwise, the HUTT is negative. However, the HUTT can take up to an hour
and is stressful for the patient as it attempts to reproduce their syncope symptoms.
Early prediction of the HUTT outcome would reduce the time of the test and stress
for the patient. Reducing the time of the test would also increase efficiency and reduce
costs for healthcare providers.
During HUTT the ECG, heart rate (HR, extracted from the ECG) and blood pres-
sure are recorded. During VVS there is a marked sudden fall in blood pressure and
with an associated fall in heart rate often resulting in syncope. Generally, there are
no visually discernible features of the heart rate or blood pressure signal early on to
allow a diagnosis to be made early in the test. Thus automated syncope prediction
based on time-series analysis is required and has the potential to reduce the time of
the test and stress on the patient.
In Chapter 5, we performed an exploratory study using a novel library of time-
series analysis methods to extract a large number of features from heart rate and blood
pressure signals from a set of 309 HUTTs, and then used machine learning methods
to predict syncope.
6.2.1 Chapter 5: Syncope prediction
In Chapter 5 we pre-processed blood pressure and ECG signals of 371 HUTTs, 238
positive tests and 133 negative tests. We extract an early 5 minute time segment of the
ECG and BP before the initial tilt (interval between t = 0 minutes to t = 5 minutes from
start of test) and a late 5 minute segment prior to the administration of nitroglycerin
(interval between t = 20 minutes to t = 25 minutes from start of test). We process the
ECG signals into RR intervals which are inversely proportional to heart rate. We thus
have two outcome categories of time-series: those taken from negative or positive
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tests. We aimed to predict the outcome of the test by predicting the category of the
time-series, negative and positive.
We used a highly comparative time-series analysis (HCTSA) tool which consists
of a library of time-series analysis methods and data visualisation tools. The HCTSA
tool takes a single time series as an input. The tool consists of a diverse library of
7894 time-series analysis methods. The tool computes the output of each of the 7894
time-series analysis methods, a time-series feature, on a single input time series. Each
feature is a single real-valued number scaled to be between 0 and 1. Thus, on inserting
a group of time-series, the engine produces a data matrix where each row represents a
given time-series, each column represents a particular time-series analysis method, an
entry in the matrix is the output of applying a particular time-series analysis method
to a particular time-series. We obtained four data matrices for each group of time-
series: Early RR intervals, Late RR intervals, Early BP signal and Late BP signal. Each
time-series has a positive or negative label, and therefore can be analysed using stand-
ard machine learning methods.
We used principal component analysis to reduce the large number of time-series
features to ten principal components which contained the majority of the variability
within the data. We then used the 10 principal components in training a weighted
support vector machine classifier. We found that the specificity and sensitivity was
greatest for the late BP signal and overall the results were comparable to previous
studies without having explicitly selected and fine-tuned methods to the domain
problem (VVS). This study differed from previous studies by using a combination
of: a larger sample size, a much larger set of features across a wide variety of time-
series analysis methods, and focussing on time-series segments earlier than the onset
of syncope symptoms.
6.3 Future Work
In this section we summarise the potential future work that could follow from each
chapter of this thesis.
6.3.1 Chapter 2: Cellular automaton model of AF
This study might be followed by integrating more physiological complexity into model
and to confirm whether the main behaviours of the model are preserved. In the
present study, we aimed to study the behaviour of an ensemble of simulations. As a
result the lattice sizes were small and the model was deliberately simple. The model
could be optimised, perhaps for use with high performance or highly parallelised
computing, so that the effects of a larger lattice sizes, three-dimensional tissue and
additional physiology, can be studied. To summarise potential future work:
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• Integrate more physiology: 3-D tissue, relative refractory period, restitution, etc.
• Change lattice topology to mimic the brick-wall pattern of myocardium.
• Optimise model to study larger system sizes and complex versions of the model.
6.3.2 Chapter 3: Microscopic mechanisms and model dynamics
A natural extension of this work would be to further investigate the role of wavefront-
wavetail collisions in the model. For example, it is not clear how the structure of the
tissue, if at all, modulates the factors surrounding the occurrence of collisions and the
probability that collisions result in re-entrant circuits. In addition, if extra physiology
were added to the model, the methods defined in this chapter could be used to in-
vestigate whether the mechanisms which drive AF and their relative importance in
the model stay the same. Another investigation would be to add more detail to the
mean-field model. For example, the mean-field model currently assumes that all re-
gions are identical and contain only one dysfunctional cell, this assumption could be
relaxed. To summarise potential future work:
• Investigate structural factors of how wavefront-wavetail collisions result in re-
entrant circuits.
• Observe whether the mechanisms in the model are preserved when additional
physiology is included.
• Compute a more accurate mean-field model and compare to the cellular auto-
maton model.
6.3.3 Chapter 4: Patient variability in AF and AF progression
Sugihara et al. [86] categorised AF patients by how AF burden changed in time, they
quantified the number of patients in each category. Thus, a natural extension would
be to perform a larger number of simulations, categorise them, and observe whether
they are distributed similarly to what is seen clinically.
If the model were made more complex, the progressive uncoupling experiment
should be re-run to see if the behaviour of the original model is preserved.
This work could be extended by also progressively increasing the dysfunctional
cells in time, as well as fibrosis, to mimic the experiment performed by Baris et al.
[174] on enhanced mitochondrial dysfunction in ageing mice. Another experiment
to elucidate how mitochondrially dysfunctional cells cause AF would be to modify
dysfunctional cells in the model to have after-depolarisations. This is because after-
depolarisations are also thought to occur during abnormal calcium handling in mito-
chondrially dysfunctional cells.
6.3. FUTURE WORK 165
To summarise potential future work:
• Run a larger number of simulations and observe the frequency of different AF
categories. Compare this to clinical observations.
• Check that the AF progression behaviour is preserved if the model included
additional physiology.
• Investigate after-depolarisations as a mechanism for dysfunctional cells in the
model.
6.3.4 Chapter 5: Syncope prediction
As this was an exploratory analysis there is much room for future study. Further work
would include:
• Incorporating further patient meta-data to understand the structure shown by
clustering.
• Use feature selection algorithms, such as greedy forward feature selection, to
identify which particular time-series properties are predictive of syncope.
• Testing against and comparing multiple classifiers.
• Using other machine learning techniques such as regularisation, kernel meth-
ods, bagging or boosting [194].
• Incorporate more specific time-series features tailored for VVS from other stud-
ies.
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6.4 Concluding Remarks
In this thesis we set out to use mathematical modelling to address a varied set of ma-
jor clinical challenges in atrial fibrillation. These included the inability to: identify
regions of myocardium for ablation; predict AF, AF progression and its significant
variability in the population; and the inability to understand how small changes in
myocardium, such as the addition of a few mitochondrially dysfunctional cells, could
result in arrhythmia affecting the whole organ. We proposed that a common thread
runs through these challenges: the poorly understood relationship between the mi-
crostructure of myocardium and the dynamics of cardiac excitation waves.
We studied the relationship between structure and dynamics using a complex sys-
tems approach. Under this approach, we model the most relevant constituent com-
ponents of a system and the interactions between them in a deliberately simplified
but faithful manner. We did this by using a cellular automaton model which integ-
rated phenomenological cardiac dynamics with a pertinent structure to mimic the
anisotropic, branching, cable-like structure of myocardium. A small fraction of cells
in the model are “dysfunctional”, they stochastically interrupt cell-to-cell propagation
of excitation.
The simple model was able to reproduce many clinically observed features of AF.
These included the spontaneous onset and self-termination of AF episodes of vari-
able duration, and the observation that ablation could sometimes terminate AF. We
showed that AF in the model was driven by bouts of perpetual birth and death of
micro-re-entrant circuits. This process is determined by the presence of particular
local configurations of connectivity and dysfunctional cells, which we called critical
regions, and the collisions between wavefronts and wavetails. We showed that as the
transversal connectivity was reduced below a threshold value, mimicking the effects
of fibrosis and gap junctional uncoupling, the creation of critical regions resulted in
the sudden onset of AF behaviour in the model. These critical regions, which initiate
AF, can be removed if ablation of the observed micro-re-entrant circuit occurs close to
the time of AF initiation.
We showed that the simple model was able to reproduce clinical observations of
variability in AF progression. We achieved this by gradually removing transversal
connections during a simulation, mimicking myocardial changes as humans age. This
demonstrated that micro-structural details could generate the clinically observed tem-
poral variability in AF progression. Specifically, the number of critical regions is a
more important factor than total fibrosis burden in determining the severity of AF
and AF progression. Critical regions could be identified as ablation targets for the
treatment of AF when access to in-vivo human myocardial microstructure becomes
possible.
6.4. CONCLUDING REMARKS 167
The observation that arrhythmia can be caused by a small number of myocytes
with dysfunctional mitochondria, which occur as a result of mtDNA mutations that
accumulate with age, is currently unexplained. We propose that the dysfunctional
cells in the model can mimic the behaviour of mitochondrially dysfunctional myoc-
tyes. Thus, the model generates a hypothesis to explain this clinical observation:
mitochondrially dysfunctional myocytes come together with micro-fibrosis to create
critical regions. These regions trigger micro-re-entrant circuits through the stochastic
interruption of depolarisation, as might occur by spontaneous or after depolarisations
caused by abnormal calcium handling.
To conclude, we have studied a simple model of cardiac excitation which has been
able to reproduce clinically observed behaviours of AF. The simplicity of the model al-
lowed us to study the mechanisms causing these behaviours, thereby generating new
testable hypotheses regarding AF. Cellular automaton models are among the simplest
type of models used in the study of complex systems. Whilst the use of increasingly
complex models of cardiac dynamics have become popular, this study demonstrates
the utility of simple models and that they still have a place in contemporary research
in cardiac electrophysiology. It is remarkable that such simple models are able to
capture the complexity and diversity of phenomena we see in nature, including the
human heart.
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Appendix A
Cellular Automaton Model of Atrial
Fibrillation
A.1 Full System Size Figures
The figures shown in the manuscript were enlarged subsections of the full system
size. For completeness we include the images for the full system size.
Figure A.1: The initiation and termination of a re-entrant circuit. This is the full 200× 200 system of the
sub-section show in Fig. 2.4 of Chapter 2.
191
192 A. A CELLULAR AUTOMATON MODEL OF AF
Figure A.2: Complexity of wave behaviour at different fractions of vertical connections. This is the full
200× 200 system of the sub-section show in Fig. 2.5 of Chapter 2.
Figure A.3: A region of tissue is made unexcitable simulating ablation. This is the full 200× 200 system
of the sub-section show in Fig. 2.10 of Chapter 2.
Appendix B
Microscopic Mechanisms and the
Dynamics of the Model
B.1 Summary Data
Simulations of duration 107 time steps with parameters L = 200, τ = 50,  = 0.05,
and δ = 0.05. There were 160 simulations in total, 32 for each ν, for the range of
ν = 0.135, 0.14, 0.15, 0.16, 0.20.
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Appendix C
Patient Variability in AF and AF
Progression
C.1 Patient variability and fibrosis
We present the results of all 32 simulated “patients”. We start at ν = 0.25 where all the
simulated heart muscle tissue are in sinus rhythm (SR) but as we lower ν, fibrillation
emerges. The initial conditions for each “patient” are created by assigning the same
number of vertical connections (identical initial ν) but at different random positions.
Next the accumulation of cellular uncoupling is implemented by reducing ν (e.g., to
mimic the progression of fibrosis or gap junctional uncoupling). To do this, we run
simulations for a period of T = 4.3 × 107 time steps in the computer model and ver-
tical connections are removed at a rate of one connection every nine thousand time
steps. We observe the dynamics of excitation wavefronts as the transversal uncoup-
ling accumulates in the tissue. All other model parameters are set to physiological
values as described in Sec. 2.3: L = 200, τ = 50,  = 0.05, and δ = 0.05. Pacemaker
cells self-activate with a period of T = 220.
The AF burden and number of critical regions versus fraction of vertical connec-
tions is shown in supplementary Fig. C.1 to C.4. We show the average AF burden as
a function of the number of critical regions for each simulation in supplementary Fig.
C.5.
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Figure C.1: AF burden (blue) varies with time, calculated from the time in AF in a sliding window of
5 × 106 time steps for simulations 1 to 8. Also shown is the accumulation of initiating critical regions
(black curve) versus the fraction of vertical connections
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Figure C.2: AF burden (blue) varies with time, calculated from the time in AF in a sliding window of
5 × 106 time steps for simulations 9 to 16. Also shown is the accumulation of initiating critical regions
(black curve) versus the fraction of vertical connections
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Figure C.3: AF burden (blue) varies with time, calculated from the time in AF in a sliding window of
5× 106 time steps for simulations 17 to 24. Also shown is the accumulation of initiating critical regions
(black curve) versus the fraction of vertical connections
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Figure C.4: AF burden (blue) varies with time, calculated from the time in AF in a sliding window of
5× 106 time steps for simulations 25 to 32. Also shown is the accumulation of initiating critical regions
(black curve) versus the fraction of vertical connections
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Figure C.5: The average AF burden for all 32 simulations as a function of the number of critical regions.
The standard deviations and standard error are too small to be seen at this scale. The differences in
the accumulation of critical regions between patients better predicts the variability in the AF behaviour
observed.
C.2 Mitochondrial dysfunction and Arrhythmia
We show the number of excited cells as a function of time for a random sample of
16 of the 48 simulations for ν = 0.1, 0.175, 0.25 and δ = 0.05 in Fig. C.6 - C.8. We
use an alternative implementation of dysfunctional cells to mimic mitochondrially
dysfunctional myocytes and keep the fraction of vertical connections constant during
a simulation. We see the results are similar to the original model discussed in Chapter
2-3. The model parameters are L = 200, τ = 50,  = 2× 10−3, T = 220, δ = 0.05. The
simulation time was 106 time steps.
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Figure C.6: The number of excited cells with time for 16 randomly chosen simulations of the 48 ran for
ν = 0.1.
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Figure C.7: The number of excited cells with time for 16 randomly chosen simulations of the 48 ran for
ν = 0.175.
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Figure C.8: The number of excited cells with time for 16 randomly chosen simulations of the 48 ran for
ν = 0.25.
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